:START_ID,:END_ID,:TYPE,indication,doseAmount,doseUnit,drugSequence,route
0,7161,IS_SECONDARY_SUSPECT,Glioblastoma,400,MG,2,Oral
5,7178,IS_SECONDARY_SUSPECT,Pain in extremity,75,MG,2,Oral
6,7186,IS_SECONDARY_SUSPECT,Lipidosis,1600,IU,2,Intravenous drip
8,7188,IS_SECONDARY_SUSPECT,Plasma cell myeloma,2.3,MG,2,Subcutaneous
9,7189,IS_SECONDARY_SUSPECT,Plasma cell myeloma,59,MG,2,Intravenous drip
9,7177,IS_SECONDARY_SUSPECT,Plasma cell myeloma,10,MG,3,Oral
14,7163,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG,2,Oral
15,7177,IS_SECONDARY_SUSPECT,Plasma cell myeloma,10,MG,2,Oral
16,7190,IS_SECONDARY_SUSPECT,Plasma cell myeloma,1.3,MG/M**2,2,Subcutaneous
16,7177,IS_SECONDARY_SUSPECT,Plasma cell myeloma,40,MG,3,Oral
17,7191,IS_SECONDARY_SUSPECT,Unknown,4.5,G,3,Oral
19,7177,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG,2,Oral
20,7163,IS_SECONDARY_SUSPECT,Plasma cell myeloma,8,MG,2,Oral
22,7163,IS_SECONDARY_SUSPECT,Plasma cell myeloma,40,MG,2,Oral
22,7188,IS_SECONDARY_SUSPECT,Plasma cell myeloma,1.3,MG/M**2,3,Intravenous drip
23,7199,IS_SECONDARY_SUSPECT,Plasma cell myeloma,40,MG,2,Oral
24,7190,IS_SECONDARY_SUSPECT,Plasma cell myeloma,2.9,MG,2,Subcutaneous
25,7176,IS_SECONDARY_SUSPECT,Unknown,25,MG,2,Oral
25,7177,IS_SECONDARY_SUSPECT,Plasma cell myeloma,40,MG,3,Oral
27,7163,IS_SECONDARY_SUSPECT,Plasma cell myeloma,8,MG,2,Oral
29,7177,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG,2,Oral
30,7190,IS_SECONDARY_SUSPECT,Plasma cell myeloma,1.3,MG/M**2,2,Intravenous drip
30,7177,IS_SECONDARY_SUSPECT,Plasma cell myeloma,40,MG,3,Oral
34,7178,IS_SECONDARY_SUSPECT,Neuralgia,75,MG,2,Oral
35,7163,IS_SECONDARY_SUSPECT,Plasma cell myeloma,40,MG,2,Oral
36,7189,IS_SECONDARY_SUSPECT,Plasma cell myeloma,68,MG,2,Intravenous drip
36,7163,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG,3,Oral
37,7222,IS_SECONDARY_SUSPECT,Plasma cell myeloma,900,MG,2,Intravenous drip
37,7177,IS_SECONDARY_SUSPECT,Plasma cell myeloma,28,MG,3,Oral
38,7179,IS_SECONDARY_SUSPECT,Unknown,1.19,MG/KG,2,Intravenous drip
39,7224,IS_SECONDARY_SUSPECT,Unknown,90,MG,2,Subcutaneous
41,7191,IS_SECONDARY_SUSPECT,Cataplexy,1.5,G,2,Oral
42,7191,IS_SECONDARY_SUSPECT,Somnolence,1.25,G,2,Oral
43,7191,IS_SECONDARY_SUSPECT,Unknown,3,G,2,Oral
47,7176,IS_SECONDARY_SUSPECT,Unknown,25,MG,2,Oral
48,7235,IS_SECONDARY_SUSPECT,Unknown,1.25,MG,2,Unknown
49,7176,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Oral
50,7191,IS_SECONDARY_SUSPECT,Narcolepsy,4.5,G,3,Oral
51,7176,IS_SECONDARY_SUSPECT,Unknown,5,MG,2,Oral
51,7163,IS_SECONDARY_SUSPECT,Plasma cell myeloma,40,MG,4,Oral
51,7237,IS_SECONDARY_SUSPECT,Plasma cell myeloma,1650,MG,6,Intravenous drip
51,7190,IS_SECONDARY_SUSPECT,Plasma cell myeloma,2,MG,7,Subcutaneous
52,7244,IS_SECONDARY_SUSPECT,Hodgkin's disease,25,MG/M**2,2,Intravenous (not otherwise specified)
52,7245,IS_SECONDARY_SUSPECT,Hodgkin's disease,1.4,MG/M**2,3,Intravenous (not otherwise specified)
52,7246,IS_SECONDARY_SUSPECT,Hodgkin's disease,125,MG/M**2,4,Intravenous (not otherwise specified)
52,7171,IS_SECONDARY_SUSPECT,Hodgkin's disease,20,MG/M**2,5,Oral
52,7237,IS_SECONDARY_SUSPECT,Hodgkin's disease,600,MG/M**2,6,Intravenous (not otherwise specified)
54,7249,IS_SECONDARY_SUSPECT,Multiple sclerosis,240,MG,3,Oral
56,7178,IS_SECONDARY_SUSPECT,Neuropathy peripheral,300,MG,2,Oral
57,7176,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Oral
58,7254,IS_SECONDARY_SUSPECT,Unknown,3.8,MG,5,Subcutaneous
60,7254,IS_SECONDARY_SUSPECT,Short-bowel syndrome,0.5,MG/KG,2,Subcutaneous
61,7163,IS_SECONDARY_SUSPECT,Plasma cell myeloma,40,MG,2,Intravenous drip
61,7189,IS_SECONDARY_SUSPECT,Plasma cell myeloma,60,MG,3,Intravenous drip
62,7178,IS_SECONDARY_SUSPECT,Neuropathy peripheral,200,MG,2,Oral
62,7277,IS_SECONDARY_SUSPECT,Unknown,10,MG,4,Unknown
64,7280,IS_SECONDARY_SUSPECT,Unknown,75,MG,2,Unknown
66,7177,IS_SECONDARY_SUSPECT,Plasma cell myeloma,8,MG,2,Intravenous drip
68,7190,IS_SECONDARY_SUSPECT,Plasma cell myeloma,1.3,MG/M**2,2,Subcutaneous
69,7163,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG,2,Oral
70,7222,IS_SECONDARY_SUSPECT,Plasma cell myeloma,10,MG,2,Intravenous drip
70,7163,IS_SECONDARY_SUSPECT,Plasma cell myeloma,10,MG,3,Oral
72,7190,IS_SECONDARY_SUSPECT,Plasma cell myeloma,1.3,MG/M**2,2,Subcutaneous
72,7163,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG,3,Oral
75,7190,IS_SECONDARY_SUSPECT,Plasma cell myeloma,1.3,MG/M**2,2,Subcutaneous
75,7163,IS_SECONDARY_SUSPECT,Plasma cell myeloma,40,MG,3,Oral
76,7163,IS_SECONDARY_SUSPECT,Plasma cell myeloma,40,MG,2,Oral
76,7190,IS_SECONDARY_SUSPECT,Plasma cell myeloma,1.3,MG/M**2,3,Subcutaneous
79,7190,IS_SECONDARY_SUSPECT,Plasma cell myeloma,1.3,MG/M**2,2,Subcutaneous
79,7177,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG,3,Oral
79,7302,IS_SECONDARY_SUSPECT,Plasma cell myeloma,10,MG,4,Oral
81,7178,IS_SECONDARY_SUSPECT,Neuralgia,200,MG,2,Oral
82,7178,IS_SECONDARY_SUSPECT,Neuropathy peripheral,75,MG,2,Oral
83,7163,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG,2,Oral
84,7190,IS_SECONDARY_SUSPECT,Plasma cell myeloma,2.5,MG,2,Subcutaneous
84,7177,IS_SECONDARY_SUSPECT,Plasma cell myeloma,40,MG,3,Oral
84,7304,IS_SECONDARY_SUSPECT,Plasma cell myeloma,4,MG,4,Intravenous drip
85,7188,IS_SECONDARY_SUSPECT,Plasma cell myeloma,1.3,MG/M**2,2,Subcutaneous
85,7163,IS_SECONDARY_SUSPECT,Plasma cell myeloma,12,MG,3,Oral
86,7190,IS_SECONDARY_SUSPECT,Plasma cell myeloma,1.3,MG/M**2,2,Subcutaneous
86,7163,IS_SECONDARY_SUSPECT,Plasma cell myeloma,40,MG,3,Oral
87,7190,IS_SECONDARY_SUSPECT,Plasma cell myeloma,1.3,MG/M**2,2,Subcutaneous
87,7163,IS_SECONDARY_SUSPECT,Plasma cell myeloma,40,MG,3,Oral
89,7189,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG/M**2,2,Intravenous drip
89,7163,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG,3,Oral
90,7305,IS_SECONDARY_SUSPECT,Unknown,2,MG,2,Oral
103,7233,IS_SECONDARY_SUSPECT,End stage renal disease,50,UG,2,Unknown
114,7190,IS_SECONDARY_SUSPECT,Plasma cell myeloma,1,MG/M**2,2,Intravenous drip
114,7177,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG,3,Oral
115,7177,IS_SECONDARY_SUSPECT,Plasma cell myeloma,4,MG,2,Oral
115,7188,IS_SECONDARY_SUSPECT,Plasma cell myeloma,1.3,MG/M**2,3,Subcutaneous
116,7176,IS_SECONDARY_SUSPECT,Unknown,25,MG,2,Oral
116,7171,IS_SECONDARY_SUSPECT,Unknown,60,MG,7,Oral
118,7199,IS_SECONDARY_SUSPECT,Plasma cell myeloma,25,MG,2,Oral
120,7178,IS_SECONDARY_SUSPECT,Unknown,3,DF,2,Unknown
122,7253,IS_SECONDARY_SUSPECT,Plasma cell myeloma,16,MG/KG,2,Intravenous drip
122,7163,IS_SECONDARY_SUSPECT,Plasma cell myeloma,4,MG,3,Oral
123,7288,IS_SECONDARY_SUSPECT,Non-alcoholic steatohepatitis,1.25,MG,2,Subcutaneous
123,7316,IS_SECONDARY_SUSPECT,Diabetes mellitus management,15,MG,3,Unknown
123,7317,IS_SECONDARY_SUSPECT,Unknown,160,MG,4,Unknown
123,7318,IS_SECONDARY_SUSPECT,Pharyngitis streptococcal,875,MG,5,Unknown
125,7199,IS_SECONDARY_SUSPECT,Plasma cell myeloma,4,MG,2,Oral
126,7288,IS_SECONDARY_SUSPECT,Partial lipodystrophy,5,MG,2,Subcutaneous
127,7163,IS_SECONDARY_SUSPECT,Plasma cell myeloma,40,MG,2,Oral
127,7332,IS_SECONDARY_SUSPECT,Plasma cell myeloma,5,ML,3,Intratracheal 
127,7333,IS_SECONDARY_SUSPECT,Plasma cell myeloma,100,MG,4,Intratracheal 
145,7334,IS_SECONDARY_SUSPECT,Unknown,30,G,2,Intravenous (not otherwise specified)
147,7163,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG,2,Oral
148,7199,IS_SECONDARY_SUSPECT,Plasma cell myeloma,8,MG,3,Oral
149,7176,IS_SECONDARY_SUSPECT,Unknown,25,MG,2,Oral
149,7172,IS_SECONDARY_SUSPECT,Plasma cell myeloma,1560,UG,3,Subcutaneous
150,7338,IS_SECONDARY_SUSPECT,Unknown,5,MG,2,Unknown
151,7190,IS_SECONDARY_SUSPECT,Plasma cell myeloma,1.3,MG/M**2,2,Intravenous drip
151,7177,IS_SECONDARY_SUSPECT,Plasma cell myeloma,40,MG,3,Oral
155,7351,IS_SECONDARY_SUSPECT,Unknown,0.125,MG,2,Subcutaneous
156,7190,IS_SECONDARY_SUSPECT,Plasma cell myeloma,0.96,MG/M**2,2,Intravenous drip
156,7199,IS_SECONDARY_SUSPECT,Plasma cell myeloma,32,MG,3,Oral
158,7176,IS_SECONDARY_SUSPECT,Unknown,15,MG,2,Oral
158,7250,IS_SECONDARY_SUSPECT,Stem cell transplant,190,MG,3,Intravenous drip
158,7283,IS_SECONDARY_SUSPECT,Plasma cell myeloma,3,MG,4,Oral
159,7177,IS_SECONDARY_SUSPECT,Plasma cell myeloma,10,MG,2,Oral
160,7189,IS_SECONDARY_SUSPECT,Plasma cell myeloma,58,MG,2,Intravenous drip
160,7177,IS_SECONDARY_SUSPECT,Plasma cell myeloma,10,MG,3,Oral
161,7283,IS_SECONDARY_SUSPECT,Unknown,1,MG,2,Oral
162,7190,IS_SECONDARY_SUSPECT,Plasma cell myeloma,1,MG/M**2,2,Subcutaneous
162,7199,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG,3,Oral
163,7333,IS_SECONDARY_SUSPECT,Chemotherapy,98,MG,3,Subcutaneous
163,7353,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,50,MG,5,Oral
163,7354,IS_SECONDARY_SUSPECT,Chemotherapy,75,MG,6,Oral
163,7237,IS_SECONDARY_SUSPECT,Chemotherapy,1310,MG,8,Intravenous (not otherwise specified)
163,7355,IS_SECONDARY_SUSPECT,Chemotherapy,3330,IU,10,Intravenous (not otherwise specified)
166,7357,IS_SECONDARY_SUSPECT,Unknown,40,MG,2,Oral
167,7190,IS_SECONDARY_SUSPECT,Plasma cell myeloma,1.3,MG/M**2,2,Intravenous drip
168,7359,IS_SECONDARY_SUSPECT,Unknown,500,MG,2,Oral
169,7199,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG,2,Oral
170,7177,IS_SECONDARY_SUSPECT,Plasma cell myeloma,40,MG,2,Oral
171,7360,IS_SECONDARY_SUSPECT,Plasma cell myeloma,4,MG,2,Oral
171,7199,IS_SECONDARY_SUSPECT,Plasma cell myeloma,4,MG,3,Oral
173,7361,IS_SECONDARY_SUSPECT,Unknown,11,MG,2,Oral
174,7361,IS_SECONDARY_SUSPECT,Unknown,11,MG,2,Unknown
175,7199,IS_SECONDARY_SUSPECT,Plasma cell myeloma,28,MG,2,Oral
175,7189,IS_SECONDARY_SUSPECT,Plasma cell myeloma,27,MG/M**2,3,Intravenous drip
176,7222,IS_SECONDARY_SUSPECT,Plasma cell myeloma,10,MG/KG,2,Intravenous drip
179,7163,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG,3,Oral
180,7178,IS_SECONDARY_SUSPECT,Pain in extremity,200,MG,2,Oral
181,7380,IS_SECONDARY_SUSPECT,Plasma cell myeloma,10,MG/KG,2,Intravenous drip
181,7199,IS_SECONDARY_SUSPECT,Plasma cell myeloma,40,MG,3,Oral
182,7253,IS_SECONDARY_SUSPECT,Plasma cell myeloma,16,MG/KG,2,Intravenous drip
182,7199,IS_SECONDARY_SUSPECT,Plasma cell myeloma,4,MG,3,Oral
183,7177,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG,2,Oral
184,7199,IS_SECONDARY_SUSPECT,Plasma cell myeloma,40,MG,2,Oral
184,7360,IS_SECONDARY_SUSPECT,Plasma cell myeloma,4,MG,3,Oral
185,7199,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG,2,Oral
186,7163,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG,2,Oral
187,7384,IS_SECONDARY_SUSPECT,Malignant melanoma,2,MG,2,Oral
188,7178,IS_SECONDARY_SUSPECT,Fibromyalgia,150,MG,2,Oral
189,7394,IS_SECONDARY_SUSPECT,Parkinson's disease psychosis,17,MG,2,Oral
190,7402,IS_SECONDARY_SUSPECT,Plasma cell myeloma,90,MG/M**2,2,Intravenous (not otherwise specified)
190,7163,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG,3,Intravenous (not otherwise specified)
191,7283,IS_SECONDARY_SUSPECT,Unknown,3,MG,2,Oral
191,7199,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG,3,Oral
191,7188,IS_SECONDARY_SUSPECT,Plasma cell myeloma,1.3,MG/M**2,4,Intravenous drip
192,7178,IS_SECONDARY_SUSPECT,Connective tissue disorder,100,MG,2,Oral
193,7361,IS_SECONDARY_SUSPECT,Unknown,11,MG,2,Oral
194,7415,IS_SECONDARY_SUSPECT,Unknown,150,MG,2,Unknown
195,7177,IS_SECONDARY_SUSPECT,Plasma cell myeloma,10,MG,2,Intravenous drip
195,7253,IS_SECONDARY_SUSPECT,Plasma cell myeloma,900,MG,4,Intravenous drip
196,7416,IS_SECONDARY_SUSPECT,Fallopian tube cancer,200,MG,2,Oral
197,7189,IS_SECONDARY_SUSPECT,Plasma cell myeloma,36,MG/M**2,2,Intravenous drip
197,7199,IS_SECONDARY_SUSPECT,Plasma cell myeloma,10,MG,3,Oral
199,7432,IS_SECONDARY_SUSPECT,Pancreas transplant,500,MG,2,Oral
199,7321,IS_SECONDARY_SUSPECT,Renal transplant,500,MG,3,Oral
200,7177,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG,2,Oral
200,7360,IS_SECONDARY_SUSPECT,Plasma cell myeloma,3,MG,3,Oral
201,7199,IS_SECONDARY_SUSPECT,Plasma cell myeloma,40,MG,2,Oral
201,7435,IS_SECONDARY_SUSPECT,Plasma cell myeloma,3,MG/KG,3,Intravenous drip
202,7171,IS_SECONDARY_SUSPECT,Plasma cell myeloma,5,MG,2,Oral
203,7163,IS_SECONDARY_SUSPECT,Plasma cell myeloma,8,MG,2,Oral
204,7218,IS_SECONDARY_SUSPECT,Hypertonic bladder,50,MG,5,Oral
204,7436,IS_SECONDARY_SUSPECT,Hypertonic bladder,10,MG,9,Unknown
205,7199,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG,2,Oral
206,7437,IS_SECONDARY_SUSPECT,Unknown,45,MG,3,Oral
207,7163,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG,2,Oral
208,7176,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Oral
209,7438,IS_SECONDARY_SUSPECT,Unknown,0.06,UG/KG,2,Subcutaneous
209,7439,IS_SECONDARY_SUSPECT,Heritable pulmonary arterial hypertension,10,MG,3,Oral
210,7188,IS_SECONDARY_SUSPECT,Plasma cell myeloma,1.3,MG/M**2,2,Subcutaneous
210,7199,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG,3,Oral
210,7302,IS_SECONDARY_SUSPECT,Plasma cell myeloma,10,MG,4,Unknown
211,7189,IS_SECONDARY_SUSPECT,Plasma cell myeloma,56,MG/M**2,2,Intravenous drip
211,7237,IS_SECONDARY_SUSPECT,Plasma cell myeloma,500,MG,3,Intravenous drip
211,7163,IS_SECONDARY_SUSPECT,Plasma cell myeloma,40,MG,4,Oral
212,7280,IS_SECONDARY_SUSPECT,Unknown,125,MG,2,Oral
213,7394,IS_SECONDARY_SUSPECT,Parkinson's disease psychosis,34,MG,2,Oral
214,7442,IS_SECONDARY_SUSPECT,Squamous cell carcinoma of head and neck,594,MG,1,Intravenous drip
214,7443,IS_SECONDARY_SUSPECT,Squamous cell carcinoma of head and neck,124,MG,2,Intravenous drip
214,7445,IS_SECONDARY_SUSPECT,Light anaesthesia,5,MG,4,Intravenous (not otherwise specified)
215,7191,IS_SECONDARY_SUSPECT,Unknown,3.75,G,2,Oral
216,7190,IS_SECONDARY_SUSPECT,Plasma cell myeloma,1,MG/M**2,2,Subcutaneous
216,7177,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG,3,Oral
217,7189,IS_SECONDARY_SUSPECT,Plasma cell myeloma,56,MG/M**2,2,Intravenous drip
217,7199,IS_SECONDARY_SUSPECT,Plasma cell myeloma,8,MG,3,Oral
218,7446,IS_SECONDARY_SUSPECT,Unknown,70,MG,2,Intravenous (not otherwise specified)
218,7165,IS_SECONDARY_SUSPECT,Hypertension,20,MG,3,Oral
219,7451,IS_SECONDARY_SUSPECT,Plasma cell myeloma recurrent,32,MG,2,Intravenous drip
219,7222,IS_SECONDARY_SUSPECT,Plasma cell myeloma recurrent,10,MG/KG,3,Intravenous drip
220,7452,IS_SECONDARY_SUSPECT,Unknown,8.4,G,2,Oral
221,7191,IS_SECONDARY_SUSPECT,Unknown,4.5,G,3,Oral
223,7176,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Oral
223,7177,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG,4,Intravenous drip
225,7291,IS_SECONDARY_SUSPECT,Unknown,150,MG,2,Oral
231,7199,IS_SECONDARY_SUSPECT,Plasma cell myeloma,40,MG,2,Oral
232,7468,IS_SECONDARY_SUSPECT,Plasma cell myeloma,350,MG/M**2,2,Intravenous drip
232,7177,IS_SECONDARY_SUSPECT,Plasma cell myeloma,40,MG,3,Oral
234,7176,IS_SECONDARY_SUSPECT,Unknown,15,MG,2,Oral
234,7190,IS_SECONDARY_SUSPECT,Plasma cell myeloma,1.3,MG/M**2,3,Subcutaneous
234,7177,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG,4,Oral
235,7473,IS_SECONDARY_SUSPECT,Neoplasm,1850,MG,2,Intravenous drip
236,7191,IS_SECONDARY_SUSPECT,Unknown,4.5,G,3,Oral
238,7477,IS_SECONDARY_SUSPECT,Unknown,2.3,MG,2,Oral
239,7190,IS_SECONDARY_SUSPECT,Plasma cell myeloma,2.1,MG,2,Subcutaneous
239,7177,IS_SECONDARY_SUSPECT,Plasma cell myeloma,12,MG,3,Oral
241,7478,IS_SECONDARY_SUSPECT,Unknown,37.5,MG,2,Oral
242,7360,IS_SECONDARY_SUSPECT,Plasma cell myeloma,4,MG,2,Oral
242,7199,IS_SECONDARY_SUSPECT,Plasma cell myeloma,40,MG,3,Oral
243,7178,IS_SECONDARY_SUSPECT,Fibromyalgia,150,MG,2,Oral
245,7280,IS_SECONDARY_SUSPECT,Unknown,100,MG,2,Unknown
246,7199,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG,2,Oral
250,7163,IS_SECONDARY_SUSPECT,Unknown,40,MG,2,Unknown
250,7176,IS_SECONDARY_SUSPECT,Unknown,25,MG,3,Unknown
251,7188,IS_SECONDARY_SUSPECT,Plasma cell myeloma,1,MG/M**2,2,Subcutaneous
251,7199,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG,3,Oral
252,7496,IS_SECONDARY_SUSPECT,Unknown,600,MG,2,Intravenous (not otherwise specified)
253,7206,IS_SECONDARY_SUSPECT,Plasma cell myeloma,50,MG,2,Oral
254,7361,IS_SECONDARY_SUSPECT,Unknown,11,MG,2,Unknown
255,7502,IS_SECONDARY_SUSPECT,Unknown,40,MG,2,Oral
257,7451,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG,2,Intravenous drip
257,7189,IS_SECONDARY_SUSPECT,Plasma cell myeloma,21.5,MG/M**2,3,Intravenous drip
259,7520,IS_SECONDARY_SUSPECT,Unknown,1,MG,2,Unknown
261,7248,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Oral
261,7524,IS_SECONDARY_SUSPECT,Unknown,12,MG,6,Intravenous drip
261,7525,IS_SECONDARY_SUSPECT,Multiple sclerosis,12,MG,8,Intravenous (not otherwise specified)
262,7163,IS_SECONDARY_SUSPECT,Plasma cell myeloma,4,MG,2,Oral
263,7526,IS_SECONDARY_SUSPECT,Unknown,500,MG,3,Unknown
264,7361,IS_SECONDARY_SUSPECT,Unknown,11,MG,2,Oral
265,7253,IS_SECONDARY_SUSPECT,Plasma cell myeloma,16,MG/KG,2,Intravenous drip
265,7199,IS_SECONDARY_SUSPECT,Plasma cell myeloma,2,MG,3,Oral
266,7254,IS_SECONDARY_SUSPECT,Unknown,0.269,ML,5,Subcutaneous
269,7338,IS_SECONDARY_SUSPECT,Unknown,5,MG,2,Oral
271,7530,IS_SECONDARY_SUSPECT,Unknown,0.4,MG,2,Unknown
272,7178,IS_SECONDARY_SUSPECT,Pain,100,MG,3,Oral
282,7199,IS_SECONDARY_SUSPECT,Plasma cell myeloma,40,MG,2,Oral
282,7188,IS_SECONDARY_SUSPECT,Plasma cell myeloma,2.3,MG/M**2,3,Subcutaneous
283,7189,IS_SECONDARY_SUSPECT,Plasma cell myeloma,70,MG,2,Intravenous drip
283,7199,IS_SECONDARY_SUSPECT,Plasma cell myeloma,40,MG,3,Oral
284,7199,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG,2,Oral
284,7188,IS_SECONDARY_SUSPECT,Plasma cell myeloma,1.3,MG/M**2,3,Subcutaneous
286,7537,IS_SECONDARY_SUSPECT,Ovarian cancer,826.5,MG,2,Intravenous (not otherwise specified)
286,7538,IS_SECONDARY_SUSPECT,Ovarian cancer,271,MG,3,Intravenous (not otherwise specified)
286,7539,IS_SECONDARY_SUSPECT,Ovarian cancer,385,MG,4,Intravenous (not otherwise specified)
288,7199,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG,2,Oral
288,7360,IS_SECONDARY_SUSPECT,Plasma cell myeloma,3,MG,3,Oral
289,7361,IS_SECONDARY_SUSPECT,Unknown,11,MG,2,Oral
290,7496,IS_SECONDARY_SUSPECT,Unknown,300,MG,3,Unknown
293,7406,IS_SECONDARY_SUSPECT,Pain,1,DF,2,Transplacental
293,7542,IS_SECONDARY_SUSPECT,Pain,8,MG,3,Transplacental
293,7543,IS_SECONDARY_SUSPECT,Pain,8,MG,4,Transplacental
293,7544,IS_SECONDARY_SUSPECT,Pain,8,MG,5,Transplacental
296,7271,IS_SECONDARY_SUSPECT,Unknown,20,MG,3,Oral
296,7325,IS_SECONDARY_SUSPECT,Unknown,40,MG,6,Unknown
296,7546,IS_SECONDARY_SUSPECT,Unknown,20,MG,9,Unknown
296,7203,IS_SECONDARY_SUSPECT,Unknown,20,MG,12,Oral
296,7230,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,20,MG,14,Unknown
296,7371,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,20,MG,15,Unknown
297,7495,IS_SECONDARY_SUSPECT,Unknown,30,MG,2,Unknown
297,7325,IS_SECONDARY_SUSPECT,Unknown,40,MG,7,Unknown
297,7203,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,20,MG,15,Oral
298,7325,IS_SECONDARY_SUSPECT,Unknown,20,MG,4,Oral
298,7552,IS_SECONDARY_SUSPECT,Unknown,20,MG,10,Oral
300,7230,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,40,MG,5,Oral
300,7371,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,40,MG,8,Unknown
300,7325,IS_SECONDARY_SUSPECT,Unknown,40,MG,10,Unknown
300,7553,IS_SECONDARY_SUSPECT,Unknown,60,MG,11,Unknown
300,7271,IS_SECONDARY_SUSPECT,Unknown,40,MG,12,Unknown
301,7271,IS_SECONDARY_SUSPECT,Unknown,40,MG,3,Oral
301,7371,IS_SECONDARY_SUSPECT,Barrett's oesophagus,40,MG,5,Intravenous (not otherwise specified)
301,7325,IS_SECONDARY_SUSPECT,Unknown,40,MG,7,Unknown
301,7203,IS_SECONDARY_SUSPECT,Barrett's oesophagus,20,MG,12,Unknown
301,7230,IS_SECONDARY_SUSPECT,Barrett's oesophagus,40,MG,16,Unknown
302,7325,IS_SECONDARY_SUSPECT,Unknown,20,MG,4,Unknown
302,7546,IS_SECONDARY_SUSPECT,Unknown,20,MG,6,Unknown
302,7553,IS_SECONDARY_SUSPECT,Unknown,60,MG,8,Unknown
302,7203,IS_SECONDARY_SUSPECT,Unknown,40,MG,10,Unknown
302,7561,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,15,MG,13,Oral
302,7562,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,40,MG,14,Unknown
302,7230,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,20,MG,15,Unknown
302,7563,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,60,MG,16,Oral
303,7271,IS_SECONDARY_SUSPECT,Gastrointestinal disorder,40,MG,3,Unknown
303,7230,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,20,MG,10,Unknown
303,7562,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,40,MG,12,Unknown
306,7552,IS_SECONDARY_SUSPECT,Unknown,20,MG,11,Unknown
306,7230,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,20,MG,12,Unknown
307,7271,IS_SECONDARY_SUSPECT,Unknown,40,MG,2,Unknown
307,7552,IS_SECONDARY_SUSPECT,Unknown,20,MG,11,Oral
307,7230,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,20,MG,12,Unknown
307,7371,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,40,MG,18,Unknown
308,7325,IS_SECONDARY_SUSPECT,Unknown,40,MG,7,Unknown
308,7546,IS_SECONDARY_SUSPECT,Unknown,20,MG,9,Unknown
308,7552,IS_SECONDARY_SUSPECT,Unknown,20,MG,13,Unknown
309,7271,IS_SECONDARY_SUSPECT,Prophylaxis,40,MG,3,Unknown
309,7325,IS_SECONDARY_SUSPECT,Unknown,40,MG,8,Unknown
310,7230,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,20,MG,6,Oral
310,7203,IS_SECONDARY_SUSPECT,Unknown,20,MG,10,Unknown
310,7552,IS_SECONDARY_SUSPECT,Unknown,20,MG,13,Unknown
311,7495,IS_SECONDARY_SUSPECT,Unknown,40,MG,2,Unknown
311,7271,IS_SECONDARY_SUSPECT,Unknown,40,MG,5,Unknown
311,7371,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,40,MG,8,Oral
311,7571,IS_SECONDARY_SUSPECT,Unknown,40,MG,11,Unknown
312,7495,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,15,MG,3,Unknown
312,7325,IS_SECONDARY_SUSPECT,Unknown,20,MG,6,Oral
312,7546,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,20,MG,8,Unknown
312,7571,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,15,MG,11,Unknown
312,7203,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,20,MG,13,Oral
312,7552,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,20,MG,15,Oral
312,7366,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,20,MG,17,Unknown
312,7230,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,20,MG,18,Unknown
313,7552,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,20,MG,8,Oral
315,7495,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,30,MG,2,Oral
315,7325,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,40,MG,3,Unknown
315,7371,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,40,MG,5,Unknown
315,7230,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,20,MG,6,Oral
315,7552,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,20,MG,11,Unknown
315,7271,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,40,MG,12,Unknown
316,7325,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,40,MG,2,Oral
316,7495,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,30,MG,11,Oral
316,7271,IS_SECONDARY_SUSPECT,Flatulence,40,MG,12,Unknown
317,7561,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,30,MG,1,Oral
317,7546,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,20,MG,6,Oral
317,7371,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,40,MG,8,Oral
317,7230,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,40,MG,11,Oral
317,7552,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,20,MG,15,Unknown
318,7546,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,20,MG,6,Unknown
318,7571,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,15,MG,8,Oral
318,7552,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,20,MG,11,Oral
320,7162,IS_SECONDARY_SUSPECT,Unknown,2,MG,3,Unknown
320,7612,IS_SECONDARY_SUSPECT,Anxiety,0.5,MG,4,Unknown
321,7613,IS_SECONDARY_SUSPECT,Malignant melanoma,240,MG,3,Intravenous (not otherwise specified)
323,7495,IS_SECONDARY_SUSPECT,Unknown,40,MG,3,Oral
323,7626,IS_SECONDARY_SUSPECT,Product use in unapproved indication,40,MG,6,Oral
323,7230,IS_SECONDARY_SUSPECT,Product use in unapproved indication,20,MG,7,Oral
324,7199,IS_SECONDARY_SUSPECT,Plasma cell myeloma,8,MG,2,Oral
326,7177,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG,2,Oral
326,7253,IS_SECONDARY_SUSPECT,Plasma cell myeloma,1660,MG,3,Intravenous drip
327,7189,IS_SECONDARY_SUSPECT,Plasma cell myeloma,56,MG,2,Intravenous drip
327,7177,IS_SECONDARY_SUSPECT,Plasma cell myeloma,40,MG,3,Oral
328,7495,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,30,MG,1,Oral
328,7271,IS_SECONDARY_SUSPECT,Unknown,40,MG,4,Oral
328,7325,IS_SECONDARY_SUSPECT,Unknown,40,MG,6,Oral
328,7546,IS_SECONDARY_SUSPECT,Unknown,20,MG,9,Unknown
328,7552,IS_SECONDARY_SUSPECT,Unknown,20,MG,13,Unknown
329,7632,IS_SECONDARY_SUSPECT,Nausea,1,MG,2,Subcutaneous
331,7251,IS_SECONDARY_SUSPECT,Plasma cell myeloma,58,MG,2,Intravenous drip
331,7451,IS_SECONDARY_SUSPECT,Plasma cell myeloma,40,MG,3,Intravenous drip
332,7634,IS_SECONDARY_SUSPECT,Unknown,180,MG,2,Unknown
332,7635,IS_SECONDARY_SUSPECT,HER2 positive breast cancer,180,MG,3,Unknown
332,7636,IS_SECONDARY_SUSPECT,HER2 positive breast cancer,180,MG,11,Unknown
333,7254,IS_SECONDARY_SUSPECT,Short-bowel syndrome,5,MG,2,Unknown
334,7361,IS_SECONDARY_SUSPECT,Unknown,11,MG,2,Oral
335,7271,IS_SECONDARY_SUSPECT,Unknown,40,MG,4,Oral
335,7645,IS_SECONDARY_SUSPECT,Unknown,20,MG,11,Oral
336,7414,IS_SECONDARY_SUSPECT,Dyslipidaemia,80,MG,2,Unknown
337,7191,IS_SECONDARY_SUSPECT,Unknown,3.75,G,3,Oral
338,7206,IS_SECONDARY_SUSPECT,Plasma cell myeloma,50,MG,2,Oral
338,7253,IS_SECONDARY_SUSPECT,Plasma cell myeloma,1600,MG,3,Intravenous drip
338,7190,IS_SECONDARY_SUSPECT,Plasma cell myeloma,2.1,MG,4,Subcutaneous
339,7286,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,40,MG,2,Oral
339,7561,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,30,MG,6,Oral
339,7546,IS_SECONDARY_SUSPECT,Unknown,20,MG,10,Oral
339,7230,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,40,MG,12,Oral
339,7645,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,20,MG,13,Oral
341,7253,IS_SECONDARY_SUSPECT,Plasma cell myeloma,1600,MG,2,Intravenous drip
341,7451,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG,3,Intravenous drip
341,7188,IS_SECONDARY_SUSPECT,Plasma cell myeloma,2.1,MG,4,Subcutaneous
342,7361,IS_SECONDARY_SUSPECT,Unknown,11,MG,2,Oral
344,7394,IS_SECONDARY_SUSPECT,Hallucination,17,MG,2,Unknown
346,7662,IS_SECONDARY_SUSPECT,Malignant melanoma,1,MG/KG,1,Intravenous (not otherwise specified)
348,7502,IS_SECONDARY_SUSPECT,Unknown,40,MG,3,Oral
349,7163,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG,2,Intravenous (not otherwise specified)
349,7402,IS_SECONDARY_SUSPECT,Plasma cell myeloma,90,MG/M**2,4,Intravenous (not otherwise specified)
350,7681,IS_SECONDARY_SUSPECT,Unknown,14,MG,2,Oral
351,7682,IS_SECONDARY_SUSPECT,Plasma cell myeloma,75,MG/M**2,2,Intravenous drip
351,7163,IS_SECONDARY_SUSPECT,Plasma cell myeloma,40,MG,3,Oral
352,7191,IS_SECONDARY_SUSPECT,Unknown,3.5,G,3,Oral
353,7683,IS_SECONDARY_SUSPECT,Plasma cell myeloma,16,MG/KG,2,Intravenous drip
353,7177,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG,3,Intravenous drip
354,7520,IS_SECONDARY_SUSPECT,Unknown,75,MG/M**2,2,Intravenous (not otherwise specified)
355,7361,IS_SECONDARY_SUSPECT,Unknown,11,MG,2,Oral
357,7361,IS_SECONDARY_SUSPECT,Rheumatoid arthritis,11,MG,2,Unknown
359,7520,IS_SECONDARY_SUSPECT,Unknown,145,MG,2,Unknown
360,7687,IS_SECONDARY_SUSPECT,Pituitary tumour benign,20,MG,2,Unknown
361,7163,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG,2,Oral
361,7251,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG/M**2,3,Intravenous drip
361,7190,IS_SECONDARY_SUSPECT,Plasma cell myeloma,1.3,MG/M**2,4,Intravenous drip
363,7218,IS_SECONDARY_SUSPECT,Unknown,25,MG,2,Oral
366,7178,IS_SECONDARY_SUSPECT,Fibromyalgia,75,MG,2,Oral
367,7338,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Oral
368,7338,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Oral
369,7254,IS_SECONDARY_SUSPECT,Unknown,0.214,ML,9,Subcutaneous
370,7177,IS_SECONDARY_SUSPECT,Plasma cell myeloma,40,MG,2,Oral
370,7189,IS_SECONDARY_SUSPECT,Plasma cell myeloma,56,MG,3,Intravenous drip
371,7699,IS_SECONDARY_SUSPECT,Breast cancer female,990,MG,2,Intravenous (not otherwise specified)
372,7702,IS_SECONDARY_SUSPECT,Breast cancer,500,MG,2,Intravenous (not otherwise specified)
373,7468,IS_SECONDARY_SUSPECT,Breast cancer metastatic,500,MG/M**2,2,Intravenous (not otherwise specified)
373,7244,IS_SECONDARY_SUSPECT,Breast cancer metastatic,50,MG/M**2,3,Intravenous (not otherwise specified)
374,7468,IS_SECONDARY_SUSPECT,Breast cancer,780,MG,2,Intravenous (not otherwise specified)
374,7244,IS_SECONDARY_SUSPECT,Breast cancer,80,MG,3,Intravenous (not otherwise specified)
375,7539,IS_SECONDARY_SUSPECT,Breast cancer,942,MG,2,Unknown
375,7684,IS_SECONDARY_SUSPECT,Breast cancer,318,MG,3,Unknown
376,7468,IS_SECONDARY_SUSPECT,Breast cancer,1200,MG,2,Unknown
381,7662,IS_SECONDARY_SUSPECT,Malignant melanoma,1,MG,1,Intravenous (not otherwise specified)
382,7702,IS_SECONDARY_SUSPECT,Breast cancer,150,MG,2,Unknown
382,7684,IS_SECONDARY_SUSPECT,Breast cancer,150,MG,3,Unknown
386,7719,IS_SECONDARY_SUSPECT,Unknown,300,MG,5,Subcutaneous
388,7443,IS_SECONDARY_SUSPECT,Squamous cell carcinoma of head and neck,120,MG,2,Intravenous drip
388,7262,IS_SECONDARY_SUSPECT,Pain,300,MG,5,Oral
390,7254,IS_SECONDARY_SUSPECT,Unknown,0.331,ML,5,Unknown
391,7338,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Oral
393,7199,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG,2,Oral
393,7253,IS_SECONDARY_SUSPECT,Unknown,2090,MG,4,Intravenous drip
394,7176,IS_SECONDARY_SUSPECT,Unknown,25,MG,2,Oral
394,7190,IS_SECONDARY_SUSPECT,Plasma cell myeloma,1.3,MG/M**2,3,Intravenous drip
394,7199,IS_SECONDARY_SUSPECT,Plasma cell myeloma,40,MG,4,Oral
395,7416,IS_SECONDARY_SUSPECT,Unknown,200,MG,2,Oral
396,7520,IS_SECONDARY_SUSPECT,Unknown,160,MG,2,Intravenous (not otherwise specified)
397,7733,IS_SECONDARY_SUSPECT,Unknown,600,MG,2,Oral
398,7734,IS_SECONDARY_SUSPECT,Breast cancer female,131,MG,2,Unknown
398,7735,IS_SECONDARY_SUSPECT,Breast cancer female,131,MG,3,Unknown
398,7736,IS_SECONDARY_SUSPECT,Breast cancer female,131,MG,4,Unknown
398,7737,IS_SECONDARY_SUSPECT,Breast cancer female,131,MG,5,Unknown
398,7738,IS_SECONDARY_SUSPECT,Breast cancer female,131,MG,6,Unknown
398,7520,IS_SECONDARY_SUSPECT,Breast cancer female,131,MG,7,Unknown
399,7254,IS_SECONDARY_SUSPECT,Unknown,0.31,ML,9,Subcutaneous
401,7468,IS_SECONDARY_SUSPECT,Plasma cell myeloma,200,MG,2,Oral
401,7199,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG,3,Oral
402,7632,IS_SECONDARY_SUSPECT,Unknown,2,MG,3,Unknown
403,7384,IS_SECONDARY_SUSPECT,Unknown,0.5,MG,2,Oral
405,7687,IS_SECONDARY_SUSPECT,Acromegaly,30,MG,2,Subcutaneous
406,7495,IS_SECONDARY_SUSPECT,Unknown,30,MG,2,Unknown
406,7571,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,30,MG,4,Oral
406,7561,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,30,MG,6,Oral
406,7371,IS_SECONDARY_SUSPECT,Unknown,40,MG,13,Oral
406,7325,IS_SECONDARY_SUSPECT,Unknown,20,MG,18,Oral
407,7178,IS_SECONDARY_SUSPECT,Fibromyalgia,150,MG,2,Oral
408,7160,IS_SECONDARY_SUSPECT,Seizure,10,MG,2,Oral
409,7520,IS_SECONDARY_SUSPECT,Unknown,75,MG,2,Unknown
416,7176,IS_SECONDARY_SUSPECT,Plasma cell myeloma,25,MG,2,Oral
416,7199,IS_SECONDARY_SUSPECT,Plasma cell myeloma,4,MG,7,Oral
416,7253,IS_SECONDARY_SUSPECT,Plasma cell myeloma,16,MG/KG,8,Intravenous drip
416,7237,IS_SECONDARY_SUSPECT,Plasma cell myeloma,2700,MG,9,Intravenous drip
418,7283,IS_SECONDARY_SUSPECT,Unknown,4,MG,2,Oral
418,7176,IS_SECONDARY_SUSPECT,Unknown,25,MG,5,Oral
418,7190,IS_SECONDARY_SUSPECT,Plasma cell myeloma,1.3,MG/M**2,8,Subcutaneous
418,7302,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG,9,Oral
418,7237,IS_SECONDARY_SUSPECT,Plasma cell myeloma,2100,MG,10,Intravenous drip
418,7188,IS_SECONDARY_SUSPECT,Unknown,1.3,UG/M**2,11,Subcutaneous
419,7760,IS_SECONDARY_SUSPECT,Colon cancer metastatic,1500,MG,2,Intravenous (not otherwise specified)
421,7237,IS_SECONDARY_SUSPECT,Plasma cell myeloma,300,MG/M**2,2,Oral
421,7189,IS_SECONDARY_SUSPECT,Plasma cell myeloma,27,MG/M**2,3,Intravenous drip
421,7199,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG,4,Oral
421,7222,IS_SECONDARY_SUSPECT,Plasma cell myeloma,10,MG/KG,5,Intravenous drip
421,7451,IS_SECONDARY_SUSPECT,Plasma cell myeloma,8,MG,6,Intravenous drip
422,7283,IS_SECONDARY_SUSPECT,Plasma cell myeloma,2,MG,2,Oral
422,7222,IS_SECONDARY_SUSPECT,Plasma cell myeloma,10,MG/KG,3,Intravenous drip
422,7237,IS_SECONDARY_SUSPECT,Plasma cell myeloma,2000,MG/M**2,4,Intravenous drip
423,7764,IS_SECONDARY_SUSPECT,Unknown,100,MG,2,Unknown
427,7254,IS_SECONDARY_SUSPECT,Short-bowel syndrome,5,MG,2,Unknown
428,7163,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG,2,Oral
428,7683,IS_SECONDARY_SUSPECT,Plasma cell myeloma,16,MG/KG,3,Intravenous drip
429,7253,IS_SECONDARY_SUSPECT,Plasma cell myeloma,16,MG/KG,2,Intravenous drip
429,7451,IS_SECONDARY_SUSPECT,Plasma cell myeloma,40,MG,3,Intravenous drip
429,7189,IS_SECONDARY_SUSPECT,Plasma cell myeloma,56,MG/M**2,4,Intravenous drip
431,7178,IS_SECONDARY_SUSPECT,Neuralgia,25,MG,2,Oral
433,7338,IS_SECONDARY_SUSPECT,Unknown,5,MG,2,Unknown
435,7520,IS_SECONDARY_SUSPECT,Unknown,197,MG,2,Unknown
437,7361,IS_SECONDARY_SUSPECT,Unknown,11,MG,2,Oral
440,7189,IS_SECONDARY_SUSPECT,Plasma cell myeloma,56,MG,2,Intravenous drip
441,7538,IS_SECONDARY_SUSPECT,Ovarian cancer,175,MG/M**2,2,Intravenous (not otherwise specified)
441,7539,IS_SECONDARY_SUSPECT,Ovarian cancer,605,MG,3,Intravenous (not otherwise specified)
442,7360,IS_SECONDARY_SUSPECT,Unknown,4,MG,2,Oral
442,7163,IS_SECONDARY_SUSPECT,Unknown,4,MG,3,Unknown
444,7537,IS_SECONDARY_SUSPECT,Ovarian cancer,1304,MG,2,Intravenous (not otherwise specified)
444,7538,IS_SECONDARY_SUSPECT,Ovarian cancer,343,MG,3,Intravenous (not otherwise specified)
444,7539,IS_SECONDARY_SUSPECT,Ovarian cancer,827.7,MG,4,Intravenous (not otherwise specified)
446,7788,IS_SECONDARY_SUSPECT,Unknown,28.6,MG,12,Intravenous (not otherwise specified)
446,7237,IS_SECONDARY_SUSPECT,B precursor type acute leukaemia,1840,MG,13,Intravenous (not otherwise specified)
446,7353,IS_SECONDARY_SUSPECT,B precursor type acute leukaemia,90,MG,15,Oral
446,7781,IS_SECONDARY_SUSPECT,B precursor type acute leukaemia,2,MG,19,Intravenous (not otherwise specified)
446,7789,IS_SECONDARY_SUSPECT,B precursor type acute leukaemia,120,MG,21,Oral
447,7199,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG,2,Oral
447,7253,IS_SECONDARY_SUSPECT,Plasma cell myeloma,16,MG/KG,3,Intravenous drip
448,7790,IS_SECONDARY_SUSPECT,Unknown,22,G,2,Unknown
449,7520,IS_SECONDARY_SUSPECT,Unknown,75,MG,2,Unknown
450,7176,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Oral
451,7538,IS_SECONDARY_SUSPECT,Ovarian cancer stage III,252,MG,3,Intravenous (not otherwise specified)
451,7539,IS_SECONDARY_SUSPECT,Ovarian cancer stage III,510,MG,4,Intravenous (not otherwise specified)
454,7338,IS_SECONDARY_SUSPECT,Unknown,5,MG,2,Unknown
456,7190,IS_SECONDARY_SUSPECT,Plasma cell myeloma,1.3,MG/M**2,2,Subcutaneous
456,7177,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG,3,Oral
458,7254,IS_SECONDARY_SUSPECT,Short-bowel syndrome,3.1,MG,2,Unknown
459,7338,IS_SECONDARY_SUSPECT,Unknown,5,MG,2,Oral
460,7766,IS_SECONDARY_SUSPECT,Unknown,40,MG,2,Unknown
461,7807,IS_SECONDARY_SUSPECT,Immunisation,240,UG,1,Intramuscular
461,7516,IS_SECONDARY_SUSPECT,Neuropathy peripheral,10,MG,4,Oral
462,7361,IS_SECONDARY_SUSPECT,Unknown,11,MG,4,Oral
467,7496,IS_SECONDARY_SUSPECT,Unknown,600,MG,2,Intravenous (not otherwise specified)
468,7808,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,37.75,UG,2,Unknown
469,7171,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG,2,Oral
470,7818,IS_SECONDARY_SUSPECT,Macular degeneration,0.3,MG,2,Other
471,7687,IS_SECONDARY_SUSPECT,Unknown,40,MG,2,Subcutaneous
473,7178,IS_SECONDARY_SUSPECT,Pain in extremity,150,MG,2,Oral
474,7178,IS_SECONDARY_SUSPECT,Unknown,50,MG,2,Oral
476,7325,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,40,MG,2,Oral
478,7178,IS_SECONDARY_SUSPECT,Neuralgia,20,MG,2,Unknown
479,7325,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,40,MG,2,Unknown
479,7546,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,20,MG,6,Oral
479,7366,IS_SECONDARY_SUSPECT,Gastrointestinal disorder,40,MG,8,Unknown
479,7371,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,40,MG,10,Unknown
479,7571,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,15,MG,11,Unknown
479,7203,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,20,MG,12,Unknown
479,7552,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,20,MG,13,Oral
479,7821,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,20,MG,14,Unknown
479,7230,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,20,MG,15,Unknown
480,7536,IS_SECONDARY_SUSPECT,Non-small cell lung cancer,1200,MG,2,Intravenous (not otherwise specified)
481,7178,IS_SECONDARY_SUSPECT,Pain in extremity,75,MG,2,Oral
482,7178,IS_SECONDARY_SUSPECT,Lumbar radiculopathy,100,MG,2,Oral
483,7199,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG,2,Oral
483,7477,IS_SECONDARY_SUSPECT,Plasma cell myeloma,3,MG,3,Oral
484,7280,IS_SECONDARY_SUSPECT,Unknown,125,MG,2,Oral
486,7832,IS_SECONDARY_SUSPECT,Hypogammaglobulinaemia,30,MG,3,Intravenous (not otherwise specified)
488,7496,IS_SECONDARY_SUSPECT,Unknown,600,MG,2,Intravenous (not otherwise specified)
488,7835,IS_SECONDARY_SUSPECT,Neuralgia,800,MG,8,Unknown
491,7352,IS_SECONDARY_SUSPECT,Unknown,2,MG,2,Intravenous (not otherwise specified)
491,7333,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,1.38,ML,3,Subcutaneous
491,7643,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,8600,MG,6,Intravenous (not otherwise specified)
491,7353,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,90,MG,9,Oral
491,7354,IS_SECONDARY_SUSPECT,Unknown,50,MG,14,Oral
491,7237,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,1840,MG,15,Intravenous (not otherwise specified)
491,7788,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,28.6,MG,17,Intravenous (not otherwise specified)
491,7838,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,120,MG,18,Oral
491,7355,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,4598,IU,20,Unknown
492,7190,IS_SECONDARY_SUSPECT,Plasma cell myeloma,0.7,MG/M**2,2,Subcutaneous
492,7177,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG,3,Oral
493,7268,IS_SECONDARY_SUSPECT,Stent placement,80,MG,2,Unknown
496,7502,IS_SECONDARY_SUSPECT,Cholangiocarcinoma,60,MG,2,Oral
499,7850,IS_SECONDARY_SUSPECT,Anaplastic lymphoma kinase gene mutation,180,MG,2,Oral
502,7478,IS_SECONDARY_SUSPECT,Metastatic gastric cancer,37.5,MG,2,Oral
503,7851,IS_SECONDARY_SUSPECT,Unknown,30,MG,2,Oral
507,7437,IS_SECONDARY_SUSPECT,Leukaemia,30,MG,2,Oral
508,7632,IS_SECONDARY_SUSPECT,Bone disorder,1.6,MG,2,Unknown
509,7790,IS_SECONDARY_SUSPECT,Unknown,12,G,2,Subcutaneous
511,7189,IS_SECONDARY_SUSPECT,Plasma cell myeloma,36,MG,2,Intravenous drip
512,7853,IS_SECONDARY_SUSPECT,Unknown,300,MG,2,Subcutaneous
513,7520,IS_SECONDARY_SUSPECT,Unknown,75,MG,2,Unknown
514,7235,IS_SECONDARY_SUSPECT,Vulvovaginal dryness,1,G,3,Vaginal
517,7325,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,40,MG,2,Unknown
520,7178,IS_SECONDARY_SUSPECT,Unknown,150,MG,3,Oral
521,7178,IS_SECONDARY_SUSPECT,Fibromyalgia,300,MG,2,Unknown
525,7176,IS_SECONDARY_SUSPECT,Unknown,15,MG,2,Oral
525,7199,IS_SECONDARY_SUSPECT,Plasma cell myeloma,40,MG,4,Oral
527,7361,IS_SECONDARY_SUSPECT,Unknown,11,MG,2,Oral
528,7178,IS_SECONDARY_SUSPECT,Testicular pain,300,MG,2,Oral
530,7860,IS_SECONDARY_SUSPECT,Unknown,14,MG,2,Oral
530,7861,IS_SECONDARY_SUSPECT,Neoplasm,200,MG,5,Intravenous drip
531,7176,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Oral
531,7177,IS_SECONDARY_SUSPECT,Plasma cell myeloma,40,MG,5,Oral
532,7520,IS_SECONDARY_SUSPECT,Unknown,75,MG,2,Intravenous (not otherwise specified)
534,7863,IS_SECONDARY_SUSPECT,Menopause,0.037,MG,2,Transdermal
535,7178,IS_SECONDARY_SUSPECT,Unknown,75,MG,2,Oral
536,7338,IS_SECONDARY_SUSPECT,Unknown,5,MG,2,Oral
537,7178,IS_SECONDARY_SUSPECT,Neuropathy peripheral,100,MG,2,Oral
539,7874,IS_SECONDARY_SUSPECT,Factor VIII deficiency,2235,IU,2,Intravenous (not otherwise specified)
540,7178,IS_SECONDARY_SUSPECT,Unknown,100,MG,2,Oral
541,7190,IS_SECONDARY_SUSPECT,Plasma cell myeloma,1.3,MG/M**2,2,Subcutaneous
541,7199,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG,3,Oral
542,7361,IS_SECONDARY_SUSPECT,Unknown,11,MG,2,Oral
543,7199,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG,2,Oral
543,7253,IS_SECONDARY_SUSPECT,Plasma cell myeloma,16,MG/KG,3,Intravenous drip
549,7325,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,40,MG,4,Oral
549,7271,IS_SECONDARY_SUSPECT,Unknown,40,MG,8,Intravenous (not otherwise specified)
549,7230,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,40,MG,9,Unknown
550,7235,IS_SECONDARY_SUSPECT,Unknown,0.3,MG,2,Unknown
552,7851,IS_SECONDARY_SUSPECT,Unknown,30,MG,2,Topical
553,7190,IS_SECONDARY_SUSPECT,Plasma cell myeloma,1.3,MG/M**2,2,Intravenous drip
553,7171,IS_SECONDARY_SUSPECT,Plasma cell myeloma,10,MG,4,Oral
554,7876,IS_SECONDARY_SUSPECT,Unknown,1312,MG,2,Intravenous (not otherwise specified)
554,7877,IS_SECONDARY_SUSPECT,Plasma cell myeloma,4,MG,4,Oral
554,7163,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG,5,Oral
554,7878,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG,7,Intravenous (not otherwise specified)
555,7718,IS_SECONDARY_SUSPECT,Unknown,300,MG,2,Subcutaneous
555,7719,IS_SECONDARY_SUSPECT,Immune system disorder,1000,IU,3,Intravenous (not otherwise specified)
555,7882,IS_SECONDARY_SUSPECT,Immune system disorder,30,MG,9,Subcutaneous
556,7538,IS_SECONDARY_SUSPECT,Ovarian cancer,175,MG/M**2,4,Intravenous (not otherwise specified)
558,7884,IS_SECONDARY_SUSPECT,Unknown,100,MG,2,Oral
560,7176,IS_SECONDARY_SUSPECT,Plasma cell myeloma,25,MG,3,Oral
560,7251,IS_SECONDARY_SUSPECT,Plasma cell myeloma,70,MG,5,Intravenous drip
561,7887,IS_SECONDARY_SUSPECT,Immunisation,240,UG,2,Intramuscular
562,7178,IS_SECONDARY_SUSPECT,Cystic fibrosis,75,MG,2,Oral
563,7199,IS_SECONDARY_SUSPECT,Plasma cell myeloma,12,MG,2,Oral
564,7553,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,60,MG,2,Unknown
565,7359,IS_SECONDARY_SUSPECT,Unknown,200,MG,2,Oral
566,7325,IS_SECONDARY_SUSPECT,Unknown,40,MG,4,Unknown
566,7371,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,40,MG,9,Oral
566,7230,IS_SECONDARY_SUSPECT,Gastrointestinal disorder,20,MG,13,Oral
566,7271,IS_SECONDARY_SUSPECT,Unknown,40,MG,16,Unknown
566,7552,IS_SECONDARY_SUSPECT,Unknown,20,MG,20,Unknown
567,7176,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Oral
567,7283,IS_SECONDARY_SUSPECT,Plasma cell myeloma,2,MG,7,Oral
567,7188,IS_SECONDARY_SUSPECT,Plasma cell myeloma,1.3,MG/M**2,8,Intravenous drip
567,7163,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG,11,Oral
567,7237,IS_SECONDARY_SUSPECT,Plasma cell myeloma,3100,MG,18,Intravenous drip
567,7250,IS_SECONDARY_SUSPECT,Plasma cell myeloma,153,MG,20,Intravenous drip
567,7251,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG/M**2,22,Intravenous drip
567,7302,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG,23,Oral
567,7360,IS_SECONDARY_SUSPECT,Plasma cell myeloma,4,MG,25,Oral
567,7253,IS_SECONDARY_SUSPECT,Plasma cell myeloma,8,MG/M**2,27,Intravenous drip
567,7892,IS_SECONDARY_SUSPECT,Plasma cell myeloma,7.5,MG/M**2,29,Intravenous drip
567,7443,IS_SECONDARY_SUSPECT,Plasma cell myeloma,12,MG,30,Intravenous drip
567,7246,IS_SECONDARY_SUSPECT,Plasma cell myeloma,310,MG,31,Intravenous drip
571,7893,IS_SECONDARY_SUSPECT,Unknown,250,MG,2,Oral
572,7538,IS_SECONDARY_SUSPECT,Ovarian cancer,175,MG/M**2,2,Intravenous (not otherwise specified)
573,7233,IS_SECONDARY_SUSPECT,Unknown,225,UG,2,Intravenous bolus
575,7177,IS_SECONDARY_SUSPECT,Plasma cell myeloma,40,MG,2,Oral
575,7683,IS_SECONDARY_SUSPECT,Plasma cell myeloma,16,MG/KG,3,Intravenous drip
576,7176,IS_SECONDARY_SUSPECT,Unknown,25,MG,2,Oral
576,7199,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG,7,Oral
576,7190,IS_SECONDARY_SUSPECT,Plasma cell myeloma,1.3,MG/M**2,12,Subcutaneous
577,7520,IS_SECONDARY_SUSPECT,Unknown,135,MG,2,Intravenous (not otherwise specified)
578,7199,IS_SECONDARY_SUSPECT,Plasma cell myeloma,40,MG,2,Oral
578,7189,IS_SECONDARY_SUSPECT,Plasma cell myeloma,27,MG/M**2,3,Intravenous drip
579,7253,IS_SECONDARY_SUSPECT,Plasma cell myeloma,16,MG/KG,2,Intravenous drip
579,7451,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG,3,Intravenous drip
580,7897,IS_SECONDARY_SUSPECT,On and off phenomenon,84,MG,2,Unknown
581,7199,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG,2,Oral
581,7222,IS_SECONDARY_SUSPECT,Plasma cell myeloma,10,MG/KG,3,Intravenous drip
582,7178,IS_SECONDARY_SUSPECT,Type 2 diabetes mellitus,200,MG,2,Unknown
583,7451,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG,2,Intravenous drip
583,7253,IS_SECONDARY_SUSPECT,Plasma cell myeloma,16,MG/KG,3,Intravenous drip
584,7199,IS_SECONDARY_SUSPECT,Unknown,4,MG,9,Oral
584,7253,IS_SECONDARY_SUSPECT,Plasma cell myeloma,16,MG/KG,10,Intravenous drip
585,7898,IS_SECONDARY_SUSPECT,Pulmonary arterial hypertension,8,MG,2,Oral
586,7538,IS_SECONDARY_SUSPECT,Ovarian cancer,175,MG/M**2,2,Intravenous (not otherwise specified)
586,7537,IS_SECONDARY_SUSPECT,Ovarian cancer,15,MG/KG,4,Intravenous (not otherwise specified)
587,7246,IS_SECONDARY_SUSPECT,Hodgkin's disease,125,MG/M**2,2,Intravenous (not otherwise specified)
587,7244,IS_SECONDARY_SUSPECT,Hodgkin's disease,25,MG/M**2,3,Intravenous (not otherwise specified)
587,7237,IS_SECONDARY_SUSPECT,Hodgkin's disease,600,MG/M**2,4,Intravenous (not otherwise specified)
587,7245,IS_SECONDARY_SUSPECT,Hodgkin's disease,1.4,MG/M**2,5,Intravenous (not otherwise specified)
587,7171,IS_SECONDARY_SUSPECT,Hodgkin's disease,20,MG/M**2,6,Oral
590,7199,IS_SECONDARY_SUSPECT,Plasma cell myeloma,2,MG,2,Oral
596,7199,IS_SECONDARY_SUSPECT,Plasma cell myeloma,2,MG,2,Oral
596,7253,IS_SECONDARY_SUSPECT,Plasma cell myeloma,1180,MG,3,Intravenous drip
597,7283,IS_SECONDARY_SUSPECT,Unknown,2,MG,2,Oral
597,7253,IS_SECONDARY_SUSPECT,Plasma cell myeloma,900,MG,3,Intravenous drip
598,7902,IS_SECONDARY_SUSPECT,Haemophagocytic lymphohistiocytosis,35,MG/KG,2,Unknown
598,7903,IS_SECONDARY_SUSPECT,Juvenile idiopathic arthritis,25,MG,19,Unknown
598,7904,IS_SECONDARY_SUSPECT,Haemophagocytic lymphohistiocytosis,100,MG,20,Unknown
598,7905,IS_SECONDARY_SUSPECT,Haemophagocytic lymphohistiocytosis,240,MG,28,Unknown
599,7178,IS_SECONDARY_SUSPECT,Neuropathy peripheral,100,MG,2,Oral
601,7913,IS_SECONDARY_SUSPECT,Pancreatic carcinoma metastatic,3,UG/KG,2,Intravenous (not otherwise specified)
603,7914,IS_SECONDARY_SUSPECT,Unknown,4,MG,2,Unknown
604,7918,IS_SECONDARY_SUSPECT,Unknown,400,MG,2,Subcutaneous
608,7222,IS_SECONDARY_SUSPECT,Plasma cell myeloma,10,MG/KG,2,Intravenous drip
608,7177,IS_SECONDARY_SUSPECT,Plasma cell myeloma,8,MG,3,Intravenous drip
619,7702,IS_SECONDARY_SUSPECT,Breast cancer,140,MG,2,Unknown
619,7684,IS_SECONDARY_SUSPECT,Breast cancer,140,MG,3,Unknown
622,7688,IS_SECONDARY_SUSPECT,Unknown,120,MG,2,Oral
624,7790,IS_SECONDARY_SUSPECT,Unknown,16,G,2,Subcutaneous
625,7178,IS_SECONDARY_SUSPECT,Neuritis,200,MG,2,Oral
628,7931,IS_SECONDARY_SUSPECT,Hypertension,160,MG,2,Unknown
629,7253,IS_SECONDARY_SUSPECT,Plasma cell myeloma,960,MG,2,Intravenous drip
629,7451,IS_SECONDARY_SUSPECT,Plasma cell myeloma,10,MG,3,Intravenous drip
631,7537,IS_SECONDARY_SUSPECT,Ovarian cancer,15,MG/M**2,2,Intravenous (not otherwise specified)
631,7538,IS_SECONDARY_SUSPECT,Ovarian cancer,175,MG/M**2,3,Intravenous (not otherwise specified)
632,7199,IS_SECONDARY_SUSPECT,Plasma cell myeloma,8,MG,2,Oral
633,7254,IS_SECONDARY_SUSPECT,Short-bowel syndrome,4.35,MG,2,Unknown
634,7222,IS_SECONDARY_SUSPECT,Plasma cell myeloma,10,MG/KG,2,Intravenous drip
635,7222,IS_SECONDARY_SUSPECT,Plasma cell myeloma,10,MG/KG,2,Intravenous drip
636,7176,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Oral
636,7199,IS_SECONDARY_SUSPECT,Plasma cell myeloma,40,MG,3,Oral
637,7176,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Oral
637,7189,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG/M**2,3,Intravenous drip
637,7163,IS_SECONDARY_SUSPECT,Plasma cell myeloma,40,MG,6,Oral
638,7280,IS_SECONDARY_SUSPECT,Unknown,125,MG,2,Unknown
640,7178,IS_SECONDARY_SUSPECT,Neuropathy peripheral,150,MG,2,Unknown
642,7940,IS_SECONDARY_SUSPECT,Diffuse large B-cell lymphoma,758,MG,3,Intravenous (not otherwise specified)
642,7244,IS_SECONDARY_SUSPECT,Diffuse large B-cell lymphoma,101,MG,4,Intravenous (not otherwise specified)
642,7237,IS_SECONDARY_SUSPECT,Diffuse large B-cell lymphoma,1516,MG,5,Intravenous (not otherwise specified)
642,7171,IS_SECONDARY_SUSPECT,Diffuse large B-cell lymphoma,100,MG,6,Intravenous (not otherwise specified)
646,7333,IS_SECONDARY_SUSPECT,Acute myeloid leukaemia,205,MG,2,Intravenous drip
646,7950,IS_SECONDARY_SUSPECT,Acute myeloid leukaemia,122.5,MG,3,Intravenous drip
647,7178,IS_SECONDARY_SUSPECT,Migraine,400,MG,2,Unknown
648,7520,IS_SECONDARY_SUSPECT,Unknown,110,MG,2,Intravenous (not otherwise specified)
650,7442,IS_SECONDARY_SUSPECT,Neoplasm,800,MG,1,Intravenous (not otherwise specified)
651,7199,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG,2,Oral
651,7360,IS_SECONDARY_SUSPECT,Plasma cell myeloma,4,MG,3,Oral
653,7748,IS_SECONDARY_SUSPECT,Pain,10,MG,2,Unknown
653,7178,IS_SECONDARY_SUSPECT,Neuralgia,50,MG,3,Unknown
653,7618,IS_SECONDARY_SUSPECT,Pain,800,MG,6,Unknown
654,7536,IS_SECONDARY_SUSPECT,Metastatic neoplasm,1200,MG,2,Intravenous drip
655,7862,IS_SECONDARY_SUSPECT,Dermatitis,300,MG,2,Subcutaneous
656,7961,IS_SECONDARY_SUSPECT,Post procedural hypoparathyroidism,25,UG,2,Subcutaneous
657,7520,IS_SECONDARY_SUSPECT,Unknown,75,MG,2,Unknown
658,7520,IS_SECONDARY_SUSPECT,Unknown,60,MG,2,Intravenous (not otherwise specified)
659,7178,IS_SECONDARY_SUSPECT,Type 2 diabetes mellitus,300,MG,2,Oral
660,7520,IS_SECONDARY_SUSPECT,Unknown,150,MG,2,Unknown
661,7520,IS_SECONDARY_SUSPECT,Unknown,150,MG,2,Unknown
662,7520,IS_SECONDARY_SUSPECT,Unknown,180,G,2,Unknown
665,7190,IS_SECONDARY_SUSPECT,Unknown,3.18,MG,2,Subcutaneous
665,7177,IS_SECONDARY_SUSPECT,Plasma cell myeloma,10,MG,3,Unknown
665,7176,IS_SECONDARY_SUSPECT,Plasma cell myeloma,25,MG,5,Oral
665,7876,IS_SECONDARY_SUSPECT,Plasma cell myeloma,1800,MG,9,Subcutaneous
667,7178,IS_SECONDARY_SUSPECT,Neuropathy peripheral,75,MG,2,Oral
668,7188,IS_SECONDARY_SUSPECT,Plasma cell myeloma,3.1,MG,1,Subcutaneous
668,7876,IS_SECONDARY_SUSPECT,Unknown,1800,MG,4,Subcutaneous
668,7177,IS_SECONDARY_SUSPECT,Plasma cell myeloma,10,MG,5,Unknown
668,7176,IS_SECONDARY_SUSPECT,Plasma cell myeloma,25,MG,7,Oral
671,7961,IS_SECONDARY_SUSPECT,Post procedural hypoparathyroidism,50,UG,2,Subcutaneous
672,7178,IS_SECONDARY_SUSPECT,Osteoarthritis,75,MG,2,Unknown
673,7502,IS_SECONDARY_SUSPECT,Cholangiocarcinoma,780,MG,2,Oral
674,7950,IS_SECONDARY_SUSPECT,Acute myeloid leukaemia,150,MG,2,Intravenous drip
675,7237,IS_SECONDARY_SUSPECT,Peripheral T-cell lymphoma unspecified,750,MG/M**2,2,Intravenous (not otherwise specified)
675,7976,IS_SECONDARY_SUSPECT,Peripheral T-cell lymphoma unspecified,1.8,MG/KG,3,Intravenous (not otherwise specified)
675,7246,IS_SECONDARY_SUSPECT,Peripheral T-cell lymphoma unspecified,100,MG/M**2,4,Intravenous (not otherwise specified)
675,7171,IS_SECONDARY_SUSPECT,Peripheral T-cell lymphoma unspecified,100,MG,5,Oral
676,7940,IS_SECONDARY_SUSPECT,Diffuse large B-cell lymphoma,800,MG,2,Intravenous (not otherwise specified)
676,7246,IS_SECONDARY_SUSPECT,Diffuse large B-cell lymphoma,298,MG,3,Unknown
676,7171,IS_SECONDARY_SUSPECT,Diffuse large B-cell lymphoma,125,MG,4,Oral
676,7237,IS_SECONDARY_SUSPECT,Diffuse large B-cell lymphoma,1610,MG,5,Intravenous (not otherwise specified)
676,7352,IS_SECONDARY_SUSPECT,Diffuse large B-cell lymphoma,1.7,MG,6,Intravenous (not otherwise specified)
676,7977,IS_SECONDARY_SUSPECT,Diffuse large B-cell lymphoma,60,MG,7,Intravenous (not otherwise specified)
682,7940,IS_SECONDARY_SUSPECT,Diffuse large B-cell lymphoma,375,MG/M**2,2,Intravenous (not otherwise specified)
682,7473,IS_SECONDARY_SUSPECT,Diffuse large B-cell lymphoma,1000,MG/M**2,3,Intravenous (not otherwise specified)
682,7978,IS_SECONDARY_SUSPECT,Diffuse large B-cell lymphoma,100,MG/M**2,4,Intravenous (not otherwise specified)
684,7359,IS_SECONDARY_SUSPECT,Unknown,400,MG,2,Unknown
685,7520,IS_SECONDARY_SUSPECT,Unknown,160,MG,2,Unknown
686,7982,IS_SECONDARY_SUSPECT,Unknown,60,G,2,Intravenous (not otherwise specified)
688,7179,IS_SECONDARY_SUSPECT,Unknown,45,MG,2,Intravenous drip
690,7477,IS_SECONDARY_SUSPECT,Unknown,4,MG,2,Oral
690,7920,IS_SECONDARY_SUSPECT,Plasma cell myeloma,10,MG,5,Oral
692,7321,IS_SECONDARY_SUSPECT,Renal transplant,250,MG,2,Oral
693,7984,IS_SECONDARY_SUSPECT,Unknown,300,MG,2,Subcutaneous
694,7496,IS_SECONDARY_SUSPECT,Unknown,300,MG,2,Intravenous (not otherwise specified)
695,7991,IS_SECONDARY_SUSPECT,Hodgkin's disease,9900,MG,2,Intravenous (not otherwise specified)
695,7539,IS_SECONDARY_SUSPECT,Hodgkin's disease,750,MG,3,Intravenous (not otherwise specified)
695,7246,IS_SECONDARY_SUSPECT,Hodgkin's disease,200,MG,4,Intravenous (not otherwise specified)
697,7790,IS_SECONDARY_SUSPECT,Immunodeficiency common variable,12,G,2,Subcutaneous
698,7632,IS_SECONDARY_SUSPECT,Unknown,0.8,MG,2,Unknown
699,7477,IS_SECONDARY_SUSPECT,Unknown,3,MG,2,Oral
699,7468,IS_SECONDARY_SUSPECT,Unknown,50,MG,6,Unknown
699,7992,IS_SECONDARY_SUSPECT,Unknown,20,MG,7,Unknown
700,7982,IS_SECONDARY_SUSPECT,Unknown,10,G,2,Subcutaneous
701,7451,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG,2,Intravenous drip
701,7237,IS_SECONDARY_SUSPECT,Plasma cell myeloma,150,MG/M**2,4,Intravenous drip
701,7199,IS_SECONDARY_SUSPECT,Plasma cell myeloma,40,MG,6,Oral
701,7188,IS_SECONDARY_SUSPECT,Plasma cell myeloma,1.3,MG/M**2,8,Subcutaneous
701,7189,IS_SECONDARY_SUSPECT,Plasma cell myeloma,35,MG,13,Intravenous drip
702,7993,IS_SECONDARY_SUSPECT,Unknown,50,MG,2,Oral
702,7994,IS_SECONDARY_SUSPECT,Chronic lymphocytic leukaemia,420,MG,6,Oral
703,7982,IS_SECONDARY_SUSPECT,Unknown,25,G,2,Intravenous (not otherwise specified)
704,7790,IS_SECONDARY_SUSPECT,Primary immunodeficiency syndrome,8,G,1,Subcutaneous
705,7790,IS_SECONDARY_SUSPECT,Immunodeficiency common variable,12,G,2,Subcutaneous
706,7790,IS_SECONDARY_SUSPECT,Unknown,7,G,2,Subcutaneous
707,7982,IS_SECONDARY_SUSPECT,Unknown,40,G,2,Intravenous (not otherwise specified)
708,7982,IS_SECONDARY_SUSPECT,Chronic lymphocytic leukaemia,30,G,2,Intravenous (not otherwise specified)
709,7790,IS_SECONDARY_SUSPECT,Unknown,7,G,2,Subcutaneous
711,7280,IS_SECONDARY_SUSPECT,Unknown,75,MG,2,Unknown
712,7520,IS_SECONDARY_SUSPECT,Unknown,140,MG,2,Intravenous (not otherwise specified)
714,7253,IS_SECONDARY_SUSPECT,Plasma cell myeloma refractory,16,MG/KG,2,Intravenous (not otherwise specified)
714,7252,IS_SECONDARY_SUSPECT,Plasma cell myeloma refractory,4,MG,3,Oral
714,7163,IS_SECONDARY_SUSPECT,Plasma cell myeloma refractory,40,MG,6,Oral
716,8004,IS_SECONDARY_SUSPECT,Unknown,84,MG,2,Unknown
718,7790,IS_SECONDARY_SUSPECT,Unknown,20,G,2,Subcutaneous
720,8005,IS_SECONDARY_SUSPECT,Metastatic malignant melanoma,360,MG,1,Intravenous (not otherwise specified)
721,7782,IS_SECONDARY_SUSPECT,Cerebrovascular accident prophylaxis,20,MG,2,Oral
721,8011,IS_SECONDARY_SUSPECT,Acute myeloid leukaemia,100,MG,5,Oral
722,7361,IS_SECONDARY_SUSPECT,Unknown,11,MG,3,Unknown
725,7790,IS_SECONDARY_SUSPECT,Immunodeficiency common variable,16,G,3,Subcutaneous
726,7918,IS_SECONDARY_SUSPECT,Unknown,200,MG,2,Subcutaneous
727,8011,IS_SECONDARY_SUSPECT,Unknown,75,MG,3,Oral
727,7333,IS_SECONDARY_SUSPECT,Acute myeloid leukaemia,186,MG,4,Intravenous drip
727,7950,IS_SECONDARY_SUSPECT,Acute myeloid leukaemia,114,MG,5,Intravenous drip
727,7270,IS_SECONDARY_SUSPECT,Nausea,8,MG,6,Intravenous bolus
728,7982,IS_SECONDARY_SUSPECT,Unknown,25,G,2,Intravenous (not otherwise specified)
729,8014,IS_SECONDARY_SUSPECT,Unknown,140,MG,2,Oral
730,7734,IS_SECONDARY_SUSPECT,Unknown,1,MG,2,Unknown
733,7982,IS_SECONDARY_SUSPECT,Unknown,45,G,2,Intravenous (not otherwise specified)
735,7995,IS_SECONDARY_SUSPECT,Chronic lymphocytic leukaemia,100,MG,2,Intravenous (not otherwise specified)
735,7994,IS_SECONDARY_SUSPECT,Chronic lymphocytic leukaemia,420,MG,3,Oral
736,7982,IS_SECONDARY_SUSPECT,Unknown,12,G,2,Subcutaneous
737,7718,IS_SECONDARY_SUSPECT,Immune system disorder,300,MG,2,Subcutaneous
739,7790,IS_SECONDARY_SUSPECT,Illness,16,G,2,Unknown
741,7961,IS_SECONDARY_SUSPECT,Hypoparathyroidism,100,UG,2,Unknown
742,7178,IS_SECONDARY_SUSPECT,Fibromyalgia,75,MG,2,Oral
743,7520,IS_SECONDARY_SUSPECT,Unknown,120,MG,2,Intravenous (not otherwise specified)
744,7520,IS_SECONDARY_SUSPECT,Unknown,140,MG,2,Intravenous (not otherwise specified)
745,7790,IS_SECONDARY_SUSPECT,Unknown,3,G,2,Subcutaneous
749,7790,IS_SECONDARY_SUSPECT,Immunodeficiency common variable,16,G,2,Subcutaneous
750,7982,IS_SECONDARY_SUSPECT,Unknown,20,G,2,Subcutaneous
751,7897,IS_SECONDARY_SUSPECT,On and off phenomenon,84,MG,2,Unknown
751,8034,IS_SECONDARY_SUSPECT,Dyskinesia,274,MG,4,Unknown
752,7979,IS_SECONDARY_SUSPECT,Unknown,300,G,2,Intravenous (not otherwise specified)
753,7361,IS_SECONDARY_SUSPECT,Unknown,11,MG,2,Oral
755,7961,IS_SECONDARY_SUSPECT,Hypocalcaemia,75,UG,2,Subcutaneous
756,8039,IS_SECONDARY_SUSPECT,Peripheral T-cell lymphoma unspecified refractory,28,MG,2,Intravenous (not otherwise specified)
760,7178,IS_SECONDARY_SUSPECT,Unknown,150,MG,2,Oral
761,7280,IS_SECONDARY_SUSPECT,Breast cancer female,125,MG,2,Oral
762,8040,IS_SECONDARY_SUSPECT,Multiple sclerosis,30,UG,14,Intramuscular
763,7993,IS_SECONDARY_SUSPECT,Acute myeloid leukaemia,100,MG,2,Oral
763,8042,IS_SECONDARY_SUSPECT,Acute myeloid leukaemia,35,MG,5,Intravenous drip
764,7353,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,35,MG,2,Oral
764,7163,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,4,MG,6,Oral
764,8048,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,1.14,MG,8,Intravenous (not otherwise specified)
764,8049,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,19000,IU,13,Intramuscular
764,7332,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,12,MG,17,Intrathecal
764,7333,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,57,MG,22,Intravenous (not otherwise specified)
764,8050,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,45,MG,24,Oral
765,8014,IS_SECONDARY_SUSPECT,Unknown,280,MG,2,Oral
767,7790,IS_SECONDARY_SUSPECT,Unknown,30,G,2,Subcutaneous
769,7361,IS_SECONDARY_SUSPECT,Unknown,11,MG,2,Oral
770,7536,IS_SECONDARY_SUSPECT,Unknown,1200,MG,2,Intravenous drip
770,8053,IS_SECONDARY_SUSPECT,Transitional cell carcinoma,600,MG,14,Oral
772,7496,IS_SECONDARY_SUSPECT,Unknown,300,MG,2,Intravenous (not otherwise specified)
773,7352,IS_SECONDARY_SUSPECT,Unknown,1.14,MG,2,Intravenous (not otherwise specified)
773,7333,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,57,MG,4,Intravenous (not otherwise specified)
773,7643,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,12,MG,5,Intrathecal
773,7353,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,35,MG,10,Oral
773,8057,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,19000,IU,13,Intramuscular
773,7237,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,760,MG,15,Intravenous (not otherwise specified)
773,7838,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,45,MG,16,Oral
773,7163,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,4,MG,17,Oral
774,8058,IS_SECONDARY_SUSPECT,Alpha-1 antitrypsin deficiency,60,MG/KG,2,Intravenous (not otherwise specified)
775,7982,IS_SECONDARY_SUSPECT,Unknown,40,G,2,Intravenous (not otherwise specified)
776,7876,IS_SECONDARY_SUSPECT,Plasma cell myeloma,16,MG/KG,2,Intravenous (not otherwise specified)
777,7176,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Oral
779,7718,IS_SECONDARY_SUSPECT,Unknown,2,ML,2,Subcutaneous
779,7882,IS_SECONDARY_SUSPECT,Hereditary angioedema,3,MG,3,Subcutaneous
781,8058,IS_SECONDARY_SUSPECT,Alpha-1 antitrypsin deficiency,4328,MG,2,Intravenous (not otherwise specified)
784,7254,IS_SECONDARY_SUSPECT,Unknown,0.42,ML,5,Other
787,7874,IS_SECONDARY_SUSPECT,Factor VIII deficiency,2500,IU,2,Intravenous drip
789,7280,IS_SECONDARY_SUSPECT,Unknown,100,MG,2,Oral
790,7827,IS_SECONDARY_SUSPECT,Unknown,1,MG,2,Oral
791,8063,IS_SECONDARY_SUSPECT,Unknown,75,UG,4,Subcutaneous
792,7176,IS_SECONDARY_SUSPECT,Unknown,15,MG,2,Oral
793,7982,IS_SECONDARY_SUSPECT,Unknown,12,G,2,Subcutaneous
794,8066,IS_SECONDARY_SUSPECT,Pancreatic carcinoma metastatic,16,MG,2,Subcutaneous
794,7473,IS_SECONDARY_SUSPECT,Pancreatic carcinoma metastatic,1920,MG,3,Intravenous (not otherwise specified)
794,8067,IS_SECONDARY_SUSPECT,Pancreatic carcinoma metastatic,240,MG,4,Intravenous (not otherwise specified)
795,7982,IS_SECONDARY_SUSPECT,Unknown,100,G,2,Intravenous (not otherwise specified)
796,8069,IS_SECONDARY_SUSPECT,Unknown,20,MG,2,Unknown
797,8069,IS_SECONDARY_SUSPECT,Unknown,20,MG,2,Oral
798,8069,IS_SECONDARY_SUSPECT,Unknown,20,MG,2,Oral
799,7982,IS_SECONDARY_SUSPECT,Unknown,75,G,2,Intravenous (not otherwise specified)
800,7333,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,57,MG,2,Intravenous (not otherwise specified)
800,8072,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,12,MG,3,Intrathecal
800,7353,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,35,MG,8,Oral
800,7781,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,1.14,MG,11,Intravenous (not otherwise specified)
800,8057,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,19000,IU,14,Intramuscular
800,7237,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,760,MG,16,Intravenous (not otherwise specified)
800,7789,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,45,MG,17,Oral
801,7333,IS_SECONDARY_SUSPECT,Acute myeloid leukaemia,180,MG,2,Intravenous drip
801,7950,IS_SECONDARY_SUSPECT,Acute myeloid leukaemia,110,MG,3,Intravenous drip
802,7178,IS_SECONDARY_SUSPECT,Unknown,75,MG,3,Oral
803,7982,IS_SECONDARY_SUSPECT,Unknown,35,G,2,Intravenous (not otherwise specified)
804,7477,IS_SECONDARY_SUSPECT,Unknown,4,MG,2,Oral
806,7178,IS_SECONDARY_SUSPECT,Unknown,150,MG,2,Oral
808,7176,IS_SECONDARY_SUSPECT,Plasma cell myeloma,25,MG,2,Oral
808,7222,IS_SECONDARY_SUSPECT,Plasma cell myeloma,1200,MG,4,Intravenous drip
809,8085,IS_SECONDARY_SUSPECT,Non-small cell lung cancer,1.5,ML,1,Subcutaneous
815,7790,IS_SECONDARY_SUSPECT,Selective IgG subclass deficiency,11,G,2,Subcutaneous
817,7254,IS_SECONDARY_SUSPECT,Short-bowel syndrome,0.09,ML,2,Subcutaneous
818,7685,IS_SECONDARY_SUSPECT,Unknown,6,MG,2,Unknown
820,7994,IS_SECONDARY_SUSPECT,Chronic lymphocytic leukaemia,420,MG,2,Oral
821,7893,IS_SECONDARY_SUSPECT,PIK3CA related overgrowth spectrum,250,MG,2,Oral
822,7994,IS_SECONDARY_SUSPECT,Chronic lymphocytic leukaemia,420,MG,2,Oral
823,7283,IS_SECONDARY_SUSPECT,Unknown,3,MG,2,Oral
824,7283,IS_SECONDARY_SUSPECT,Plasma cell myeloma,3,MG,2,Oral
824,7477,IS_SECONDARY_SUSPECT,Plasma cell myeloma,3,MG,3,Oral
824,7253,IS_SECONDARY_SUSPECT,Plasma cell myeloma,16,MG/KG,7,Intravenous drip
824,7188,IS_SECONDARY_SUSPECT,Plasma cell myeloma,2.9,MG,8,Subcutaneous
824,7237,IS_SECONDARY_SUSPECT,Plasma cell myeloma,500,MG,9,Oral
824,7177,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG,11,Oral
824,7189,IS_SECONDARY_SUSPECT,Plasma cell myeloma,45,MG,15,Intravenous drip
825,7254,IS_SECONDARY_SUSPECT,Short-bowel syndrome,2.93,MG,2,Unknown
827,7790,IS_SECONDARY_SUSPECT,Unknown,16,G,2,Subcutaneous
828,7978,IS_SECONDARY_SUSPECT,Transitional cell cancer of renal pelvis and ureter metastatic,215,MG,3,Intravenous (not otherwise specified)
829,7782,IS_SECONDARY_SUSPECT,Non-small cell lung cancer,10,MG,3,Oral
829,8089,IS_SECONDARY_SUSPECT,Non-small cell lung cancer,500,MG/M**2,4,Unknown
830,7176,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Oral
830,7190,IS_SECONDARY_SUSPECT,Plasma cell myeloma,1.3,MG/M**2,4,Subcutaneous
830,7250,IS_SECONDARY_SUSPECT,Plasma cell myeloma,100,MG/M**2,5,Intravenous drip
830,7451,IS_SECONDARY_SUSPECT,Plasma cell myeloma,40,MG,6,Intravenous drip
831,7280,IS_SECONDARY_SUSPECT,Breast cancer metastatic,100,MG,2,Oral
832,7280,IS_SECONDARY_SUSPECT,Unknown,75,MG,2,Oral
833,7790,IS_SECONDARY_SUSPECT,Immunodeficiency common variable,16,G,2,Subcutaneous
834,7790,IS_SECONDARY_SUSPECT,Unknown,20,G,2,Subcutaneous
835,7982,IS_SECONDARY_SUSPECT,Unknown,25,G,2,Intravenous (not otherwise specified)
836,7982,IS_SECONDARY_SUSPECT,B-lymphocyte abnormalities,50,G,2,Intravenous (not otherwise specified)
837,7176,IS_SECONDARY_SUSPECT,Plasma cell myeloma,10,MG,2,Oral
838,7979,IS_SECONDARY_SUSPECT,Unknown,40,G,2,Subcutaneous
839,7979,IS_SECONDARY_SUSPECT,Primary immunodeficiency syndrome,25,G,2,Subcutaneous
840,7790,IS_SECONDARY_SUSPECT,Unknown,25,G,2,Subcutaneous
842,7196,IS_SECONDARY_SUSPECT,Unknown,75,MG,2,Unknown
843,7178,IS_SECONDARY_SUSPECT,Unknown,300,MG,2,Oral
845,8092,IS_SECONDARY_SUSPECT,Pain,10,MG,3,Oral
847,7783,IS_SECONDARY_SUSPECT,Hepatitis B,300,MG,2,Oral
847,8096,IS_SECONDARY_SUSPECT,HIV infection,1,DF,6,Oral
848,7790,IS_SECONDARY_SUSPECT,Immunodeficiency common variable,18,G,2,Subcutaneous
849,7982,IS_SECONDARY_SUSPECT,Encephalitis,67.5,G,2,Intravenous (not otherwise specified)
851,8097,IS_SECONDARY_SUSPECT,Unknown,90,MG,4,Oral
853,8099,IS_SECONDARY_SUSPECT,Hepatocellular carcinoma,40,MG,2,Oral
854,7718,IS_SECONDARY_SUSPECT,Hereditary angioedema with C1 esterase inhibitor deficiency,300,MG,1,Subcutaneous
854,7719,IS_SECONDARY_SUSPECT,Immune system disorder,1000,IU,6,Intravenous (not otherwise specified)
855,7278,IS_SECONDARY_SUSPECT,Unknown,40,MG,2,Subcutaneous
855,8100,IS_SECONDARY_SUSPECT,Crohn's disease,25,MG,9,Oral
856,7734,IS_SECONDARY_SUSPECT,Unknown,130,MG,2,Unknown
856,7735,IS_SECONDARY_SUSPECT,Invasive ductal breast carcinoma,165,MG,6,Unknown
856,7737,IS_SECONDARY_SUSPECT,Invasive ductal breast carcinoma,165,MG,10,Unknown
857,7790,IS_SECONDARY_SUSPECT,Unknown,6,G,2,Subcutaneous
860,7179,IS_SECONDARY_SUSPECT,Lipidosis,85,MG,2,Intravenous (not otherwise specified)
861,8114,IS_SECONDARY_SUSPECT,Unknown,1200,MG,2,Oral
862,7790,IS_SECONDARY_SUSPECT,Unknown,10,G,2,Subcutaneous
864,8119,IS_SECONDARY_SUSPECT,Unknown,300,MG,2,Oral
865,8014,IS_SECONDARY_SUSPECT,Unknown,420,MG,2,Oral
865,7171,IS_SECONDARY_SUSPECT,Chronic lymphocytic leukaemia,10,MG,6,Oral
866,7176,IS_SECONDARY_SUSPECT,Plasma cell myeloma,25,MG,2,Unknown
866,7876,IS_SECONDARY_SUSPECT,Plasma cell myeloma,16,MG/KG,3,Intravenous (not otherwise specified)
867,7283,IS_SECONDARY_SUSPECT,Plasma cell myeloma,4,MG,2,Oral
867,7222,IS_SECONDARY_SUSPECT,Plasma cell myeloma,10,MG/KG,3,Intravenous drip
867,7177,IS_SECONDARY_SUSPECT,Plasma cell myeloma,40,MG,5,Oral
867,7189,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG/M**2,10,Intravenous drip
867,7253,IS_SECONDARY_SUSPECT,Plasma cell myeloma,16,MG/KG,12,Intravenous drip
867,7190,IS_SECONDARY_SUSPECT,Plasma cell myeloma,1.3,MG/M**2,13,Subcutaneous
867,7237,IS_SECONDARY_SUSPECT,Plasma cell myeloma,300,MG/M**2,16,Oral
869,7333,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,160,MG,2,Intravenous (not otherwise specified)
869,7643,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,15,MG,3,Intrathecal
869,7353,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,100,MG,4,Oral
869,7237,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,2200,MG,5,Intravenous (not otherwise specified)
869,7355,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,5500,IU,7,Intravenous (not otherwise specified)
870,8123,IS_SECONDARY_SUSPECT,Glycogen storage disease type II,22.6,MG/KG,2,Intravenous (not otherwise specified)
871,8124,IS_SECONDARY_SUSPECT,Unknown,15,MG,2,Intrathecal
871,8125,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,20,MG/M**2,3,Oral
871,7171,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,20,MG/M**2,5,Oral
871,7354,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,60,MG,7,Oral
871,7353,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,35,MG,9,Oral
871,7781,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,1.19,MG,24,Intravenous (not otherwise specified)
872,8126,IS_SECONDARY_SUSPECT,Unknown,2,DF,2,Oral
874,7520,IS_SECONDARY_SUSPECT,Unknown,75,MG,2,Unknown
875,8132,IS_SECONDARY_SUSPECT,Unknown,56.6,MG,2,Intravenous bolus
876,7832,IS_SECONDARY_SUSPECT,Immunodeficiency common variable,50,G,2,Intravenous (not otherwise specified)
880,7790,IS_SECONDARY_SUSPECT,Unknown,24,G,2,Subcutaneous
881,7254,IS_SECONDARY_SUSPECT,Short-bowel syndrome,0.318,ML,2,Subcutaneous
882,7790,IS_SECONDARY_SUSPECT,Hypogammaglobulinaemia,10,G,2,Subcutaneous
883,8138,IS_SECONDARY_SUSPECT,Unknown,1,DF,2,Oral
884,8139,IS_SECONDARY_SUSPECT,Unknown,284,MG,3,Subcutaneous
885,8139,IS_SECONDARY_SUSPECT,Unknown,284,MG,7,Subcutaneous
886,8139,IS_SECONDARY_SUSPECT,Unknown,284,MG,3,Subcutaneous
888,7613,IS_SECONDARY_SUSPECT,Angiosarcoma,240,MG,2,Unknown
889,7354,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,150,MG,2,Oral
889,7332,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,15,MG,4,Intrathecal
889,7353,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,100,MG,5,Oral
889,7237,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,2200,MG,6,Intravenous (not otherwise specified)
889,7781,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,2,MG,7,Intravenous (not otherwise specified)
889,7355,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,5500,IU,8,Intravenous (not otherwise specified)
890,7790,IS_SECONDARY_SUSPECT,Immunodeficiency common variable,30,G,2,Subcutaneous
893,7790,IS_SECONDARY_SUSPECT,Combined immunodeficiency,8,G,2,Subcutaneous
894,8151,IS_SECONDARY_SUSPECT,Unknown,640,MG,2,Unknown
896,7982,IS_SECONDARY_SUSPECT,Unknown,25,G,2,Intravenous (not otherwise specified)
897,7467,IS_SECONDARY_SUSPECT,Unknown,50,MG,2,Oral
897,8153,IS_SECONDARY_SUSPECT,Dementia Alzheimer's type,450,UG,3,Intramuscular
898,7979,IS_SECONDARY_SUSPECT,Immunodeficiency common variable,30,G,2,Subcutaneous
899,7254,IS_SECONDARY_SUSPECT,Short-bowel syndrome,3,MG,2,Unknown
901,8058,IS_SECONDARY_SUSPECT,Alpha-1 antitrypsin deficiency,3387,MG,2,Intravenous (not otherwise specified)
902,7790,IS_SECONDARY_SUSPECT,Monoclonal gammopathy,16,G,2,Subcutaneous
904,8014,IS_SECONDARY_SUSPECT,Unknown,420,MG,2,Oral
905,7718,IS_SECONDARY_SUSPECT,Unknown,300,MG,3,Subcutaneous
906,7234,IS_SECONDARY_SUSPECT,Multiple sclerosis,0.5,MG,2,Oral
907,7979,IS_SECONDARY_SUSPECT,Unknown,25,G,2,Subcutaneous
908,7832,IS_SECONDARY_SUSPECT,Selective IgG subclass deficiency,30,G,2,Intravenous (not otherwise specified)
909,7361,IS_SECONDARY_SUSPECT,Unknown,11,MG,2,Oral
910,7790,IS_SECONDARY_SUSPECT,Unknown,20,G,2,Subcutaneous
911,7178,IS_SECONDARY_SUSPECT,Back pain,200,MG,2,Oral
912,7790,IS_SECONDARY_SUSPECT,Unknown,33,G,2,Subcutaneous
913,7982,IS_SECONDARY_SUSPECT,Unknown,10,G,2,Subcutaneous
914,7961,IS_SECONDARY_SUSPECT,Hypoparathyroidism,50,UG,2,Unknown
915,7254,IS_SECONDARY_SUSPECT,Unknown,0.39,ML,5,Subcutaneous
916,7278,IS_SECONDARY_SUSPECT,Crohn's disease,40,MG,2,Subcutaneous
917,8168,IS_SECONDARY_SUSPECT,HIV infection,200,MG,2,Oral
917,8169,IS_SECONDARY_SUSPECT,HIV infection,25,MG,3,Oral
920,8173,IS_SECONDARY_SUSPECT,Unknown,300,MG,2,Subcutaneous
921,7982,IS_SECONDARY_SUSPECT,Immunodeficiency,30,G,2,Intravenous (not otherwise specified)
922,8174,IS_SECONDARY_SUSPECT,Unknown,300,MG,4,Intravenous drip
923,7979,IS_SECONDARY_SUSPECT,Unknown,50,G,2,Unknown
924,7982,IS_SECONDARY_SUSPECT,Unknown,40,G,2,Intravenous (not otherwise specified)
925,8176,IS_SECONDARY_SUSPECT,B-cell lymphoma,172,MG,2,Intravenous (not otherwise specified)
926,7191,IS_SECONDARY_SUSPECT,Unknown,4.5,G,3,Oral
927,8182,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,40,MG,11,Unknown
928,7495,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,30,MG,2,Unknown
928,7230,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,20,MG,3,Unknown
928,8182,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,20,MG,5,Unknown
928,8183,IS_SECONDARY_SUSPECT,Unknown,20,MG,7,Oral
928,7562,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,40,MG,8,Unknown
928,7371,IS_SECONDARY_SUSPECT,Unknown,40,MG,9,Unknown
928,7325,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,40,MG,10,Unknown
928,7546,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,20,MG,12,Unknown
928,7203,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,20,MG,13,Unknown
928,7553,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,30,MG,15,Unknown
930,7790,IS_SECONDARY_SUSPECT,Unknown,20,G,2,Subcutaneous
931,7993,IS_SECONDARY_SUSPECT,Unknown,50,MG,2,Oral
931,7995,IS_SECONDARY_SUSPECT,Chronic lymphocytic leukaemia,100,MG,6,Intravenous (not otherwise specified)
931,7994,IS_SECONDARY_SUSPECT,Chronic lymphocytic leukaemia,420,MG,12,Oral
932,7979,IS_SECONDARY_SUSPECT,Unknown,30,G,2,Subcutaneous
933,7982,IS_SECONDARY_SUSPECT,Unknown,40,G,2,Intravenous (not otherwise specified)
934,7536,IS_SECONDARY_SUSPECT,Unknown,1200,MG,2,Intravenous (not otherwise specified)
934,8185,IS_SECONDARY_SUSPECT,Bladder cancer,294,MG,3,Intravenous (not otherwise specified)
935,7254,IS_SECONDARY_SUSPECT,Unknown,2.74,MG,5,Other
937,7520,IS_SECONDARY_SUSPECT,Unknown,75,MG,2,Intravenous (not otherwise specified)
938,7520,IS_SECONDARY_SUSPECT,Unknown,75,MG,2,Intravenous (not otherwise specified)
939,7536,IS_SECONDARY_SUSPECT,Hormone-refractory prostate cancer,1200,MG,2,Intravenous (not otherwise specified)
940,7254,IS_SECONDARY_SUSPECT,Short-bowel syndrome,2.54,MG,2,Subcutaneous
950,7384,IS_SECONDARY_SUSPECT,Malignant melanoma,2,MG,2,Oral
950,7662,IS_SECONDARY_SUSPECT,Unknown,550,MG,4,Oral
950,7613,IS_SECONDARY_SUSPECT,Unknown,182,MG,6,Oral
951,7790,IS_SECONDARY_SUSPECT,Unknown,14,G,2,Subcutaneous
952,8099,IS_SECONDARY_SUSPECT,Hormone-refractory prostate cancer,40,MG,2,Oral
953,8188,IS_SECONDARY_SUSPECT,Prostate cancer metastatic,120,MG,2,Oral
955,8190,IS_SECONDARY_SUSPECT,Pain,7.5,MG,3,Oral
955,8191,IS_SECONDARY_SUSPECT,Pain,10,MG,12,Oral
955,8192,IS_SECONDARY_SUSPECT,Pain,7.5,MG,13,Unknown
956,8063,IS_SECONDARY_SUSPECT,Hypoparathyroidism,50,UG,2,Subcutaneous
957,7254,IS_SECONDARY_SUSPECT,Short-bowel syndrome,0.35,DF,2,Other
958,8193,IS_SECONDARY_SUSPECT,Unknown,4,DF,6,Unknown
959,8194,IS_SECONDARY_SUSPECT,Unknown,300,MG,2,Intravenous (not otherwise specified)
960,8058,IS_SECONDARY_SUSPECT,Alpha-1 antitrypsin deficiency,60,MG/KG,2,Intravenous (not otherwise specified)
961,8014,IS_SECONDARY_SUSPECT,Unknown,420,MG,2,Oral
964,8058,IS_SECONDARY_SUSPECT,Alpha-1 antitrypsin deficiency,60,MG/KG,2,Intravenous (not otherwise specified)
965,7832,IS_SECONDARY_SUSPECT,Colitis ulcerative,50,G,2,Intravenous (not otherwise specified)
966,7300,IS_SECONDARY_SUSPECT,Unknown,2,MG,2,Oral
966,8202,IS_SECONDARY_SUSPECT,Prophylaxis,25,MG,4,Intravenous (not otherwise specified)
967,8092,IS_SECONDARY_SUSPECT,Unknown,240,MG,2,Oral
968,7338,IS_SECONDARY_SUSPECT,Raynaud's phenomenon,5,MG,2,Oral
970,7790,IS_SECONDARY_SUSPECT,Hypogammaglobulinaemia,4,G,2,Subcutaneous
972,8139,IS_SECONDARY_SUSPECT,Unknown,284,MG,3,Subcutaneous
973,7477,IS_SECONDARY_SUSPECT,Unknown,3,MG,2,Oral
974,7416,IS_SECONDARY_SUSPECT,Unknown,200,MG,2,Unknown
974,8204,IS_SECONDARY_SUSPECT,Ovarian cancer,500,MG,3,Unknown
974,7538,IS_SECONDARY_SUSPECT,Ovarian cancer,300,MG,7,Intravenous (not otherwise specified)
974,7537,IS_SECONDARY_SUSPECT,Unknown,504,MG/KG,10,Intravenous (not otherwise specified)
975,7901,IS_SECONDARY_SUSPECT,Unknown,150,MG,2,Subcutaneous
976,7982,IS_SECONDARY_SUSPECT,Unknown,30,G,2,Intravenous (not otherwise specified)
977,7982,IS_SECONDARY_SUSPECT,Unknown,20,G,2,Intravenous (not otherwise specified)
979,8209,IS_SECONDARY_SUSPECT,Unknown,50,MG,24,Unknown
981,7356,IS_SECONDARY_SUSPECT,Unknown,4,MG,2,Oral
982,8210,IS_SECONDARY_SUSPECT,Ovarian cancer,600,MG,1,Oral
983,7790,IS_SECONDARY_SUSPECT,Selective IgG subclass deficiency,12,G,2,Subcutaneous
986,7982,IS_SECONDARY_SUSPECT,Unknown,10,G,2,Subcutaneous
987,8014,IS_SECONDARY_SUSPECT,Unknown,280,MG,2,Oral
988,7832,IS_SECONDARY_SUSPECT,Transient hypogammaglobulinaemia of infancy,5,G,2,Subcutaneous
990,7176,IS_SECONDARY_SUSPECT,Unknown,10,MG,3,Oral
991,8194,IS_SECONDARY_SUSPECT,Unknown,300,MG,2,Unknown
992,7394,IS_SECONDARY_SUSPECT,Hallucination,34,MG,2,Oral
993,7394,IS_SECONDARY_SUSPECT,Hallucination,34,MG,2,Oral
994,7283,IS_SECONDARY_SUSPECT,Unknown,2,MG,2,Oral
997,7176,IS_SECONDARY_SUSPECT,Unknown,5,MG,2,Oral
998,7520,IS_SECONDARY_SUSPECT,Triple positive breast cancer,75,MG/M**2,2,Unknown
999,8218,IS_SECONDARY_SUSPECT,Optic neuritis,1000,MG,2,Intravenous (not otherwise specified)
999,7905,IS_SECONDARY_SUSPECT,Rheumatoid arthritis,180,MG,7,Intravenous (not otherwise specified)
1000,7632,IS_SECONDARY_SUSPECT,Unknown,3.6,MG,2,Unknown
1001,8222,IS_SECONDARY_SUSPECT,Immune system disorder,1000,IU,2,Unknown
1001,7882,IS_SECONDARY_SUSPECT,Immune system disorder,30,ML,10,Unknown
1002,7790,IS_SECONDARY_SUSPECT,Unknown,10,G,2,Subcutaneous
1004,7234,IS_SECONDARY_SUSPECT,Multiple sclerosis,0.5,MG,2,Oral
1005,7860,IS_SECONDARY_SUSPECT,Unknown,14,MG,2,Oral
1005,8223,IS_SECONDARY_SUSPECT,Renal cell carcinoma,5,MG,10,Oral
1005,7295,IS_SECONDARY_SUSPECT,Hypertension,50,MG,20,Oral
1006,7495,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,30,MG,2,Oral
1006,7561,IS_SECONDARY_SUSPECT,Unknown,30,MG,3,Oral
1006,7230,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,20,MG,6,Oral
1006,7203,IS_SECONDARY_SUSPECT,Unknown,20,MG,9,Oral
1008,7790,IS_SECONDARY_SUSPECT,Immunodeficiency common variable,14,G,2,Subcutaneous
1010,7280,IS_SECONDARY_SUSPECT,Unknown,75,MG,2,Oral
1010,7839,IS_SECONDARY_SUSPECT,Pain,150,MG,3,Oral
1011,7982,IS_SECONDARY_SUSPECT,Unknown,8,G,2,Subcutaneous
1012,8123,IS_SECONDARY_SUSPECT,Complement deficiency disease,250,ML,2,Intravenous (not otherwise specified)
1014,8224,IS_SECONDARY_SUSPECT,Unknown,1,DF,2,Oral
1014,8225,IS_SECONDARY_SUSPECT,Uterine leiomyoma,300,MG,4,Oral
1015,8118,IS_SECONDARY_SUSPECT,Unknown,2,MG,2,Oral
1016,7356,IS_SECONDARY_SUSPECT,Unknown,4,MG,2,Oral
1016,7181,IS_SECONDARY_SUSPECT,Blood pressure abnormal,75,MG,3,Oral
1017,7940,IS_SECONDARY_SUSPECT,Diffuse large B-cell lymphoma,1,DF,4,Intravenous (not otherwise specified)
1018,7262,IS_SECONDARY_SUSPECT,Neuralgia,900,MG,3,Unknown
1019,7437,IS_SECONDARY_SUSPECT,Unknown,15,MG,2,Oral
1021,7734,IS_SECONDARY_SUSPECT,Unknown,100,MG,2,Unknown
1023,7790,IS_SECONDARY_SUSPECT,Unknown,38,G,2,Subcutaneous
1024,7979,IS_SECONDARY_SUSPECT,Hypogammaglobulinaemia,35,G,2,Subcutaneous
1028,7632,IS_SECONDARY_SUSPECT,Growth hormone deficiency,1.2,MG,2,Unknown
1030,8176,IS_SECONDARY_SUSPECT,B-cell lymphoma,214.2,MG,2,Intravenous (not otherwise specified)
1030,7237,IS_SECONDARY_SUSPECT,B-cell lymphoma,1830,MG,3,Intravenous (not otherwise specified)
1030,7244,IS_SECONDARY_SUSPECT,B-cell lymphoma,122,MG,4,Intravenous (not otherwise specified)
1030,7171,IS_SECONDARY_SUSPECT,B-cell lymphoma,100,MG,5,Oral
1032,7961,IS_SECONDARY_SUSPECT,Hypoparathyroidism,75,UG,2,Unknown
1034,7853,IS_SECONDARY_SUSPECT,Unknown,300,MG,2,Subcutaneous
1035,7520,IS_SECONDARY_SUSPECT,Unknown,113,MG,2,Intravenous (not otherwise specified)
1037,7790,IS_SECONDARY_SUSPECT,Unknown,10,G,2,Subcutaneous
1038,7853,IS_SECONDARY_SUSPECT,Unknown,300,MG,2,Subcutaneous
1039,7982,IS_SECONDARY_SUSPECT,Unknown,7,G,2,Subcutaneous
1040,7790,IS_SECONDARY_SUSPECT,Unknown,12,G,2,Subcutaneous
1042,7632,IS_SECONDARY_SUSPECT,Unknown,3,MG,2,Unknown
1043,8232,IS_SECONDARY_SUSPECT,Hypertension,320,MG,2,Unknown
1043,7931,IS_SECONDARY_SUSPECT,Hypertension,320,MG,5,Unknown
1043,7594,IS_SECONDARY_SUSPECT,Hypertension,320,MG,6,Unknown
1045,7790,IS_SECONDARY_SUSPECT,Unknown,10,G,2,Subcutaneous
1049,7790,IS_SECONDARY_SUSPECT,Unknown,20,G,2,Subcutaneous
1050,7520,IS_SECONDARY_SUSPECT,Breast cancer female,120,MG,2,Unknown
1051,8138,IS_SECONDARY_SUSPECT,Unknown,1,DF,3,Oral
1054,7979,IS_SECONDARY_SUSPECT,Selective IgA immunodeficiency,45,G,2,Subcutaneous
1056,7178,IS_SECONDARY_SUSPECT,Back pain,200,MG,2,Oral
1057,7437,IS_SECONDARY_SUSPECT,Unknown,15,MG,2,Oral
1058,7982,IS_SECONDARY_SUSPECT,Chronic sinusitis,90,G,2,Intravenous (not otherwise specified)
1060,7520,IS_SECONDARY_SUSPECT,Unknown,185,MG,2,Unknown
1062,8237,IS_SECONDARY_SUSPECT,Hormone receptor positive HER2 negative breast cancer,2.5,MG,2,Oral
1063,7905,IS_SECONDARY_SUSPECT,Giant cell arteritis,162,MG,4,Subcutaneous
1064,7813,IS_SECONDARY_SUSPECT,Fungal infection,300,MG,2,Unknown
1065,8242,IS_SECONDARY_SUSPECT,Non-small cell lung cancer,450,MG,2,Oral
1066,7502,IS_SECONDARY_SUSPECT,Unknown,600,MG,2,Oral
1066,7536,IS_SECONDARY_SUSPECT,Lung adenocarcinoma,840,MG,4,Intravenous drip
1067,7901,IS_SECONDARY_SUSPECT,Unknown,90,MG,2,Subcutaneous
1068,7790,IS_SECONDARY_SUSPECT,Unknown,12,G,2,Subcutaneous
1069,8218,IS_SECONDARY_SUSPECT,Polymyositis,1000,MG,2,Intravenous (not otherwise specified)
1069,7432,IS_SECONDARY_SUSPECT,Polymyositis,1000,MG,4,Oral
1070,8243,IS_SECONDARY_SUSPECT,Neuralgia,50,MG,2,Transdermal
1074,7790,IS_SECONDARY_SUSPECT,Unknown,15,G,2,Unknown
1076,7982,IS_SECONDARY_SUSPECT,Unknown,65,G,2,Intravenous (not otherwise specified)
1081,7332,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,25,MG,2,Oral
1081,7354,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,100,MG,4,Oral
1081,7353,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,50,MG,6,Oral
1081,7781,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,1.9,MG,8,Intravenous (not otherwise specified)
1083,7790,IS_SECONDARY_SUSPECT,Immune system disorder,9,G,2,Subcutaneous
1084,7280,IS_SECONDARY_SUSPECT,Unknown,100,MG,2,Unknown
1085,7254,IS_SECONDARY_SUSPECT,Unknown,2.8,MG,5,Subcutaneous
1086,8254,IS_SECONDARY_SUSPECT,Immune enhancement therapy,1,MG,2,Subcutaneous
1086,7448,IS_SECONDARY_SUSPECT,Premedication,100,MG,3,Intravenous (not otherwise specified)
1086,8255,IS_SECONDARY_SUSPECT,Immunisation,0.5,ML,4,Intramuscular
1086,8256,IS_SECONDARY_SUSPECT,Pneumococcal immunisation,0.5,ML,5,Intramuscular
1087,7218,IS_SECONDARY_SUSPECT,Unknown,50,MG,2,Oral
1089,8005,IS_SECONDARY_SUSPECT,Malignant melanoma,160,MG,1,Intravenous (not otherwise specified)
1091,8156,IS_SECONDARY_SUSPECT,Unknown,439.86,UG,2,Intrathecal
1092,8156,IS_SECONDARY_SUSPECT,Unknown,235.26,UG,2,Intrathecal
1093,7176,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Oral
1094,7632,IS_SECONDARY_SUSPECT,Unknown,0.5,MG,2,Unknown
1095,8058,IS_SECONDARY_SUSPECT,Alpha-1 antitrypsin deficiency,3788,MG,2,Intravenous (not otherwise specified)
1097,8069,IS_SECONDARY_SUSPECT,Unknown,40,MG,2,Oral
1098,7254,IS_SECONDARY_SUSPECT,Diarrhoea,0.325,ML,2,Subcutaneous
1099,7901,IS_SECONDARY_SUSPECT,Unknown,110,MG,2,Subcutaneous
1101,7790,IS_SECONDARY_SUSPECT,Unknown,12,G,2,Subcutaneous
1106,7790,IS_SECONDARY_SUSPECT,Immunodeficiency common variable,13,G,1,Subcutaneous
1106,7996,IS_SECONDARY_SUSPECT,Unknown,37.5,G,3,Intravenous (not otherwise specified)
1110,7790,IS_SECONDARY_SUSPECT,Unknown,20,G,2,Subcutaneous
1111,8291,IS_SECONDARY_SUSPECT,Unknown,28,UG,2,Intravenous (not otherwise specified)
1111,7237,IS_SECONDARY_SUSPECT,B precursor type acute leukaemia,1730,MG,3,Unknown
1111,7354,IS_SECONDARY_SUSPECT,B precursor type acute leukaemia,104,MG,6,Unknown
1111,8292,IS_SECONDARY_SUSPECT,B precursor type acute leukaemia,70,MG,9,Unknown
1111,7163,IS_SECONDARY_SUSPECT,B precursor type acute leukaemia,5.5,MG,11,Unknown
1111,7352,IS_SECONDARY_SUSPECT,B precursor type acute leukaemia,2,MG,13,Unknown
1111,7977,IS_SECONDARY_SUSPECT,B precursor type acute leukaemia,48,MG,17,Unknown
1111,8293,IS_SECONDARY_SUSPECT,B precursor type acute leukaemia,4477.5,IU,18,Unknown
1111,7332,IS_SECONDARY_SUSPECT,B precursor type acute leukaemia,12,MG,22,Intrathecal
1111,8294,IS_SECONDARY_SUSPECT,B precursor type acute leukaemia,26.25,MG,30,Unknown
1112,7416,IS_SECONDARY_SUSPECT,Unknown,200,MG,2,Oral
1114,7790,IS_SECONDARY_SUSPECT,Unknown,3,G,2,Intravenous (not otherwise specified)
1114,7982,IS_SECONDARY_SUSPECT,Unknown,5,G,4,Intravenous (not otherwise specified)
1115,8222,IS_SECONDARY_SUSPECT,Immune system disorder,500,IU,2,Intravenous (not otherwise specified)
1115,7996,IS_SECONDARY_SUSPECT,Immune system disorder,40,G,7,Intravenous (not otherwise specified)
1118,7861,IS_SECONDARY_SUSPECT,Neoplasm,200,MG,2,Intravenous (not otherwise specified)
1119,7538,IS_SECONDARY_SUSPECT,Ovarian cancer recurrent,60,MG/M**2,2,Intravenous (not otherwise specified)
1119,8236,IS_SECONDARY_SUSPECT,Ovarian cancer recurrent,400,MG,3,Oral
1120,7790,IS_SECONDARY_SUSPECT,Unknown,24,G,2,Subcutaneous
1121,7551,IS_SECONDARY_SUSPECT,Unknown,1,DF,5,Oral
1121,7785,IS_SECONDARY_SUSPECT,Unknown,1,DF,6,Oral
1122,7979,IS_SECONDARY_SUSPECT,Unknown,25,G,2,Subcutaneous
1123,8139,IS_SECONDARY_SUSPECT,Unknown,284,MG,3,Subcutaneous
1124,8298,IS_SECONDARY_SUSPECT,Erectile dysfunction,1,ML,2,INTRACAVITY
1126,7982,IS_SECONDARY_SUSPECT,Hypogammaglobulinaemia,8,G,2,Subcutaneous
1127,7853,IS_SECONDARY_SUSPECT,Unknown,600,MG,2,Subcutaneous
1132,7982,IS_SECONDARY_SUSPECT,Unknown,35,G,2,Intravenous (not otherwise specified)
1133,8285,IS_SECONDARY_SUSPECT,Hepato-lenticular degeneration,550,MG,2,Oral
1133,8302,IS_SECONDARY_SUSPECT,Hepato-lenticular degeneration,250,MG,3,Oral
1134,7790,IS_SECONDARY_SUSPECT,Unknown,16,G,2,Subcutaneous
1137,7982,IS_SECONDARY_SUSPECT,Unknown,10,G,2,Subcutaneous
1139,7961,IS_SECONDARY_SUSPECT,Hypoparathyroidism,100,UG,2,Subcutaneous
1145,7979,IS_SECONDARY_SUSPECT,Infection,20,G,2,Subcutaneous
1146,7536,IS_SECONDARY_SUSPECT,Transitional cell carcinoma,1200,MG,2,Intravenous drip
1146,8317,IS_SECONDARY_SUSPECT,Transitional cell carcinoma,1.25,MG/KG,4,Intravenous (not otherwise specified)
1147,7536,IS_SECONDARY_SUSPECT,Hormone-refractory prostate cancer,1200,MG,2,Intravenous (not otherwise specified)
1148,7832,IS_SECONDARY_SUSPECT,Immunodeficiency common variable,45,G,2,Intravenous (not otherwise specified)
1149,8321,IS_SECONDARY_SUSPECT,Unknown,6000,IU,3,Subcutaneous
1150,7632,IS_SECONDARY_SUSPECT,Unknown,1,MG,2,Unknown
1151,7254,IS_SECONDARY_SUSPECT,Short-bowel syndrome,0.3,MG,2,Subcutaneous
1153,8323,IS_SECONDARY_SUSPECT,Unknown,100,MG,2,Unknown
1155,7790,IS_SECONDARY_SUSPECT,Immunodeficiency common variable,10,G,2,Subcutaneous
1156,7982,IS_SECONDARY_SUSPECT,Unknown,30,G,2,Intravenous (not otherwise specified)
1158,7982,IS_SECONDARY_SUSPECT,Unknown,30,MG,2,Unknown
1160,7632,IS_SECONDARY_SUSPECT,Unknown,0.7,MG,2,Unknown
1162,7176,IS_SECONDARY_SUSPECT,Unknown,25,MG,2,Oral
1162,7283,IS_SECONDARY_SUSPECT,Plasma cell myeloma,2,MG,3,Oral
1162,7468,IS_SECONDARY_SUSPECT,Plasma cell myeloma,25,MG,4,Oral
1162,7190,IS_SECONDARY_SUSPECT,Plasma cell myeloma,1.3,MG/M**2,5,Subcutaneous
1162,7250,IS_SECONDARY_SUSPECT,Plasma cell myeloma,100,MG/M**2,7,Oral
1162,7163,IS_SECONDARY_SUSPECT,Plasma cell myeloma,40,MG,8,Oral
1162,7189,IS_SECONDARY_SUSPECT,Plasma cell myeloma,43,MG,12,Intravenous drip
1162,7222,IS_SECONDARY_SUSPECT,Plasma cell myeloma,10,MG/KG,13,Intravenous drip
1162,7253,IS_SECONDARY_SUSPECT,Plasma cell myeloma,8,MG/KG,14,Intravenous drip
1163,7940,IS_SECONDARY_SUSPECT,Diffuse large B-cell lymphoma,375,MG/M**2,2,Intravenous (not otherwise specified)
1163,8185,IS_SECONDARY_SUSPECT,Diffuse large B-cell lymphoma,750,MG/M**2,3,Intravenous (not otherwise specified)
1163,7978,IS_SECONDARY_SUSPECT,Diffuse large B-cell lymphoma,75,MG/M**2,4,Intravenous (not otherwise specified)
1164,7790,IS_SECONDARY_SUSPECT,Unknown,14,G,2,Subcutaneous
1165,7254,IS_SECONDARY_SUSPECT,Illness,0.36,ML,5,Subcutaneous
1167,8190,IS_SECONDARY_SUSPECT,Pain,7.5,MG,2,Oral
1167,8327,IS_SECONDARY_SUSPECT,Pain,1,DF,3,Oral
1167,8328,IS_SECONDARY_SUSPECT,Unknown,2,MG,4,Oral
1167,8329,IS_SECONDARY_SUSPECT,Pain,5,MG,6,Unknown
1167,8330,IS_SECONDARY_SUSPECT,Pain,1,DF,7,Unknown
1167,8277,IS_SECONDARY_SUSPECT,Pain,50,MG,8,Unknown
1167,7911,IS_SECONDARY_SUSPECT,Unknown,50,MG,10,Unknown
1167,7822,IS_SECONDARY_SUSPECT,Unknown,30,MG,11,Unknown
1167,7551,IS_SECONDARY_SUSPECT,Unknown,0.5,MG,12,Unknown
1167,7493,IS_SECONDARY_SUSPECT,Unknown,0.5,MG,13,Unknown
1167,7843,IS_SECONDARY_SUSPECT,Unknown,50,MG,14,Unknown
1167,7247,IS_SECONDARY_SUSPECT,Unknown,300,MG,16,Unknown
1167,7714,IS_SECONDARY_SUSPECT,Unknown,150,MG,20,Unknown
1168,7982,IS_SECONDARY_SUSPECT,Unknown,70,G,2,Intravenous (not otherwise specified)
1169,7536,IS_SECONDARY_SUSPECT,Mesothelioma malignant,1200,MG,2,Intravenous (not otherwise specified)
1169,7443,IS_SECONDARY_SUSPECT,Pleural mesothelioma malignant,146,MG,3,Intravenous (not otherwise specified)
1169,8089,IS_SECONDARY_SUSPECT,Pleural mesothelioma malignant,1000,MG,5,Intravenous (not otherwise specified)
1170,7790,IS_SECONDARY_SUSPECT,Unknown,20,G,2,Subcutaneous
1171,8335,IS_SECONDARY_SUSPECT,Unknown,200,MG,2,Oral
1172,7979,IS_SECONDARY_SUSPECT,Immune system disorder,40,G,2,Subcutaneous
1173,7176,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Oral
1176,7996,IS_SECONDARY_SUSPECT,Unknown,105,G,2,Intravenous (not otherwise specified)
1181,7982,IS_SECONDARY_SUSPECT,Unknown,55,G,2,Intravenous (not otherwise specified)
1183,8340,IS_SECONDARY_SUSPECT,Unknown,150,MG,2,Oral
1184,8344,IS_SECONDARY_SUSPECT,Breast cancer,500,MG,2,Intramuscular
1185,7394,IS_SECONDARY_SUSPECT,Hallucination,34,MG,2,Oral
1187,7862,IS_SECONDARY_SUSPECT,Unknown,300,MG,2,Subcutaneous
1189,7237,IS_SECONDARY_SUSPECT,Chemotherapy,500,MG/M**2,3,Unknown
1190,7632,IS_SECONDARY_SUSPECT,Growth retardation,1.7,MG,2,Subcutaneous
1191,7280,IS_SECONDARY_SUSPECT,Unknown,75,MG,2,Oral
1193,7249,IS_SECONDARY_SUSPECT,Unknown,120,MG,2,Oral
1194,8099,IS_SECONDARY_SUSPECT,Non-small cell lung cancer,40,MG,2,Oral
1196,7982,IS_SECONDARY_SUSPECT,Unknown,10,G,2,Subcutaneous
1199,7832,IS_SECONDARY_SUSPECT,Immunodeficiency common variable,10,G,2,Intravenous (not otherwise specified)
1200,7790,IS_SECONDARY_SUSPECT,Unknown,12,G,2,Subcutaneous
1201,7718,IS_SECONDARY_SUSPECT,Immune system disorder,300,MG,2,Subcutaneous
1201,7882,IS_SECONDARY_SUSPECT,Unknown,30,MG,5,Unknown
1207,8014,IS_SECONDARY_SUSPECT,Unknown,280,MG,2,Oral
1217,8350,IS_SECONDARY_SUSPECT,Acute myeloid leukaemia,145,MG,2,Subcutaneous
1218,7790,IS_SECONDARY_SUSPECT,Unknown,21,G,2,Subcutaneous
1220,7982,IS_SECONDARY_SUSPECT,Unknown,40,G,2,Intravenous (not otherwise specified)
1221,7536,IS_SECONDARY_SUSPECT,Transitional cell carcinoma,1200,MG,2,Intravenous (not otherwise specified)
1222,7790,IS_SECONDARY_SUSPECT,Unknown,20,G,2,Subcutaneous
1223,7982,IS_SECONDARY_SUSPECT,Encephalomyelitis,30,G,2,Intravenous (not otherwise specified)
1224,7790,IS_SECONDARY_SUSPECT,Primary immunodeficiency syndrome,20,G,2,Subcutaneous
1225,7982,IS_SECONDARY_SUSPECT,Unknown,15,G,2,Subcutaneous
1226,8352,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Unknown
1226,7171,IS_SECONDARY_SUSPECT,Dizziness,5,MG,3,Unknown
1228,7982,IS_SECONDARY_SUSPECT,Unknown,30,G,2,Intravenous (not otherwise specified)
1229,8353,IS_SECONDARY_SUSPECT,Idiopathic pulmonary fibrosis,267,MG,3,Oral
1231,8285,IS_SECONDARY_SUSPECT,Hepatic encephalopathy,550,MG,2,Oral
1233,7536,IS_SECONDARY_SUSPECT,Hepatocellular carcinoma,1200,MG,2,Intravenous (not otherwise specified)
1234,7982,IS_SECONDARY_SUSPECT,Unknown,400,MG/KG,2,Intravenous (not otherwise specified)
1236,7662,IS_SECONDARY_SUSPECT,Prostate cancer,1,MG/KG,2,Intravenous (not otherwise specified)
1236,8364,IS_SECONDARY_SUSPECT,Prostate cancer,40,MG,3,Oral
1237,8367,IS_SECONDARY_SUSPECT,Unknown,20,IU,2,Subcutaneous
1238,7176,IS_SECONDARY_SUSPECT,Unknown,2.5,MG,2,Oral
1239,8375,IS_SECONDARY_SUSPECT,Prostate cancer,1,MG/KG,2,Intravenous (not otherwise specified)
1239,7435,IS_SECONDARY_SUSPECT,Prostate cancer,3,MG/KG,3,Intravenous (not otherwise specified)
1240,7334,IS_SECONDARY_SUSPECT,Unknown,35,G,3,Intravenous (not otherwise specified)
1241,7334,IS_SECONDARY_SUSPECT,Unknown,30,G,2,Intravenous (not otherwise specified)
1242,7334,IS_SECONDARY_SUSPECT,Unknown,75,G,3,Intravenous (not otherwise specified)
1243,7334,IS_SECONDARY_SUSPECT,Unknown,5,G,2,Intravenous (not otherwise specified)
1246,7334,IS_SECONDARY_SUSPECT,Unknown,120,G,2,Intravenous (not otherwise specified)
1248,8092,IS_SECONDARY_SUSPECT,Pain,10,MG,2,Unknown
1248,8379,IS_SECONDARY_SUSPECT,Pain,20,MG,3,Oral
1248,8380,IS_SECONDARY_SUSPECT,Pain,20,MG,4,Oral
1248,7386,IS_SECONDARY_SUSPECT,Pain,10,MG,5,Oral
1248,7711,IS_SECONDARY_SUSPECT,Pain,15,MG,6,Oral
1249,7458,IS_SECONDARY_SUSPECT,Unknown,3,DF,2,Unknown
1251,7632,IS_SECONDARY_SUSPECT,Unknown,3.6,MG,2,Unknown
1252,7979,IS_SECONDARY_SUSPECT,Unknown,17.5,G,2,Subcutaneous
1255,7901,IS_SECONDARY_SUSPECT,Unknown,150,MG,2,Subcutaneous
1256,7905,IS_SECONDARY_SUSPECT,Rheumatoid arthritis,420,MG,2,Subcutaneous
1257,8115,IS_SECONDARY_SUSPECT,Unknown,500,MG,2,Oral
1257,8382,IS_SECONDARY_SUSPECT,Essential thrombocythaemia,5,MG,3,Oral
1260,8014,IS_SECONDARY_SUSPECT,Unknown,420,MG,2,Oral
1260,7993,IS_SECONDARY_SUSPECT,Chronic lymphocytic leukaemia,100,MG,4,Oral
1262,8383,IS_SECONDARY_SUSPECT,Unknown,16,MG,2,Oral
1263,7922,IS_SECONDARY_SUSPECT,Unknown,4,MG,2,Oral
1264,8387,IS_SECONDARY_SUSPECT,Unknown,1,GTT,2,Ophthalmic
1265,7632,IS_SECONDARY_SUSPECT,Unknown,1.8,MG,2,Unknown
1267,7790,IS_SECONDARY_SUSPECT,Unknown,5,G,2,Subcutaneous
1270,8388,IS_SECONDARY_SUSPECT,Unknown,1,PCT,2,Rectal
1271,7334,IS_SECONDARY_SUSPECT,Unknown,5,G,2,Intravenous (not otherwise specified)
1272,7334,IS_SECONDARY_SUSPECT,Unknown,5,G,2,Intravenous (not otherwise specified)
1273,7982,IS_SECONDARY_SUSPECT,Unknown,32,G,2,Intravenous (not otherwise specified)
1277,7993,IS_SECONDARY_SUSPECT,Chronic lymphocytic leukaemia,100,MG,2,Oral
1277,7994,IS_SECONDARY_SUSPECT,Chronic lymphocytic leukaemia,420,MG,5,Oral
1278,7632,IS_SECONDARY_SUSPECT,Unknown,1.4,MG,2,Unknown
1280,7178,IS_SECONDARY_SUSPECT,Back pain,150,MG,2,Unknown
1282,7790,IS_SECONDARY_SUSPECT,Unknown,8,G,2,Subcutaneous
1285,7982,IS_SECONDARY_SUSPECT,Unknown,5,G,2,Subcutaneous
1287,7790,IS_SECONDARY_SUSPECT,Unknown,24,G,2,Subcutaneous
1289,8396,IS_SECONDARY_SUSPECT,Acute myeloid leukaemia,120,MG,2,Oral
1290,8375,IS_SECONDARY_SUSPECT,Renal cell carcinoma,1,MG/KG,2,Intravenous (not otherwise specified)
1290,7435,IS_SECONDARY_SUSPECT,Renal cell carcinoma,3,MG/KG,3,Intravenous (not otherwise specified)
1294,8399,IS_SECONDARY_SUSPECT,Unknown,1200,UG,2,Oral
1294,8400,IS_SECONDARY_SUSPECT,Pulmonary arterial hypertension,10,MG,3,Oral
1295,7632,IS_SECONDARY_SUSPECT,Short stature,0.9,MG,2,Unknown
1297,8403,IS_SECONDARY_SUSPECT,Immunodeficiency common variable,12.5,G,2,Subcutaneous
1298,8404,IS_SECONDARY_SUSPECT,Weight decreased,1,DF,2,Oral
1299,8364,IS_SECONDARY_SUSPECT,Renal cell carcinoma,40,MG,1,Oral
1299,7613,IS_SECONDARY_SUSPECT,Renal cell carcinoma,3,MG/KG,3,Intravenous (not otherwise specified)
1300,7254,IS_SECONDARY_SUSPECT,Unknown,1.55,MG,5,Subcutaneous
1302,8188,IS_SECONDARY_SUSPECT,Hormone-refractory prostate cancer,160,MG,2,Oral
1303,7506,IS_SECONDARY_SUSPECT,Dyspepsia,150,MG,2,Unknown
1304,8406,IS_SECONDARY_SUSPECT,Hereditary angioedema,30,MG,3,Subcutaneous
1306,8201,IS_SECONDARY_SUSPECT,Unknown,61,MG,2,Oral
1307,7178,IS_SECONDARY_SUSPECT,Pain in extremity,200,MG,2,Oral
1309,7982,IS_SECONDARY_SUSPECT,Unknown,10,G,2,Subcutaneous
1311,7280,IS_SECONDARY_SUSPECT,Breast cancer female,100,MG,2,Oral
1312,8407,IS_SECONDARY_SUSPECT,Unknown,380,MG,2,Intramuscular
1314,7280,IS_SECONDARY_SUSPECT,Unknown,100,MG,2,Unknown
1317,8414,IS_SECONDARY_SUSPECT,Factor VIII deficiency,2400,IU,2,Intravenous (not otherwise specified)
1320,7416,IS_SECONDARY_SUSPECT,Fallopian tube cancer,100,MG,2,Oral
1320,7537,IS_SECONDARY_SUSPECT,Ovarian cancer,15,MG/KG,4,Intravenous (not otherwise specified)
1321,8415,IS_SECONDARY_SUSPECT,Unknown,0.1,MG,2,Transdermal
1323,7790,IS_SECONDARY_SUSPECT,Unknown,10,G,2,Unknown
1323,7832,IS_SECONDARY_SUSPECT,Immunodeficiency common variable,20,G,3,Intravenous (not otherwise specified)
1323,7996,IS_SECONDARY_SUSPECT,Immunodeficiency common variable,10,G,7,Subcutaneous
1324,8417,IS_SECONDARY_SUSPECT,Unknown,10,MG,4,Oral
1324,8418,IS_SECONDARY_SUSPECT,Pain,5,MG,5,Oral
1324,8329,IS_SECONDARY_SUSPECT,Arthralgia,5,MG,7,Unknown
1326,8419,IS_SECONDARY_SUSPECT,Unknown,1700,MG,2,Intravenous (not otherwise specified)
1331,8419,IS_SECONDARY_SUSPECT,Unknown,1300,MG,2,Intravenous (not otherwise specified)
1332,8419,IS_SECONDARY_SUSPECT,Unknown,1100,MG,2,Intravenous (not otherwise specified)
1333,8419,IS_SECONDARY_SUSPECT,Unknown,1100,MG,2,Intravenous (not otherwise specified)
1334,8419,IS_SECONDARY_SUSPECT,Unknown,2580,MG,2,Intravenous (not otherwise specified)
1336,8419,IS_SECONDARY_SUSPECT,Unknown,2000,MG,2,Intravenous (not otherwise specified)
1337,8419,IS_SECONDARY_SUSPECT,Unknown,2200,MG,2,Intravenous (not otherwise specified)
1338,8419,IS_SECONDARY_SUSPECT,Unknown,1400,MG,2,Intravenous (not otherwise specified)
1340,7443,IS_SECONDARY_SUSPECT,Squamous cell carcinoma of the cervix,40,MG/M**2,2,Intravenous (not otherwise specified)
1351,8350,IS_SECONDARY_SUSPECT,Unknown,75,MG/M**2,2,Subcutaneous
1352,7477,IS_SECONDARY_SUSPECT,Unknown,4,MG,2,Oral
1363,7982,IS_SECONDARY_SUSPECT,Unknown,100,G,2,Intravenous (not otherwise specified)
1365,7254,IS_SECONDARY_SUSPECT,Unknown,0.13,ML,5,Subcutaneous
1368,7254,IS_SECONDARY_SUSPECT,Unknown,0.328,ML,9,Unknown
1369,7477,IS_SECONDARY_SUSPECT,Unknown,2.3,MG,2,Oral
1371,8224,IS_SECONDARY_SUSPECT,Unknown,1,DF,2,Oral
1371,8225,IS_SECONDARY_SUSPECT,Endometriosis,200,MG,3,Oral
1372,8434,IS_SECONDARY_SUSPECT,Cystic fibrosis,300,MG,2,Unknown
1372,8020,IS_SECONDARY_SUSPECT,Unknown,75,MG,4,Unknown
1374,8176,IS_SECONDARY_SUSPECT,Non-Hodgkin's lymphoma,214.2,MG,2,Intravenous (not otherwise specified)
1374,7237,IS_SECONDARY_SUSPECT,Non-Hodgkin's lymphoma,1830,MG,3,Intravenous (not otherwise specified)
1374,7244,IS_SECONDARY_SUSPECT,Non-Hodgkin's lymphoma,122,MG,4,Intravenous (not otherwise specified)
1374,7171,IS_SECONDARY_SUSPECT,Non-Hodgkin's lymphoma,100,MG,5,Oral
1376,7790,IS_SECONDARY_SUSPECT,Unknown,10,G,2,Subcutaneous
1379,8444,IS_SECONDARY_SUSPECT,Plasma cell myeloma refractory,17,MG,3,Intravenous (not otherwise specified)
1379,7188,IS_SECONDARY_SUSPECT,Plasma cell myeloma refractory,1.7,MG,5,Subcutaneous
1379,7443,IS_SECONDARY_SUSPECT,Plasma cell myeloma refractory,17,MG,7,Intravenous (not otherwise specified)
1379,7246,IS_SECONDARY_SUSPECT,Plasma cell myeloma refractory,68,MG,9,Intravenous (not otherwise specified)
1380,7176,IS_SECONDARY_SUSPECT,Plasma cell myeloma in remission,25,MG,2,Oral
1381,8446,IS_SECONDARY_SUSPECT,Unknown,20,MG,2,Oral
1381,7940,IS_SECONDARY_SUSPECT,Follicular lymphoma,784,MG,3,Intravenous drip
1382,7832,IS_SECONDARY_SUSPECT,Immunodeficiency common variable,35,G,2,Intravenous (not otherwise specified)
1383,7394,IS_SECONDARY_SUSPECT,Hallucination,34,MG,2,Oral
1384,8014,IS_SECONDARY_SUSPECT,Unknown,420,MG,2,Oral
1388,7790,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Subcutaneous
1391,7979,IS_SECONDARY_SUSPECT,Unknown,22.5,G,2,Subcutaneous
1392,8451,IS_SECONDARY_SUSPECT,Unknown,0.66,MG,5,Subcutaneous
1393,7280,IS_SECONDARY_SUSPECT,Neoplasm malignant,75,MG,2,Unknown
1394,7443,IS_SECONDARY_SUSPECT,B-cell lymphoma,200,MG,2,Intravenous (not otherwise specified)
1394,7333,IS_SECONDARY_SUSPECT,B-cell lymphoma,4000,MG,3,Intravenous (not otherwise specified)
1394,8454,IS_SECONDARY_SUSPECT,B-cell lymphoma,40,MG,4,Oral
1394,7475,IS_SECONDARY_SUSPECT,Back pain,40,MG,6,Oral
1395,8465,IS_SECONDARY_SUSPECT,Unknown,1.8,ML,2,Oral
1395,8466,IS_SECONDARY_SUSPECT,Unknown,250,MG,3,Unknown
1395,8467,IS_SECONDARY_SUSPECT,Unknown,150,MG,4,Unknown
1396,7832,IS_SECONDARY_SUSPECT,Immunodeficiency common variable,30,G,2,Intravenous (not otherwise specified)
1398,8468,IS_SECONDARY_SUSPECT,Unknown,180,MG,2,Unknown
1399,7632,IS_SECONDARY_SUSPECT,Unknown,3.2,MG,3,Unknown
1400,8469,IS_SECONDARY_SUSPECT,Secondary progressive multiple sclerosis,1,DF,2,Oral
1401,8471,IS_SECONDARY_SUSPECT,Unknown,15,MG,2,Oral
1403,7178,IS_SECONDARY_SUSPECT,Arthritis,150,MG,2,Oral
1404,7632,IS_SECONDARY_SUSPECT,Unknown,1.4,MG,2,Unknown
1405,8476,IS_SECONDARY_SUSPECT,Unknown,160,MG,2,Unknown
1405,8477,IS_SECONDARY_SUSPECT,Hypertension,160,MG,7,Unknown
1406,8478,IS_SECONDARY_SUSPECT,Renal cell carcinoma,60,MG,2,Oral
1407,8040,IS_SECONDARY_SUSPECT,Unknown,7.5,UG,2,Intramuscular
1411,7733,IS_SECONDARY_SUSPECT,Hepatic cancer recurrent,2,DF,2,Oral
1412,7237,IS_SECONDARY_SUSPECT,Bone marrow conditioning regimen,900,MG/M**2,2,Intravenous (not otherwise specified)
1412,7883,IS_SECONDARY_SUSPECT,Bone marrow conditioning regimen,25,MG/M**2,3,Intravenous (not otherwise specified)
1413,7249,IS_SECONDARY_SUSPECT,Unknown,240,MG,2,Oral
1414,8486,IS_SECONDARY_SUSPECT,Systemic lupus erythematosus,200,MG,2,Subcutaneous
1415,8487,IS_SECONDARY_SUSPECT,Alpha-1 antitrypsin deficiency,60,MG/KG,2,Intravenous (not otherwise specified)
1415,8488,IS_SECONDARY_SUSPECT,Alpha-1 antitrypsin deficiency,60,MG/KG,7,Intravenous (not otherwise specified)
1416,8489,IS_SECONDARY_SUSPECT,Unknown,5,ML,2,Oral
1417,7280,IS_SECONDARY_SUSPECT,Unknown,125,MG,2,Unknown
1418,8139,IS_SECONDARY_SUSPECT,Unknown,284,MG,10,Subcutaneous
1419,7280,IS_SECONDARY_SUSPECT,Unknown,125,MG,2,Oral
1420,8139,IS_SECONDARY_SUSPECT,Unknown,284,MG,3,Subcutaneous
1421,8139,IS_SECONDARY_SUSPECT,Unknown,284,MG,13,Subcutaneous
1423,8492,IS_SECONDARY_SUSPECT,Gastric cancer,400,MG,1,Oral
1423,7503,IS_SECONDARY_SUSPECT,Pulmonary embolism,100,MG,3,Unknown
1423,7173,IS_SECONDARY_SUSPECT,Gastric cancer,125,MG,4,Oral
1425,8328,IS_SECONDARY_SUSPECT,Unknown,2,MG,5,Oral
1426,8493,IS_SECONDARY_SUSPECT,Hodgkin's disease,20,MG,2,Unknown
1429,7632,IS_SECONDARY_SUSPECT,Unknown,0.8,MG,2,Unknown
1430,8139,IS_SECONDARY_SUSPECT,Unknown,284,MG,3,Subcutaneous
1431,8500,IS_SECONDARY_SUSPECT,Hereditary angioedema,30,MG,2,Subcutaneous
1432,7237,IS_SECONDARY_SUSPECT,Bone marrow conditioning regimen,1700,MG,2,Intravenous (not otherwise specified)
1432,7883,IS_SECONDARY_SUSPECT,Bone marrow conditioning regimen,47.5,MG,3,Intravenous (not otherwise specified)
1433,8335,IS_SECONDARY_SUSPECT,Unknown,200,MG,2,Oral
1434,8502,IS_SECONDARY_SUSPECT,Hodgkin's disease,148,MG,2,Intravenous (not otherwise specified)
1436,8503,IS_SECONDARY_SUSPECT,Pain,5.963,MG,3,Intrathecal
1436,8504,IS_SECONDARY_SUSPECT,Pain,9.981,MG,5,Intrathecal
1438,7443,IS_SECONDARY_SUSPECT,Cervix carcinoma stage III,40,MG/M**2,2,Intravenous (not otherwise specified)
1440,8364,IS_SECONDARY_SUSPECT,Renal cell carcinoma,40,MG,3,Oral
1442,7632,IS_SECONDARY_SUSPECT,Short stature,1,MG,2,Unknown
1443,8506,IS_SECONDARY_SUSPECT,Mucopolysaccharidosis I,12,MG,2,Intravenous (not otherwise specified)
1444,8507,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Unknown
1445,8508,IS_SECONDARY_SUSPECT,Unknown,15,MG,2,Unknown
1445,8509,IS_SECONDARY_SUSPECT,Malignant melanoma,450,MG,3,Oral
1446,7535,IS_SECONDARY_SUSPECT,Pain,60,MG,6,Oral
1447,8247,IS_SECONDARY_SUSPECT,Unknown,100,MG,2,Unknown
1448,7632,IS_SECONDARY_SUSPECT,Unknown,1.7,MG,2,Unknown
1449,7850,IS_SECONDARY_SUSPECT,Bronchial neoplasm,30,MG,2,Oral
1450,7504,IS_SECONDARY_SUSPECT,Unknown,20,MG,2,Oral
1450,7262,IS_SECONDARY_SUSPECT,Pain,1200,MG,10,Unknown
1451,7979,IS_SECONDARY_SUSPECT,Unknown,50,G,2,Subcutaneous
1452,7790,IS_SECONDARY_SUSPECT,Asthma,5,G,2,Subcutaneous
1454,7504,IS_SECONDARY_SUSPECT,Back pain,20,MG,2,Oral
1454,8418,IS_SECONDARY_SUSPECT,Back pain,10,MG,15,Oral
1455,8194,IS_SECONDARY_SUSPECT,Unknown,300,MG,2,Unknown
1456,8513,IS_SECONDARY_SUSPECT,Spinal muscular atrophy,5,MG,2,Unknown
1457,7632,IS_SECONDARY_SUSPECT,Unknown,2,MG,2,Unknown
1458,8509,IS_SECONDARY_SUSPECT,Unknown,450,MG,2,Oral
1458,8508,IS_SECONDARY_SUSPECT,Metastatic malignant melanoma,45,MG,3,Oral
1461,7176,IS_SECONDARY_SUSPECT,Unknown,25,MG,3,Oral
1464,7254,IS_SECONDARY_SUSPECT,Short-bowel syndrome,3,MG,2,Unknown
1466,7790,IS_SECONDARY_SUSPECT,Unknown,18,MG,2,Subcutaneous
1467,7832,IS_SECONDARY_SUSPECT,Immunodeficiency common variable,10,G,2,Unknown
1467,7790,IS_SECONDARY_SUSPECT,Primary immunodeficiency syndrome,10,G,9,Subcutaneous
1469,7790,IS_SECONDARY_SUSPECT,Unknown,8,G,2,Subcutaneous
1470,7790,IS_SECONDARY_SUSPECT,Unknown,5,G,2,Subcutaneous
1472,7536,IS_SECONDARY_SUSPECT,Non-small cell lung cancer,1200,MG,2,Intravenous (not otherwise specified)
1472,7539,IS_SECONDARY_SUSPECT,Non-small cell lung cancer,410,MG,3,Intravenous (not otherwise specified)
1472,8089,IS_SECONDARY_SUSPECT,Non-small cell lung cancer,1010,MG,4,Intravenous (not otherwise specified)
1473,8054,IS_SECONDARY_SUSPECT,Unknown,90,G,2,Intravenous (not otherwise specified)
1474,8354,IS_SECONDARY_SUSPECT,Unknown,24,UG,3,Oral
1475,8242,IS_SECONDARY_SUSPECT,Synovial sarcoma,450,MG,2,Oral
1479,7790,IS_SECONDARY_SUSPECT,Unknown,22,G,2,Unknown
1480,7979,IS_SECONDARY_SUSPECT,Unknown,40,G,2,Subcutaneous
1485,8225,IS_SECONDARY_SUSPECT,Uterine leiomyoma,300,MG,2,Oral
1487,8518,IS_SECONDARY_SUSPECT,Unknown,25,MG,5,Unknown
1488,7995,IS_SECONDARY_SUSPECT,Unknown,900,MG,2,Intravenous (not otherwise specified)
1488,7994,IS_SECONDARY_SUSPECT,Chronic lymphocytic leukaemia,420,MG,6,Oral
1489,7790,IS_SECONDARY_SUSPECT,Immune system disorder,8,G,2,Subcutaneous
1490,7790,IS_SECONDARY_SUSPECT,Unknown,10,G,2,Subcutaneous
1491,7394,IS_SECONDARY_SUSPECT,Hallucination,34,MG,2,Oral
1491,8034,IS_SECONDARY_SUSPECT,Dyskinesia,137,MG,5,Oral
1492,8520,IS_SECONDARY_SUSPECT,Pancreatic carcinoma metastatic,0.3,MG/KG,2,Unknown
1492,8185,IS_SECONDARY_SUSPECT,Pancreatic carcinoma metastatic,1000,MG/M**2,3,Unknown
1492,8521,IS_SECONDARY_SUSPECT,Pancreatic carcinoma metastatic,125,MG/M**2,4,Unknown
1493,8204,IS_SECONDARY_SUSPECT,Ovarian cancer,500,MG,2,Unknown
1493,7538,IS_SECONDARY_SUSPECT,Ovarian cancer,403,MG,7,Intravenous (not otherwise specified)
1493,7537,IS_SECONDARY_SUSPECT,Unknown,1431,MG/KG,10,Intravenous (not otherwise specified)
1493,8526,IS_SECONDARY_SUSPECT,Hypertension,5,MG,13,Unknown
1495,7718,IS_SECONDARY_SUSPECT,Unknown,300,MG,2,Subcutaneous
1495,7719,IS_SECONDARY_SUSPECT,Immune system disorder,2000,IU,3,Intravenous (not otherwise specified)
1498,7687,IS_SECONDARY_SUSPECT,Unknown,25,MG,2,Subcutaneous
1499,8530,IS_SECONDARY_SUSPECT,Metastatic renal cell carcinoma,0.65,MG,1,Intravenous (not otherwise specified)
1499,8531,IS_SECONDARY_SUSPECT,Metastatic renal cell carcinoma,3,MG,3,Oral
1500,7681,IS_SECONDARY_SUSPECT,Unknown,20,MG,2,Subcutaneous
1501,8535,IS_SECONDARY_SUSPECT,Unknown,1,DF,2,Vaginal
1502,7632,IS_SECONDARY_SUSPECT,Unknown,0.5,MG,2,Unknown
1503,7898,IS_SECONDARY_SUSPECT,Pulmonary arterial hypertension,1.5,MG,5,Oral
1504,7254,IS_SECONDARY_SUSPECT,Short-bowel syndrome,4.437,ML,2,Subcutaneous
1505,7979,IS_SECONDARY_SUSPECT,Congenital hypogammaglobulinaemia,27.5,G,2,Subcutaneous
1508,8538,IS_SECONDARY_SUSPECT,Unknown,75,MG,2,Oral
1511,7254,IS_SECONDARY_SUSPECT,Unknown,4.13,MG,13,Subcutaneous
1512,7982,IS_SECONDARY_SUSPECT,Unknown,25,G,2,Intravenous (not otherwise specified)
1513,8541,IS_SECONDARY_SUSPECT,Unknown,6,MG,2,Subcutaneous
1514,8143,IS_SECONDARY_SUSPECT,Diabetes mellitus,25,MG,2,Oral
1514,8543,IS_SECONDARY_SUSPECT,Immunisation,1,DF,3,Intramuscular
1514,8544,IS_SECONDARY_SUSPECT,Immunisation,0.5,ML,4,Intramuscular
1515,7254,IS_SECONDARY_SUSPECT,Short-bowel syndrome,0.65,MG,2,Other
1518,7979,IS_SECONDARY_SUSPECT,Immunodeficiency,50,G,2,Unknown
1519,7982,IS_SECONDARY_SUSPECT,Unknown,40,G,2,Intravenous (not otherwise specified)
1521,7254,IS_SECONDARY_SUSPECT,Short-bowel syndrome,0.24,ML,2,Unknown
1522,7982,IS_SECONDARY_SUSPECT,Unknown,80,G,2,Intravenous (not otherwise specified)
1523,8381,IS_SECONDARY_SUSPECT,Unknown,750,MG,2,Intravenous (not otherwise specified)
1525,7662,IS_SECONDARY_SUSPECT,Renal cell carcinoma,59.8,MG,2,Unknown
1526,7254,IS_SECONDARY_SUSPECT,Short-bowel syndrome,0.492,ML,2,Unknown
1528,7790,IS_SECONDARY_SUSPECT,Primary immunodeficiency syndrome,8,G,2,Subcutaneous
1529,7718,IS_SECONDARY_SUSPECT,Unknown,300,MG,2,Subcutaneous
1531,7790,IS_SECONDARY_SUSPECT,Immunodeficiency common variable,10,G,2,Subcutaneous
1533,8399,IS_SECONDARY_SUSPECT,Unknown,1400,UG,2,Oral
1534,7681,IS_SECONDARY_SUSPECT,Unknown,20,MG,3,Subcutaneous
1535,8417,IS_SECONDARY_SUSPECT,Unknown,40,MG,3,Oral
1535,8190,IS_SECONDARY_SUSPECT,Unknown,1,DF,4,Oral
1536,7632,IS_SECONDARY_SUSPECT,Blood growth hormone abnormal,2.4,MG,2,Unknown
1537,7254,IS_SECONDARY_SUSPECT,Unknown,0.208,MG,5,Subcutaneous
1538,8335,IS_SECONDARY_SUSPECT,Unknown,50,MG,2,Oral
1539,8548,IS_SECONDARY_SUSPECT,Unknown,15,MG,2,Oral
1540,7832,IS_SECONDARY_SUSPECT,Immunodeficiency common variable,25,G,2,Intravenous (not otherwise specified)
1540,7790,IS_SECONDARY_SUSPECT,Immunodeficiency common variable,16,G,5,Subcutaneous
1541,7254,IS_SECONDARY_SUSPECT,Short-bowel syndrome,0.6,MG,2,Subcutaneous
1544,7982,IS_SECONDARY_SUSPECT,Illness,1000,MG/KG,2,Intravenous (not otherwise specified)
1545,7254,IS_SECONDARY_SUSPECT,Short-bowel syndrome,4.5,MG,2,Unknown
1546,7254,IS_SECONDARY_SUSPECT,Short-bowel syndrome,0.24,ML,2,Subcutaneous
1548,7254,IS_SECONDARY_SUSPECT,Unknown,3.25,MG,5,Subcutaneous
1549,8240,IS_SECONDARY_SUSPECT,Plasma cell myeloma,50,MG,2,Oral
1552,8552,IS_SECONDARY_SUSPECT,Bipolar disorder,40,MG,2,Oral
1553,8553,IS_SECONDARY_SUSPECT,Endocrine ophthalmopathy,25.2,ML,2,Intravenous (not otherwise specified)
1555,8173,IS_SECONDARY_SUSPECT,Unknown,300,MG,2,Unknown
1556,8553,IS_SECONDARY_SUSPECT,Unknown,800,MG,2,Intravenous (not otherwise specified)
1557,7280,IS_SECONDARY_SUSPECT,Unknown,100,MG,2,Oral
1558,8350,IS_SECONDARY_SUSPECT,Myelodysplastic syndrome,75,MG/M**2,2,Subcutaneous
1565,8559,IS_SECONDARY_SUSPECT,Hypothyroidism,200,UG,2,Oral
1566,8548,IS_SECONDARY_SUSPECT,Unknown,15,MG,2,Oral
1567,8561,IS_SECONDARY_SUSPECT,HIV infection,1,DF,2,Transplacental
1570,8487,IS_SECONDARY_SUSPECT,Alpha-1 antitrypsin deficiency,4200,MG,2,Intravenous (not otherwise specified)
1571,8222,IS_SECONDARY_SUSPECT,Immune system disorder,1000,IU,2,Intravenous (not otherwise specified)
1571,8562,IS_SECONDARY_SUSPECT,Hereditary angioedema,300,MG,7,Other
1572,7254,IS_SECONDARY_SUSPECT,Short-bowel syndrome,0.13,ML,2,Subcutaneous
1573,7332,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,15,MG,2,Intrathecal
1573,7353,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,70,MG,3,Oral
1573,7237,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,1440,MG,4,Intravenous (not otherwise specified)
1573,7781,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,2,MG,5,Intravenous (not otherwise specified)
1573,7355,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,3600,IU,6,Intramuscular
1574,8471,IS_SECONDARY_SUSPECT,Axial spondyloarthritis,15,MG,2,Oral
1575,7176,IS_SECONDARY_SUSPECT,Plasma cell myeloma,5,MG,2,Unknown
1576,8173,IS_SECONDARY_SUSPECT,Unknown,300,MG,2,Subcutaneous
1581,8569,IS_SECONDARY_SUSPECT,Malignant melanoma,2,MG,2,Unknown
1582,7254,IS_SECONDARY_SUSPECT,Short-bowel syndrome,0.05,MG/KG,2,Unknown
1583,7982,IS_SECONDARY_SUSPECT,Unknown,30,G,2,Intravenous (not otherwise specified)
1586,7632,IS_SECONDARY_SUSPECT,Unknown,1.2,MG,2,Unknown
1588,7979,IS_SECONDARY_SUSPECT,Unknown,40,G,2,Subcutaneous
1589,8506,IS_SECONDARY_SUSPECT,Unknown,42,MG,2,Intravenous (not otherwise specified)
1590,8225,IS_SECONDARY_SUSPECT,Uterine leiomyoma,300,MG,2,Oral
1591,7898,IS_SECONDARY_SUSPECT,Unknown,1.625,MG,2,Oral
1593,7371,IS_SECONDARY_SUSPECT,Unknown,40,MG,5,Unknown
1593,7271,IS_SECONDARY_SUSPECT,Unknown,40,MG,11,Unknown
1594,7860,IS_SECONDARY_SUSPECT,Unknown,14,MG,2,Oral
1594,7861,IS_SECONDARY_SUSPECT,Metastatic renal cell carcinoma,200,MG,3,Intravenous (not otherwise specified)
1595,8578,IS_SECONDARY_SUSPECT,Unknown,150,MG,2,Subcutaneous
1598,7278,IS_SECONDARY_SUSPECT,Crohn's disease,40,MG,2,Subcutaneous
1601,7995,IS_SECONDARY_SUSPECT,Unknown,900,MG,2,Intravenous (not otherwise specified)
1601,7993,IS_SECONDARY_SUSPECT,Chronic lymphocytic leukaemia,20,MG,4,Oral
1601,7994,IS_SECONDARY_SUSPECT,Chronic lymphocytic leukaemia,420,MG,9,Oral
1602,8014,IS_SECONDARY_SUSPECT,Unknown,420,MG,2,Oral
1604,7254,IS_SECONDARY_SUSPECT,Short-bowel syndrome,0.05,MG/KG,2,Unknown
1606,8587,IS_SECONDARY_SUSPECT,Factor VIII deficiency,2000,IU,2,Intravenous (not otherwise specified)
1612,7982,IS_SECONDARY_SUSPECT,Unknown,40,G,2,Intravenous (not otherwise specified)
1613,7718,IS_SECONDARY_SUSPECT,Unknown,300,MG,2,Subcutaneous
1613,7882,IS_SECONDARY_SUSPECT,Unknown,3,MG,3,Unknown
1617,8500,IS_SECONDARY_SUSPECT,Immune system disorder,30,MG,2,Subcutaneous
1617,8562,IS_SECONDARY_SUSPECT,Unknown,300,MG,6,Subcutaneous
1618,7850,IS_SECONDARY_SUSPECT,Unknown,30,MG,2,Oral
1619,8224,IS_SECONDARY_SUSPECT,Unknown,1,DF,2,Oral
1619,8225,IS_SECONDARY_SUSPECT,Uterine leiomyoma,300,MG,3,Oral
1620,7252,IS_SECONDARY_SUSPECT,Plasma cell myeloma,4,MG,2,Unknown
1620,8517,IS_SECONDARY_SUSPECT,Plasma cell myeloma,6,MG,4,Oral
1620,7163,IS_SECONDARY_SUSPECT,Plasma cell myeloma,40,MG,5,Oral
1621,8335,IS_SECONDARY_SUSPECT,Cardiac failure,50,MG,2,Unknown
1622,7661,IS_SECONDARY_SUSPECT,Hypertension,320,MG,2,Unknown
1623,8335,IS_SECONDARY_SUSPECT,Cardiomyopathy,49.51,MG,2,Oral
1624,8517,IS_SECONDARY_SUSPECT,Plasma cell myeloma,6,MG,2,Oral
1624,7877,IS_SECONDARY_SUSPECT,Plasma cell myeloma,4,MG,3,Oral
1624,7163,IS_SECONDARY_SUSPECT,Plasma cell myeloma,40,MG,4,Oral
1624,7922,IS_SECONDARY_SUSPECT,Plasma cell myeloma,4,MG,5,Unknown
1625,7850,IS_SECONDARY_SUSPECT,Unknown,90,MG,2,Unknown
1626,8176,IS_SECONDARY_SUSPECT,B-cell lymphoma,174,MG,2,Intravenous (not otherwise specified)
1626,7171,IS_SECONDARY_SUSPECT,B-cell lymphoma,100,MG,3,Oral
1626,7244,IS_SECONDARY_SUSPECT,B-cell lymphoma,109.6,MG,5,Intravenous (not otherwise specified)
1626,7237,IS_SECONDARY_SUSPECT,B-cell lymphoma,1643,MG,7,Intravenous (not otherwise specified)
1627,7940,IS_SECONDARY_SUSPECT,Diffuse large B-cell lymphoma,375,MG/M**2,2,Intravenous (not otherwise specified)
1627,8185,IS_SECONDARY_SUSPECT,Diffuse large B-cell lymphoma,1000,MG/M**2,3,Intravenous (not otherwise specified)
1627,7978,IS_SECONDARY_SUSPECT,Diffuse large B-cell lymphoma,100,MG/M**2,4,Intravenous (not otherwise specified)
1628,8005,IS_SECONDARY_SUSPECT,Metastatic malignant melanoma,720,MG,1,Intravenous (not otherwise specified)
1631,7982,IS_SECONDARY_SUSPECT,Unknown,100,G,2,Intravenous (not otherwise specified)
1635,8058,IS_SECONDARY_SUSPECT,Alpha-1 antitrypsin deficiency,120,MG/KG,2,Intravenous (not otherwise specified)
1636,7163,IS_SECONDARY_SUSPECT,Plasma cell myeloma,40,MG,2,Unknown
1636,7253,IS_SECONDARY_SUSPECT,Plasma cell myeloma,100,MG,3,Intravenous drip
1637,7790,IS_SECONDARY_SUSPECT,Infection,4,G,2,Subcutaneous
1638,8350,IS_SECONDARY_SUSPECT,Unknown,75,MG/M**2,2,Subcutaneous
1639,7594,IS_SECONDARY_SUSPECT,Hypertension,320,MG,2,Unknown
1639,7661,IS_SECONDARY_SUSPECT,Hypertension,320,MG,3,Unknown
1641,8513,IS_SECONDARY_SUSPECT,Spinal muscular atrophy,2.5,MG,2,Oral
1642,7254,IS_SECONDARY_SUSPECT,Short-bowel syndrome,0.54,MG,2,Subcutaneous
1643,7613,IS_SECONDARY_SUSPECT,Unknown,153,MG,2,Intravenous (not otherwise specified)
1643,7662,IS_SECONDARY_SUSPECT,Unknown,51,MG,4,Intravenous (not otherwise specified)
1643,8364,IS_SECONDARY_SUSPECT,Bladder cancer,1000,MG,5,Oral
1645,7996,IS_SECONDARY_SUSPECT,Immunodeficiency common variable,32.5,G,3,Intravenous (not otherwise specified)
1647,7681,IS_SECONDARY_SUSPECT,Unknown,20,MG,2,Subcutaneous
1649,8610,IS_SECONDARY_SUSPECT,Dermatomyositis,125,MG,2,Subcutaneous
1650,7254,IS_SECONDARY_SUSPECT,Short-bowel syndrome,0.25,ML,2,Subcutaneous
1651,8611,IS_SECONDARY_SUSPECT,HER2 negative breast cancer,3.6,MG,6,Subcutaneous
1652,7681,IS_SECONDARY_SUSPECT,Unknown,20,MG,2,Subcutaneous
1655,7661,IS_SECONDARY_SUSPECT,Hypertension,320,MG,2,Unknown
1656,8612,IS_SECONDARY_SUSPECT,Hypertension,320,MG,2,Unknown
1656,8613,IS_SECONDARY_SUSPECT,Hypertension,160,MG,10,Unknown
1656,8614,IS_SECONDARY_SUSPECT,Hypertension,160,MG,11,Unknown
1659,8577,IS_SECONDARY_SUSPECT,Unknown,300,MG,13,Unknown
1662,8176,IS_SECONDARY_SUSPECT,B-cell lymphoma,174,MG,2,Intravenous (not otherwise specified)
1662,7237,IS_SECONDARY_SUSPECT,B-cell lymphoma,1643,MG,3,Intravenous (not otherwise specified)
1662,7244,IS_SECONDARY_SUSPECT,B-cell lymphoma,109.6,MG,4,Intravenous (not otherwise specified)
1662,7171,IS_SECONDARY_SUSPECT,B-cell lymphoma,100,MG,5,Oral
1665,7254,IS_SECONDARY_SUSPECT,Short-bowel syndrome,1.86,MG,2,Subcutaneous
1666,7790,IS_SECONDARY_SUSPECT,Hypogammaglobulinaemia,11,G,3,Subcutaneous
1668,7882,IS_SECONDARY_SUSPECT,Immune system disorder,30,MG,8,Subcutaneous
1670,7995,IS_SECONDARY_SUSPECT,Unknown,900,MG,2,Intravenous (not otherwise specified)
1670,7994,IS_SECONDARY_SUSPECT,Chronic lymphocytic leukaemia,420,MG,4,Oral
1672,7333,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,170,MG,2,Intravenous (not otherwise specified)
1672,7353,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,100,MG,3,Oral
1672,7354,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,125,MG,4,Oral
1672,7237,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,2280,MG,5,Intravenous (not otherwise specified)
1672,7355,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,5700,MG,6,Intravenous (not otherwise specified)
1673,8225,IS_SECONDARY_SUSPECT,Uterine leiomyoma,300,MG,3,Oral
1674,8225,IS_SECONDARY_SUSPECT,Uterine leiomyoma,300,MG,2,Oral
1677,8465,IS_SECONDARY_SUSPECT,Unknown,2.7,ML,2,Oral
1678,8465,IS_SECONDARY_SUSPECT,Severe myoclonic epilepsy of infancy,1,ML,2,Oral
1680,8465,IS_SECONDARY_SUSPECT,Seizure,4.3,ML,2,Oral
1681,8623,IS_SECONDARY_SUSPECT,Unknown,200,MG,2,Oral
1681,7435,IS_SECONDARY_SUSPECT,Fallopian tube cancer stage III,480,MG,3,Intravenous (not otherwise specified)
1682,7437,IS_SECONDARY_SUSPECT,Unknown,15,MG,2,Unknown
1685,7496,IS_SECONDARY_SUSPECT,Unknown,600,MG,2,Intravenous (not otherwise specified)
1686,8222,IS_SECONDARY_SUSPECT,Immune system disorder,1000,IU,2,Intravenous (not otherwise specified)
1686,8562,IS_SECONDARY_SUSPECT,Immune system disorder,2,ML,19,Subcutaneous
1687,7790,IS_SECONDARY_SUSPECT,Unknown,8,G,2,Subcutaneous
1688,7437,IS_SECONDARY_SUSPECT,Unknown,30,MG,2,Oral
1689,8468,IS_SECONDARY_SUSPECT,Unknown,90,MG,2,Oral
1690,8210,IS_SECONDARY_SUSPECT,Fallopian tube cancer stage III,600,MG,2,Oral
1691,8222,IS_SECONDARY_SUSPECT,Immune system disorder,1000,IU,2,Intravenous (not otherwise specified)
1692,7248,IS_SECONDARY_SUSPECT,Multiple sclerosis,10,MG,2,Oral
1692,8556,IS_SECONDARY_SUSPECT,Unknown,10,MG,3,Oral
1692,8628,IS_SECONDARY_SUSPECT,Unknown,10,MG,6,Oral
1692,8629,IS_SECONDARY_SUSPECT,Unknown,300,MG,8,Oral
1693,7163,IS_SECONDARY_SUSPECT,Plasma cell myeloma,10,MG,2,Oral
1694,7163,IS_SECONDARY_SUSPECT,Unknown,40,MG,3,Unknown
1695,8636,IS_SECONDARY_SUSPECT,Breast cancer metastatic,5.4,MG/KG,2,Intravenous (not otherwise specified)
1696,8364,IS_SECONDARY_SUSPECT,Renal cell carcinoma,40,MG,1,Oral
1696,7613,IS_SECONDARY_SUSPECT,Renal cell carcinoma,3,MG/KG,2,Intravenous (not otherwise specified)
1701,8640,IS_SECONDARY_SUSPECT,Unknown,75,MG,2,Unknown
1703,7993,IS_SECONDARY_SUSPECT,Unknown,50,MG,2,Oral
1703,8350,IS_SECONDARY_SUSPECT,Myelodysplastic syndrome,75,MG/M**2,3,Subcutaneous
1704,7416,IS_SECONDARY_SUSPECT,Unknown,200,MG,2,Unknown
1709,7443,IS_SECONDARY_SUSPECT,Squamous cell carcinoma of head and neck,40,MG/M**2,3,Intravenous (not otherwise specified)
1710,7278,IS_SECONDARY_SUSPECT,Crohn's disease,40,MG,3,Subcutaneous
1711,8173,IS_SECONDARY_SUSPECT,Unknown,150,MG,3,Subcutaneous
1712,7496,IS_SECONDARY_SUSPECT,Unknown,300,MG,2,Intravenous (not otherwise specified)
1714,7718,IS_SECONDARY_SUSPECT,Asthma,300,MG,2,Subcutaneous
1714,7719,IS_SECONDARY_SUSPECT,Asthma,1000,IU,4,Intravenous (not otherwise specified)
1715,7280,IS_SECONDARY_SUSPECT,Unknown,125,MG,2,Oral
1716,7178,IS_SECONDARY_SUSPECT,Fibromyalgia,150,MG,2,Oral
1717,8483,IS_SECONDARY_SUSPECT,Unknown,100,ML,2,Other
1717,7181,IS_SECONDARY_SUSPECT,Unknown,25,MG,4,Oral
1719,7280,IS_SECONDARY_SUSPECT,Breast cancer metastatic,125,MG,2,Unknown
1720,7254,IS_SECONDARY_SUSPECT,Unknown,2.36,MG,9,Subcutaneous
1721,7384,IS_SECONDARY_SUSPECT,Colorectal adenocarcinoma,2,MG,2,Oral
1722,8650,IS_SECONDARY_SUSPECT,B-cell lymphoma,11200,MG,2,Unknown
1722,7246,IS_SECONDARY_SUSPECT,B-cell lymphoma,224,MG,3,Intravenous (not otherwise specified)
1722,7991,IS_SECONDARY_SUSPECT,B-cell lymphoma,11200,MG,4,Intravenous drip
1722,7473,IS_SECONDARY_SUSPECT,B-cell lymphoma,2250.2,MG,6,Unknown
1722,7978,IS_SECONDARY_SUSPECT,B-cell lymphoma,225,MG,7,Unknown
1722,7940,IS_SECONDARY_SUSPECT,B-cell lymphoma,850,MG,8,Unknown
1726,8247,IS_SECONDARY_SUSPECT,Anxiety disorder,100,MG,2,Oral
1728,8224,IS_SECONDARY_SUSPECT,Unknown,1,DF,2,Oral
1728,8225,IS_SECONDARY_SUSPECT,Uterine leiomyoma,300,MG,3,Oral
1729,7982,IS_SECONDARY_SUSPECT,Unknown,1000,MG/KG,2,Intravenous (not otherwise specified)
1733,7982,IS_SECONDARY_SUSPECT,Primary immunodeficiency syndrome,50,G,2,Intravenous (not otherwise specified)
1735,7982,IS_SECONDARY_SUSPECT,Unknown,15,G,2,Subcutaneous
1736,7163,IS_SECONDARY_SUSPECT,Unknown,40,MG,2,Oral
1744,8401,IS_SECONDARY_SUSPECT,Unknown,1,DF,2,Unknown
1744,7898,IS_SECONDARY_SUSPECT,Pulmonary arterial hypertension,9,MG,3,Oral
1747,7278,IS_SECONDARY_SUSPECT,Unknown,40,MG,2,Subcutaneous
1750,8660,IS_SECONDARY_SUSPECT,Unknown,150,MG,2,Subcutaneous
1751,7876,IS_SECONDARY_SUSPECT,Unknown,16,MG/KG,2,Intravenous drip
1753,8506,IS_SECONDARY_SUSPECT,Unknown,24,MG,2,Intravenous (not otherwise specified)
1754,7993,IS_SECONDARY_SUSPECT,Unknown,800,MG,2,Oral
1754,7163,IS_SECONDARY_SUSPECT,Plasma cell myeloma,40,MG,3,Oral
1755,7982,IS_SECONDARY_SUSPECT,Unknown,30,G,2,Intravenous (not otherwise specified)
1758,8669,IS_SECONDARY_SUSPECT,Colorectal cancer,1200,MG,2,Unknown
1760,7435,IS_SECONDARY_SUSPECT,Renal cell carcinoma,3,MG/KG,2,Intravenous (not otherwise specified)
1760,8375,IS_SECONDARY_SUSPECT,Renal cell carcinoma,1,MG/KG,3,Intravenous (not otherwise specified)
1762,8671,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Oral
1762,8399,IS_SECONDARY_SUSPECT,Pulmonary arterial hypertension,200,UG,3,Oral
1765,7496,IS_SECONDARY_SUSPECT,Relapsing multiple sclerosis,600,MG,2,Intravenous (not otherwise specified)
1766,8557,IS_SECONDARY_SUSPECT,Unknown,100,MG,2,Subcutaneous
1767,7703,IS_SECONDARY_SUSPECT,Hormone receptor positive HER2 negative breast cancer,6,MG/KG,3,Intravenous (not otherwise specified)
1768,7901,IS_SECONDARY_SUSPECT,Unknown,240,MG,2,Subcutaneous
1771,8176,IS_SECONDARY_SUSPECT,B-cell lymphoma,132,MG,2,Intravenous (not otherwise specified)
1773,8194,IS_SECONDARY_SUSPECT,Unknown,300,MG,2,Intravenous (not otherwise specified)
1773,7248,IS_SECONDARY_SUSPECT,Unknown,10,MG,4,Oral
1774,8099,IS_SECONDARY_SUSPECT,Unknown,20,MG,2,Oral
1774,7536,IS_SECONDARY_SUSPECT,Non-small cell lung cancer,1200,MG,3,Intravenous (not otherwise specified)
1775,7993,IS_SECONDARY_SUSPECT,Unknown,200,MG,2,Oral
1775,8042,IS_SECONDARY_SUSPECT,Acute myeloid leukaemia,20,MG/M**2,5,Intravenous (not otherwise specified)
1778,8681,IS_SECONDARY_SUSPECT,Unknown,1.5,MG,2,Subcutaneous
1778,8367,IS_SECONDARY_SUSPECT,Type 2 diabetes mellitus,70,IU,3,Subcutaneous
1779,8335,IS_SECONDARY_SUSPECT,Unknown,200,MG,2,Oral
1780,7254,IS_SECONDARY_SUSPECT,Unknown,1.3,MG,9,Subcutaneous
1781,7611,IS_SECONDARY_SUSPECT,Unknown,50,MG,2,Intravenous (not otherwise specified)
1782,7333,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,150,MG,2,Intravenous (not otherwise specified)
1782,7643,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,15,MG,3,Intrathecal
1782,7353,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,95,MG,4,Oral
1782,7237,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,2000,MG,5,Intravenous (not otherwise specified)
1782,7354,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,103.6,MG,6,Oral
1782,7355,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,3750,IU,7,Intravenous (not otherwise specified)
1783,7718,IS_SECONDARY_SUSPECT,Unknown,300,MG,2,Subcutaneous
1784,8500,IS_SECONDARY_SUSPECT,Immune system disorder,30,MG,2,Subcutaneous
1784,8562,IS_SECONDARY_SUSPECT,Immune system disorder,300,MG,7,Subcutaneous
1785,7994,IS_SECONDARY_SUSPECT,Unknown,450,MG,2,Oral
1785,7993,IS_SECONDARY_SUSPECT,Chronic lymphocytic leukaemia,20,MG,3,Oral
1786,7790,IS_SECONDARY_SUSPECT,Primary immunodeficiency syndrome,12,G,2,Subcutaneous
1787,8407,IS_SECONDARY_SUSPECT,Unknown,380,MG,2,Intramuscular
1788,7237,IS_SECONDARY_SUSPECT,Unknown,800,MG,3,Intravenous drip
1788,7883,IS_SECONDARY_SUSPECT,Diffuse large B-cell lymphoma,55,MG,4,Intravenous drip
1789,7283,IS_SECONDARY_SUSPECT,Unknown,2,MG,2,Oral
1790,8691,IS_SECONDARY_SUSPECT,Unknown,3,MG,2,Intravenous (not otherwise specified)
1790,8350,IS_SECONDARY_SUSPECT,Acute myeloid leukaemia,115,MG,3,Intravenous (not otherwise specified)
1790,7993,IS_SECONDARY_SUSPECT,Acute myeloid leukaemia,100,MG,5,Oral
1791,7978,IS_SECONDARY_SUSPECT,Adenocarcinoma of colon,85,MG/M**2,2,Intravenous (not otherwise specified)
1791,8294,IS_SECONDARY_SUSPECT,Adenocarcinoma of colon,400,MG/M**2,3,Intravenous (not otherwise specified)
1791,8702,IS_SECONDARY_SUSPECT,Adenocarcinoma of colon,400,MG/M**2,4,Intravenous bolus
1792,8703,IS_SECONDARY_SUSPECT,Unknown,134,MG,2,Intravenous drip
1792,7473,IS_SECONDARY_SUSPECT,Unknown,1070,MG,5,Intravenous drip
1793,7437,IS_SECONDARY_SUSPECT,Chronic myeloid leukaemia,15,MG,2,Oral
1795,7464,IS_SECONDARY_SUSPECT,Hypertension,12.5,MG,6,Oral
1797,8705,IS_SECONDARY_SUSPECT,Chronic lymphocytic leukaemia,11340,MG,2,Unknown
1798,7860,IS_SECONDARY_SUSPECT,Unknown,20,MG,2,Oral
1799,7790,IS_SECONDARY_SUSPECT,Unknown,11,G,2,Subcutaneous
1800,8381,IS_SECONDARY_SUSPECT,Unknown,750,MG,2,Intravenous (not otherwise specified)
1801,7237,IS_SECONDARY_SUSPECT,B-cell lymphoma,600,MG,2,Intravenous drip
1801,7883,IS_SECONDARY_SUSPECT,B-cell lymphoma,60,MG,3,Intravenous drip
1804,8548,IS_SECONDARY_SUSPECT,Unknown,15,MG,2,Oral
1808,8725,IS_SECONDARY_SUSPECT,Unknown,36,UG,3,Unknown
1809,7254,IS_SECONDARY_SUSPECT,Short-bowel syndrome,5,MG,2,Subcutaneous
1811,7235,IS_SECONDARY_SUSPECT,Hot flush,0.3,MG,7,Oral
1812,7861,IS_SECONDARY_SUSPECT,Colon cancer metastatic,200,MG,3,Intravenous (not otherwise specified)
1818,7979,IS_SECONDARY_SUSPECT,Unknown,40,G,2,Subcutaneous
1819,8321,IS_SECONDARY_SUSPECT,Prophylaxis,5000,IU,2,Subcutaneous
1820,7249,IS_SECONDARY_SUSPECT,Unknown,240,MG,3,Oral
1820,7238,IS_SECONDARY_SUSPECT,Trigeminal neuralgia,10,MG,4,Unknown
1820,7178,IS_SECONDARY_SUSPECT,Trigeminal neuralgia,150,MG,6,Unknown
1820,8629,IS_SECONDARY_SUSPECT,Trigeminal neuralgia,900,MG,7,Oral
1821,8735,IS_SECONDARY_SUSPECT,Unknown,200,MG,2,Oral
1822,8736,IS_SECONDARY_SUSPECT,Cervix cancer metastatic,2,MG/KG,3,Intravenous (not otherwise specified)
1823,7437,IS_SECONDARY_SUSPECT,Unknown,30,MG,2,Unknown
1825,7681,IS_SECONDARY_SUSPECT,Unknown,20,MG,2,Subcutaneous
1826,7790,IS_SECONDARY_SUSPECT,Immune system disorder,4,G,2,Subcutaneous
1827,8055,IS_SECONDARY_SUSPECT,Back pain,150,MG,2,Unknown
1828,8368,IS_SECONDARY_SUSPECT,Unknown,1.33,MG/KG,2,Subcutaneous
1829,7234,IS_SECONDARY_SUSPECT,Unknown,0.5,MG,2,Oral
1830,7882,IS_SECONDARY_SUSPECT,Immune system disorder,30,MG,2,Subcutaneous
1832,7905,IS_SECONDARY_SUSPECT,Giant cell arteritis,162,MG,4,Subcutaneous
1835,7613,IS_SECONDARY_SUSPECT,Unknown,480,MG,2,Intravenous (not otherwise specified)
1835,8738,IS_SECONDARY_SUSPECT,Diffuse large B-cell lymphoma,60,MG,3,Intravenous (not otherwise specified)
1836,7237,IS_SECONDARY_SUSPECT,Follicular lymphoma,470,MG,2,Intravenous (not otherwise specified)
1836,7883,IS_SECONDARY_SUSPECT,Follicular lymphoma,37.5,MG,5,Intravenous (not otherwise specified)
1838,8739,IS_SECONDARY_SUSPECT,Unknown,75,MG,2,Oral
1839,8737,IS_SECONDARY_SUSPECT,Psoriatic arthropathy,125,MG,2,Subcutaneous
1840,7365,IS_SECONDARY_SUSPECT,Unknown,2.5,MG,2,Oral
1841,8749,IS_SECONDARY_SUSPECT,Chronic lymphocytic leukaemia,900,MG,2,Intravenous (not otherwise specified)
1841,7993,IS_SECONDARY_SUSPECT,Chronic lymphocytic leukaemia,400,MG,3,Oral
1842,7982,IS_SECONDARY_SUSPECT,Unknown,50,G,2,Intravenous (not otherwise specified)
1843,7496,IS_SECONDARY_SUSPECT,Unknown,300,MG,2,Intravenous (not otherwise specified)
1846,7940,IS_SECONDARY_SUSPECT,B-cell lymphoma,753.8,MG,2,Unknown
1846,7246,IS_SECONDARY_SUSPECT,B-cell lymphoma,450,MG,3,Intravenous (not otherwise specified)
1846,7991,IS_SECONDARY_SUSPECT,B-cell lymphoma,10050,MG,4,Intravenous (not otherwise specified)
1846,8650,IS_SECONDARY_SUSPECT,B-cell lymphoma,10050,MG,5,Unknown
1847,7983,IS_SECONDARY_SUSPECT,Renal transplant,4,ML,1,Subcutaneous
1850,7537,IS_SECONDARY_SUSPECT,Hepatocellular carcinoma,843,MG,2,Intravenous (not otherwise specified)
1851,8173,IS_SECONDARY_SUSPECT,Unknown,300,MG,2,Subcutaneous
1854,8014,IS_SECONDARY_SUSPECT,Unknown,420,MG,2,Oral
1856,7496,IS_SECONDARY_SUSPECT,Unknown,600,MG,2,Intravenous (not otherwise specified)
1857,7213,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Unknown
1858,7416,IS_SECONDARY_SUSPECT,Unknown,100,MG,2,Unknown
1860,8670,IS_SECONDARY_SUSPECT,Illness,40,MG,2,Oral
1863,7477,IS_SECONDARY_SUSPECT,Unknown,3,MG,2,Oral
1866,7254,IS_SECONDARY_SUSPECT,Short-bowel syndrome,2.2,MG,2,Subcutaneous
1868,8766,IS_SECONDARY_SUSPECT,Unknown,0.46,MG,2,Oral
1869,8098,IS_SECONDARY_SUSPECT,Unknown,1,DF,2,Vaginal
1877,7979,IS_SECONDARY_SUSPECT,Hypogammaglobulinaemia,50,G,2,Subcutaneous
1880,7333,IS_SECONDARY_SUSPECT,Unknown,150,MG,2,Intravenous (not otherwise specified)
1880,7332,IS_SECONDARY_SUSPECT,Philadelphia positive acute lymphocytic leukaemia,15,MG,3,Intrathecal
1880,7354,IS_SECONDARY_SUSPECT,Philadelphia positive acute lymphocytic leukaemia,103.6,MG,5,Oral
1880,7781,IS_SECONDARY_SUSPECT,Philadelphia positive acute lymphocytic leukaemia,2,MG,7,Intravenous (not otherwise specified)
1880,7237,IS_SECONDARY_SUSPECT,Philadelphia positive acute lymphocytic leukaemia,2000,MG,9,Intravenous (not otherwise specified)
1880,7353,IS_SECONDARY_SUSPECT,Philadelphia positive acute lymphocytic leukaemia,95,MG,11,Oral
1881,8353,IS_SECONDARY_SUSPECT,Unknown,267,MG,2,Oral
1882,7333,IS_SECONDARY_SUSPECT,Unknown,170,MG,2,Intravenous (not otherwise specified)
1882,7354,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,125,MG,3,Oral
1882,7353,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,100,MG,5,Oral
1882,7237,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,2280,MG,7,Intravenous (not otherwise specified)
1882,7355,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,5700,MG,9,Intravenous (not otherwise specified)
1883,8772,IS_SECONDARY_SUSPECT,Unknown,5,MG,5,Oral
1884,8236,IS_SECONDARY_SUSPECT,Unknown,400,MG,2,Oral
1884,8037,IS_SECONDARY_SUSPECT,HER2 negative breast cancer,1,MG,3,Oral
1884,7707,IS_SECONDARY_SUSPECT,Breast cancer,1,MG,4,Oral
1888,8506,IS_SECONDARY_SUSPECT,Unknown,24,MG,2,Intravenous (not otherwise specified)
1889,8671,IS_SECONDARY_SUSPECT,Pulmonary hypertension,10,MG,2,Oral
1890,8776,IS_SECONDARY_SUSPECT,Adrenocortical carcinoma,50,MG,2,Intravenous (not otherwise specified)
1892,8218,IS_SECONDARY_SUSPECT,Renal disorder,1000,MG,2,Intravenous (not otherwise specified)
1892,7432,IS_SECONDARY_SUSPECT,Granulomatosis with polyangiitis,500,MG,5,Oral
1893,8577,IS_SECONDARY_SUSPECT,Unknown,100,MG,2,Oral
1897,7982,IS_SECONDARY_SUSPECT,Unknown,20,G,2,Intravenous (not otherwise specified)
1898,7982,IS_SECONDARY_SUSPECT,Unknown,32,G,2,Intravenous (not otherwise specified)
1899,7613,IS_SECONDARY_SUSPECT,Leiomyosarcoma,3,MG/KG,1,Intravenous (not otherwise specified)
1899,8364,IS_SECONDARY_SUSPECT,Leiomyosarcoma,40,MG,3,Oral
1903,8787,IS_SECONDARY_SUSPECT,Unknown,400,MG,2,Transplacental
1904,7278,IS_SECONDARY_SUSPECT,Unknown,40,MG,2,Subcutaneous
1905,7901,IS_SECONDARY_SUSPECT,Unknown,247.5,MG,2,Subcutaneous
1907,8492,IS_SECONDARY_SUSPECT,Metastatic malignant melanoma,2000,MG,1,Oral
1908,8671,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Oral
1909,8788,IS_SECONDARY_SUSPECT,Unknown,150,MG,2,Unknown
1911,7993,IS_SECONDARY_SUSPECT,Chronic lymphocytic leukaemia,20,MG,2,Oral
1913,7979,IS_SECONDARY_SUSPECT,Unknown,30,G,2,Subcutaneous
1916,7254,IS_SECONDARY_SUSPECT,Malnutrition,1.8,MG,5,Subcutaneous
1917,8407,IS_SECONDARY_SUSPECT,Unknown,380,MG,2,Intramuscular
1918,8335,IS_SECONDARY_SUSPECT,Unknown,0.5,DF,2,Oral
1919,8500,IS_SECONDARY_SUSPECT,Immune system disorder,30,MG,2,Subcutaneous
1920,8406,IS_SECONDARY_SUSPECT,Immune system disorder,30,MG,3,Subcutaneous
1921,8789,IS_SECONDARY_SUSPECT,Unknown,200,MG,8,Unknown
1924,8790,IS_SECONDARY_SUSPECT,Unknown,50,MG,2,Oral
1925,7416,IS_SECONDARY_SUSPECT,Unknown,100,MG,5,Unknown
1927,7254,IS_SECONDARY_SUSPECT,Short-bowel syndrome,2.8,MG,2,Unknown
1929,8506,IS_SECONDARY_SUSPECT,Unknown,0.53,MG/KG,2,Unknown
1930,7176,IS_SECONDARY_SUSPECT,Unknown,25,MG,2,Oral
1932,7254,IS_SECONDARY_SUSPECT,Unknown,3.9,MG,5,Unknown
1933,8335,IS_SECONDARY_SUSPECT,Unknown,1,DF,2,Oral
1934,7982,IS_SECONDARY_SUSPECT,Unknown,30,G,2,Intravenous (not otherwise specified)
1938,7176,IS_SECONDARY_SUSPECT,Unknown,5,MG,3,Oral
1939,8669,IS_SECONDARY_SUSPECT,Colorectal cancer,1600,MG,1,Unknown
1940,7254,IS_SECONDARY_SUSPECT,Short-bowel syndrome,3.5,MG,2,Subcutaneous
1941,7254,IS_SECONDARY_SUSPECT,Short-bowel syndrome,0.05,MG/KG,2,Unknown
1948,7254,IS_SECONDARY_SUSPECT,Short-bowel syndrome,2.5,MG,2,Subcutaneous
1949,8806,IS_SECONDARY_SUSPECT,Factor IX deficiency,7000,IU,2,Intravenous (not otherwise specified)
1950,7978,IS_SECONDARY_SUSPECT,Colon cancer stage III,85,MG/M**2,2,Intravenous (not otherwise specified)
1950,8294,IS_SECONDARY_SUSPECT,Colon cancer stage III,400,MG/M**2,3,Intravenous (not otherwise specified)
1950,8702,IS_SECONDARY_SUSPECT,Colon cancer stage III,400,MG/M**2,4,Intravenous bolus
1954,8218,IS_SECONDARY_SUSPECT,Unknown,1000,MG,2,Intravenous (not otherwise specified)
1955,7920,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Oral
1955,7163,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG,3,Oral
1955,7188,IS_SECONDARY_SUSPECT,Plasma cell myeloma,1.3,MG/M**2,5,Subcutaneous
1956,8577,IS_SECONDARY_SUSPECT,Unknown,100,MG,2,Oral
1957,7254,IS_SECONDARY_SUSPECT,Short-bowel syndrome,1.6,MG,2,Unknown
1958,7254,IS_SECONDARY_SUSPECT,Short-bowel syndrome,2.45,MG,2,Subcutaneous
1959,8809,IS_SECONDARY_SUSPECT,Plasma cell myeloma,44,MG,2,Subcutaneous
1964,8811,IS_SECONDARY_SUSPECT,Unknown,400,MG,2,Oral
1965,8812,IS_SECONDARY_SUSPECT,Unknown,125,MG,2,Oral
1965,8813,IS_SECONDARY_SUSPECT,Breast cancer,150,MG,3,Oral
1966,8814,IS_SECONDARY_SUSPECT,Contraception,14,UG,2,Intra-uterine
1967,7319,IS_SECONDARY_SUSPECT,Type 1 diabetes mellitus,16,IU,5,Unknown
1971,7254,IS_SECONDARY_SUSPECT,Short-bowel syndrome,0.272,ML,2,Subcutaneous
1972,8815,IS_SECONDARY_SUSPECT,Iron deficiency,15,MG/KG,2,Intravenous (not otherwise specified)
1973,7993,IS_SECONDARY_SUSPECT,Unknown,200,MG,2,Oral
1973,8042,IS_SECONDARY_SUSPECT,Acute myeloid leukaemia,20,MG/M**2,5,Intravenous (not otherwise specified)
1974,8809,IS_SECONDARY_SUSPECT,Plasma cell myeloma,44,MG,2,Subcutaneous
1975,8817,IS_SECONDARY_SUSPECT,Iron deficiency,100,MG,2,Intravenous bolus
1976,7790,IS_SECONDARY_SUSPECT,Unknown,16,G,2,Subcutaneous
1977,7361,IS_SECONDARY_SUSPECT,Rheumatoid arthritis,11,MG,2,Unknown
1980,8118,IS_SECONDARY_SUSPECT,Relapsing-remitting multiple sclerosis,0.25,MG,2,Oral
1982,7338,IS_SECONDARY_SUSPECT,Unknown,5,MG,2,Oral
1984,8823,IS_SECONDARY_SUSPECT,Unknown,1,MG,2,Oral
1987,8826,IS_SECONDARY_SUSPECT,Invasive breast carcinoma,300,MG,2,Oral
1987,8827,IS_SECONDARY_SUSPECT,Invasive breast carcinoma,3.6,MG/KG,3,Intravenous (not otherwise specified)
1989,7394,IS_SECONDARY_SUSPECT,Unknown,34,MG,2,Oral
1991,8500,IS_SECONDARY_SUSPECT,Immune system disorder,30,MG,2,Subcutaneous
1991,8562,IS_SECONDARY_SUSPECT,Immune system disorder,300,MG,8,Subcutaneous
1992,7278,IS_SECONDARY_SUSPECT,Hidradenitis,40,MG,2,Subcutaneous
1996,8776,IS_SECONDARY_SUSPECT,Colon cancer,60,MG,2,Intravenous (not otherwise specified)
1998,8194,IS_SECONDARY_SUSPECT,Unknown,300,MG,3,Intravenous (not otherwise specified)
1998,8556,IS_SECONDARY_SUSPECT,Unknown,10,MG,6,Oral
2001,8838,IS_SECONDARY_SUSPECT,Unknown,200,MG,2,Subcutaneous
2002,7997,IS_SECONDARY_SUSPECT,Unknown,20,MG,2,Subcutaneous
2003,8845,IS_SECONDARY_SUSPECT,Unknown,1000,MG,2,Oral
2003,7279,IS_SECONDARY_SUSPECT,Prostate cancer metastatic,5,MG,4,Oral
2008,7850,IS_SECONDARY_SUSPECT,Acoustic neuroma,90,MG,2,Unknown
2010,8846,IS_SECONDARY_SUSPECT,Unknown,200.88,MCI,2,Unknown
2013,7685,IS_SECONDARY_SUSPECT,Unknown,6,MG,2,Unknown
2014,7332,IS_SECONDARY_SUSPECT,Philadelphia positive acute lymphocytic leukaemia,15,MG,2,Unknown
2014,7354,IS_SECONDARY_SUSPECT,Philadelphia positive acute lymphocytic leukaemia,103.6,MG,4,Oral
2014,8493,IS_SECONDARY_SUSPECT,Philadelphia positive acute lymphocytic leukaemia,95,MG,5,Oral
2014,7237,IS_SECONDARY_SUSPECT,Philadelphia positive acute lymphocytic leukaemia,200,MG,6,Intravenous (not otherwise specified)
2014,7781,IS_SECONDARY_SUSPECT,Philadelphia positive acute lymphocytic leukaemia,2,MG,7,Intravenous (not otherwise specified)
2014,7355,IS_SECONDARY_SUSPECT,Philadelphia positive acute lymphocytic leukaemia,3750,IU,8,Intravenous (not otherwise specified)
2016,8848,IS_SECONDARY_SUSPECT,K-ras gene mutation,960,MG,3,Oral
2019,7978,IS_SECONDARY_SUSPECT,Adenocarcinoma of colon,85,MG/M**2,2,Intravenous (not otherwise specified)
2019,8294,IS_SECONDARY_SUSPECT,Adenocarcinoma of colon,400,MG/M**2,3,Intravenous (not otherwise specified)
2019,8702,IS_SECONDARY_SUSPECT,Adenocarcinoma of colon,400,MG/M**2,4,Intravenous bolus
2021,8749,IS_SECONDARY_SUSPECT,Chronic lymphocytic leukaemia,900,MG,1,Unknown
2021,8748,IS_SECONDARY_SUSPECT,Unknown,800,MG,3,Unknown
2021,7993,IS_SECONDARY_SUSPECT,Chronic lymphocytic leukaemia,400,MG,4,Unknown
2024,8850,IS_SECONDARY_SUSPECT,Chemotherapy,130.892,MG,2,Intravenous (not otherwise specified)
2024,8851,IS_SECONDARY_SUSPECT,Chemotherapy,4490,MG,3,Intravenous (not otherwise specified)
2024,7613,IS_SECONDARY_SUSPECT,Chemotherapy,240,MG,4,Intravenous (not otherwise specified)
2025,7278,IS_SECONDARY_SUSPECT,Unknown,40,MG,2,Subcutaneous
2026,7536,IS_SECONDARY_SUSPECT,Unknown,1200,MG,2,Intravenous drip
2026,8852,IS_SECONDARY_SUSPECT,Skin cancer,58.75,UG,6,Intramuscular
2027,7850,IS_SECONDARY_SUSPECT,Unknown,180,MG,2,Unknown
2028,7905,IS_SECONDARY_SUSPECT,Unknown,162,MG,4,Subcutaneous
2031,8691,IS_SECONDARY_SUSPECT,Unknown,3,MG,2,Intravenous (not otherwise specified)
2031,8350,IS_SECONDARY_SUSPECT,Acute myeloid leukaemia,135,MG,3,Intravenous (not otherwise specified)
2031,7993,IS_SECONDARY_SUSPECT,Acute myeloid leukaemia,100,MG,5,Oral
2035,7335,IS_SECONDARY_SUSPECT,Unknown,5,MG,2,Oral
2035,7267,IS_SECONDARY_SUSPECT,Unknown,40,MG,3,Unknown
2038,7254,IS_SECONDARY_SUSPECT,Short-bowel syndrome,0.45,ML,2,Other
2040,7438,IS_SECONDARY_SUSPECT,Unknown,0.018,UG/KG,2,Intravenous drip
2043,8173,IS_SECONDARY_SUSPECT,Unknown,150,MG,2,Unknown
2044,8859,IS_SECONDARY_SUSPECT,Unknown,4,MG,2,Oral
2044,7188,IS_SECONDARY_SUSPECT,Plasma cell myeloma,0.7,MG/M**2,4,Subcutaneous
2044,7163,IS_SECONDARY_SUSPECT,Plasma cell myeloma,12,MG,5,Oral
2044,7920,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG,6,Oral
2045,7893,IS_SECONDARY_SUSPECT,Unknown,300,MG,2,Oral
2046,7681,IS_SECONDARY_SUSPECT,Multiple sclerosis,20,MG,2,Subcutaneous
2047,8399,IS_SECONDARY_SUSPECT,Unknown,200,UG,2,Oral
2050,8862,IS_SECONDARY_SUSPECT,Occipital neuralgia,165,MG,2,Oral
2051,8237,IS_SECONDARY_SUSPECT,Breast cancer,25,MG,2,Oral
2051,7348,IS_SECONDARY_SUSPECT,Pain,50,MG,3,Oral
2054,7176,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Oral
2056,8099,IS_SECONDARY_SUSPECT,Unknown,20,MG,2,Oral
2056,7536,IS_SECONDARY_SUSPECT,Hormone-refractory prostate cancer,1200,MG,3,Intravenous (not otherwise specified)
2058,7538,IS_SECONDARY_SUSPECT,Ovarian cancer,175,MG/M**2,2,Intravenous (not otherwise specified)
2058,7537,IS_SECONDARY_SUSPECT,Ovarian cancer,15,MG/KG,4,Intravenous (not otherwise specified)
2060,7996,IS_SECONDARY_SUSPECT,Hypogammaglobulinaemia,10,G,2,Subcutaneous
2060,7553,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,30,MG,3,Unknown
2069,8873,IS_SECONDARY_SUSPECT,Unknown,14,MG,2,Oral
2070,8702,IS_SECONDARY_SUSPECT,Adenocarcinoma of colon,400,MG/M**2,2,Intravenous bolus
2070,8294,IS_SECONDARY_SUSPECT,Adenocarcinoma of colon,400,MG/M**2,3,Intravenous (not otherwise specified)
2070,7978,IS_SECONDARY_SUSPECT,Adenocarcinoma of colon,85,MG/M**2,4,Intravenous (not otherwise specified)
2072,8874,IS_SECONDARY_SUSPECT,Soft tissue sarcoma,250,MG,3,Oral
2075,8118,IS_SECONDARY_SUSPECT,Unknown,1,MG,2,Oral
2076,7979,IS_SECONDARY_SUSPECT,Unknown,30,G,2,Subcutaneous
2077,8876,IS_SECONDARY_SUSPECT,Plasma cell myeloma,25,MG,2,Oral
2077,7163,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG,3,Oral
2078,7882,IS_SECONDARY_SUSPECT,Unknown,30,MG,3,Unknown
2079,7961,IS_SECONDARY_SUSPECT,Hypothyroidism,100,UG,2,Unknown
2080,8817,IS_SECONDARY_SUSPECT,Anaemia,100,MG,2,Unknown
2080,7233,IS_SECONDARY_SUSPECT,Unknown,150,UG,3,Unknown
2083,8881,IS_SECONDARY_SUSPECT,Gastrointestinal carcinoma,105,MG,3,Intravenous (not otherwise specified)
2086,7502,IS_SECONDARY_SUSPECT,Non-small cell lung cancer,60,MG,3,Oral
2087,8099,IS_SECONDARY_SUSPECT,Metastatic neoplasm,40,MG,2,Oral
2089,8883,IS_SECONDARY_SUSPECT,Unknown,200,MG,2,Oral
2093,8465,IS_SECONDARY_SUSPECT,Severe myoclonic epilepsy of infancy,2.2,ML,2,Oral
2094,8465,IS_SECONDARY_SUSPECT,Unknown,3.5,ML,2,Oral
2096,8201,IS_SECONDARY_SUSPECT,Unknown,61,MG,2,Unknown
2098,7893,IS_SECONDARY_SUSPECT,Unknown,200,MG,2,Oral
2101,7961,IS_SECONDARY_SUSPECT,Hypoparathyroidism,100,UG,2,Unknown
2103,8099,IS_SECONDARY_SUSPECT,Unknown,20,MG,2,Oral
2106,8892,IS_SECONDARY_SUSPECT,Unknown,1,DF,2,Unknown
2107,7502,IS_SECONDARY_SUSPECT,Unknown,40,MG,2,Oral
2108,7237,IS_SECONDARY_SUSPECT,Lung neoplasm malignant,500,MG/KG,3,Intravenous (not otherwise specified)
2108,7883,IS_SECONDARY_SUSPECT,Lung neoplasm malignant,30,MG/M**2,4,Intravenous (not otherwise specified)
2109,8896,IS_SECONDARY_SUSPECT,Unknown,44,UG,2,Subcutaneous
2110,8681,IS_SECONDARY_SUSPECT,Unknown,1.5,MG,2,Subcutaneous
2111,7280,IS_SECONDARY_SUSPECT,Unknown,125,MG,2,Oral
2114,8900,IS_SECONDARY_SUSPECT,Unknown,2,DF,2,Unknown
2114,8901,IS_SECONDARY_SUSPECT,Myasthenic syndrome,10,MG,4,Oral
2116,7978,IS_SECONDARY_SUSPECT,Colon cancer stage III,172.5,MG,2,Intravenous (not otherwise specified)
2116,8294,IS_SECONDARY_SUSPECT,Colon cancer stage III,810,MG,3,Intravenous (not otherwise specified)
2116,8702,IS_SECONDARY_SUSPECT,Colon cancer stage III,5675,MG,4,Intravenous bolus
2117,8749,IS_SECONDARY_SUSPECT,Chronic lymphocytic leukaemia,900,MG,1,Intravenous (not otherwise specified)
2117,8748,IS_SECONDARY_SUSPECT,Unknown,400,MG,3,Unknown
2117,7993,IS_SECONDARY_SUSPECT,Chronic lymphocytic leukaemia,400,MG,4,Oral
2118,8903,IS_SECONDARY_SUSPECT,Triple negative breast cancer,200,MG,2,Intravenous (not otherwise specified)
2122,7685,IS_SECONDARY_SUSPECT,Unknown,6,UG,2,Unknown
2123,8548,IS_SECONDARY_SUSPECT,Unknown,15,MG,2,Oral
2124,7416,IS_SECONDARY_SUSPECT,Unknown,100,MG,2,Unknown
2124,8204,IS_SECONDARY_SUSPECT,Ovarian cancer,500,MG,3,Unknown
2124,7538,IS_SECONDARY_SUSPECT,Ovarian cancer,269,MG,7,Intravenous (not otherwise specified)
2124,7537,IS_SECONDARY_SUSPECT,Unknown,790,MG/KG,10,Intravenous (not otherwise specified)
2129,7940,IS_SECONDARY_SUSPECT,Follicular lymphoma,375,MG/M**2,2,Intravenous (not otherwise specified)
2133,7850,IS_SECONDARY_SUSPECT,Lung neoplasm malignant,180,MG,2,Unknown
2134,8173,IS_SECONDARY_SUSPECT,Unknown,300,MG,2,Subcutaneous
2135,8766,IS_SECONDARY_SUSPECT,Unknown,0.92,MG,2,Oral
2144,7280,IS_SECONDARY_SUSPECT,Breast cancer female,125,MG,2,Oral
2146,7499,IS_SECONDARY_SUSPECT,Unknown,1000,MG,5,Intravenous (not otherwise specified)
2147,7443,IS_SECONDARY_SUSPECT,Bladder cancer,35,MG/KG,2,Intravenous (not otherwise specified)
2151,8381,IS_SECONDARY_SUSPECT,Unknown,750,MG,3,Intravenous (not otherwise specified)
2152,8173,IS_SECONDARY_SUSPECT,Unknown,300,MG,2,Unknown
2153,8807,IS_SECONDARY_SUSPECT,Unknown,14,MG,3,Oral
2154,7176,IS_SECONDARY_SUSPECT,Unknown,2.5,MG,4,Oral
2158,7537,IS_SECONDARY_SUSPECT,Ovarian cancer,10,MG/KG,2,Intravenous (not otherwise specified)
2158,8914,IS_SECONDARY_SUSPECT,Ovarian cancer,40,MG/M**2,3,Intravenous (not otherwise specified)
2159,8176,IS_SECONDARY_SUSPECT,B-cell lymphoma,176,MG,2,Intravenous (not otherwise specified)
2159,7237,IS_SECONDARY_SUSPECT,B-cell lymphoma,1612.5,MG,3,Intravenous (not otherwise specified)
2159,7244,IS_SECONDARY_SUSPECT,B-cell lymphoma,108,MG,4,Intravenous (not otherwise specified)
2159,7171,IS_SECONDARY_SUSPECT,B-cell lymphoma,100,MG,5,Oral
2160,7176,IS_SECONDARY_SUSPECT,Plasma cell myeloma,15,MG,2,Oral
2162,8489,IS_SECONDARY_SUSPECT,Unknown,20,ML,4,Oral
2164,8776,IS_SECONDARY_SUSPECT,Epithelioid mesothelioma,65,MG,2,Intravenous (not otherwise specified)
2166,8918,IS_SECONDARY_SUSPECT,Unknown,40,MG,2,Oral
2166,8919,IS_SECONDARY_SUSPECT,Plasma cell myeloma,2.5,MG/KG,3,Intravenous (not otherwise specified)
2166,7163,IS_SECONDARY_SUSPECT,Plasma cell myeloma,40,MG,5,Oral
2167,8921,IS_SECONDARY_SUSPECT,Unknown,15,MG,2,Unknown
2170,8034,IS_SECONDARY_SUSPECT,Unknown,274,MG,2,Oral
2170,7183,IS_SECONDARY_SUSPECT,Unknown,6.25,MG,4,Unknown
2171,7176,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Oral
2176,7632,IS_SECONDARY_SUSPECT,Unknown,1,MG,2,Unknown
2177,8176,IS_SECONDARY_SUSPECT,B-cell lymphoma,172,MG,2,Intravenous (not otherwise specified)
2178,7416,IS_SECONDARY_SUSPECT,Unknown,200,MG,2,Oral
2179,7170,IS_SECONDARY_SUSPECT,Unknown,10,MG/KG,2,Transplacental
2182,7354,IS_SECONDARY_SUSPECT,Unknown,100,MG,2,Oral
2182,7332,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,15,MG,3,Intrathecal
2182,7171,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,40,MG,5,Oral
2182,7353,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,100,MG,6,Oral
2182,7781,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,2,MG,7,Intravenous (not otherwise specified)
2183,7280,IS_SECONDARY_SUSPECT,Unknown,100,MG,2,Oral
2184,7283,IS_SECONDARY_SUSPECT,Unknown,1,MG,2,Unknown
2186,8500,IS_SECONDARY_SUSPECT,Immune system disorder,30,MG,2,Subcutaneous
2186,7996,IS_SECONDARY_SUSPECT,Myasthenia gravis,65,G,3,Intravenous (not otherwise specified)
2188,8407,IS_SECONDARY_SUSPECT,Unknown,380,MG,2,Intramuscular
2192,8204,IS_SECONDARY_SUSPECT,Unknown,500,MG,3,Intravenous (not otherwise specified)
2192,8935,IS_SECONDARY_SUSPECT,Breast cancer,220,MG,4,Intravenous (not otherwise specified)
2193,7759,IS_SECONDARY_SUSPECT,Papillary thyroid cancer,1.5,MG,2,Oral
2194,7685,IS_SECONDARY_SUSPECT,Unknown,6,MG,2,Unknown
2195,8173,IS_SECONDARY_SUSPECT,Unknown,300,MG,2,Unknown
2200,7790,IS_SECONDARY_SUSPECT,Unknown,6,G,2,Subcutaneous
2201,8404,IS_SECONDARY_SUSPECT,Weight decreased,1,DF,2,Oral
2203,7278,IS_SECONDARY_SUSPECT,Unknown,40,MG,2,Subcutaneous
2204,8176,IS_SECONDARY_SUSPECT,Diffuse large B-cell lymphoma,188,MG,2,Intravenous (not otherwise specified)
2206,8367,IS_SECONDARY_SUSPECT,Type 2 diabetes mellitus,10,IU,2,Subcutaneous
2207,8946,IS_SECONDARY_SUSPECT,Nephroblastoma,44,MG,2,Intravenous (not otherwise specified)
2207,8947,IS_SECONDARY_SUSPECT,Nephroblastoma,90,MG,3,Oral
2208,7994,IS_SECONDARY_SUSPECT,Chronic lymphocytic leukaemia,420,MG,2,Oral
2209,8948,IS_SECONDARY_SUSPECT,Unknown,60,MG,2,Intravenous (not otherwise specified)
2210,8500,IS_SECONDARY_SUSPECT,Immune system disorder,30,MG,2,Subcutaneous
2210,8562,IS_SECONDARY_SUSPECT,Immune system disorder,300,MG,5,Subcutaneous
2210,7719,IS_SECONDARY_SUSPECT,Immune system disorder,1000,IU,7,Intravenous (not otherwise specified)
2211,7477,IS_SECONDARY_SUSPECT,Unknown,3,MG,2,Oral
2212,7662,IS_SECONDARY_SUSPECT,Unknown,69,MG,2,Intravenous (not otherwise specified)
2212,8949,IS_SECONDARY_SUSPECT,Leiomyosarcoma,2.1,MG,3,Intravenous (not otherwise specified)
2213,8762,IS_SECONDARY_SUSPECT,Contraception,1,DF,2,Subdermal
2217,7237,IS_SECONDARY_SUSPECT,Plasma cell myeloma,498,MG,2,Intravenous drip
2217,7883,IS_SECONDARY_SUSPECT,Plasma cell myeloma,49.8,MG,3,Intravenous drip
2217,7922,IS_SECONDARY_SUSPECT,Plasma cell myeloma,4,MG,4,Oral
2217,7222,IS_SECONDARY_SUSPECT,Plasma cell myeloma,10,MG/KG,5,Intravenous drip
2217,7163,IS_SECONDARY_SUSPECT,Unknown,8,MG,9,Oral
2220,8958,IS_SECONDARY_SUSPECT,Unknown,20,MG,2,Oral
2220,8959,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,100,MG,3,Oral
2220,8960,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,80,MG,4,Oral
2221,7278,IS_SECONDARY_SUSPECT,Unknown,40,MG,2,Subcutaneous
2223,7993,IS_SECONDARY_SUSPECT,Refractory cancer,350,MG,2,Oral
2223,7237,IS_SECONDARY_SUSPECT,Recurrent cancer,250,MG/M**2,4,Intravenous (not otherwise specified)
2223,8961,IS_SECONDARY_SUSPECT,Recurrent cancer,0.75,MG/M**2,6,Intravenous (not otherwise specified)
2224,8964,IS_SECONDARY_SUSPECT,Unknown,400,MG,2,Intravenous (not otherwise specified)
2225,7782,IS_SECONDARY_SUSPECT,Cerebrovascular accident prophylaxis,20,MG,2,Oral
2227,7334,IS_SECONDARY_SUSPECT,Polyneuropathy,35,G,2,Intravenous (not otherwise specified)
2228,7782,IS_SECONDARY_SUSPECT,Thrombosis,15,MG,1,Oral
2229,7438,IS_SECONDARY_SUSPECT,Unknown,0.075,UG/KG,2,Intravenous drip
2230,7183,IS_SECONDARY_SUSPECT,Unknown,12.5,MG,2,Oral
2230,8034,IS_SECONDARY_SUSPECT,Dyskinesia,137,MG,3,Oral
2231,8335,IS_SECONDARY_SUSPECT,Cardiac failure congestive,1,DF,2,Oral
2232,7681,IS_SECONDARY_SUSPECT,Unknown,20,MG,2,Subcutaneous
2232,7499,IS_SECONDARY_SUSPECT,Multiple sclerosis,1000,MG,3,Intravenous drip
2234,7994,IS_SECONDARY_SUSPECT,Chronic lymphocytic leukaemia,420,MG,3,Oral
2235,7662,IS_SECONDARY_SUSPECT,Renal cell carcinoma,296.4,MG,2,Intravenous (not otherwise specified)
2236,8381,IS_SECONDARY_SUSPECT,Unknown,750,MG,2,Intravenous (not otherwise specified)
2237,7662,IS_SECONDARY_SUSPECT,Prostate cancer metastatic,1,MG/KG,2,Intravenous (not otherwise specified)
2238,8544,IS_SECONDARY_SUSPECT,Malignant melanoma,100,ML,2,Unknown
2239,7205,IS_SECONDARY_SUSPECT,Psychotic disorder,60,MG,2,Unknown
2240,7993,IS_SECONDARY_SUSPECT,Unknown,50,MG,2,Oral
2240,7995,IS_SECONDARY_SUSPECT,Chronic lymphocytic leukaemia,100,MG,6,Intravenous (not otherwise specified)
2240,7994,IS_SECONDARY_SUSPECT,Chronic lymphocytic leukaemia,420,MG,9,Oral
2241,8014,IS_SECONDARY_SUSPECT,Unknown,280,MG,2,Oral
2241,8240,IS_SECONDARY_SUSPECT,Chronic lymphocytic leukaemia,20,MG,4,Oral
2245,7965,IS_SECONDARY_SUSPECT,Unknown,90,MG,2,Subcutaneous
2249,7898,IS_SECONDARY_SUSPECT,Unknown,3.75,MG,2,Oral
2250,8977,IS_SECONDARY_SUSPECT,Haematological malignancy,200,MG,3,Oral
2252,7416,IS_SECONDARY_SUSPECT,Unknown,100,MG,2,Unknown
2252,8204,IS_SECONDARY_SUSPECT,Ovarian cancer,500,MG,5,Unknown
2254,7361,IS_SECONDARY_SUSPECT,Unknown,11,MG,2,Oral
2256,7416,IS_SECONDARY_SUSPECT,Unknown,300,MG,2,Unknown
2256,8204,IS_SECONDARY_SUSPECT,Ovarian cancer,500,MG,3,Unknown
2256,7538,IS_SECONDARY_SUSPECT,Ovarian cancer,301,MG,6,Intravenous (not otherwise specified)
2258,8762,IS_SECONDARY_SUSPECT,Unknown,1,DF,2,Subdermal
2259,8014,IS_SECONDARY_SUSPECT,Chronic lymphocytic leukaemia,420,MG,2,Oral
2261,7249,IS_SECONDARY_SUSPECT,Unknown,240,MG,2,Oral
2262,7537,IS_SECONDARY_SUSPECT,Hepatocellular carcinoma,1572,MG,2,Intravenous (not otherwise specified)
2262,8982,IS_SECONDARY_SUSPECT,Hepatocellular carcinoma,600,MG,3,Intravenous (not otherwise specified)
2264,7176,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Oral
2267,7502,IS_SECONDARY_SUSPECT,Non-small cell lung cancer,60,MG,2,Oral
2268,8218,IS_SECONDARY_SUSPECT,Factor VIII deficiency,625,MG,4,Intravenous (not otherwise specified)
2268,7237,IS_SECONDARY_SUSPECT,Factor VIII deficiency,150,MG,7,Unknown
2270,7993,IS_SECONDARY_SUSPECT,Chronic lymphocytic leukaemia,20,MG,2,Oral
2270,7994,IS_SECONDARY_SUSPECT,Chronic lymphocytic leukaemia,420,MG,4,Oral
2270,7335,IS_SECONDARY_SUSPECT,Unknown,5,MG,6,Unknown
2279,7283,IS_SECONDARY_SUSPECT,Unknown,2,MG,2,Oral
2280,7994,IS_SECONDARY_SUSPECT,Chronic lymphocytic leukaemia,420,MG,2,Oral
2282,7252,IS_SECONDARY_SUSPECT,Plasma cell myeloma,3,MG,2,Unknown
2282,8918,IS_SECONDARY_SUSPECT,Plasma cell myeloma,60,MG,3,Unknown
2284,7993,IS_SECONDARY_SUSPECT,Acute myeloid leukaemia,50,MG,2,Oral
2285,7176,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Oral
2286,7163,IS_SECONDARY_SUSPECT,Plasma cell myeloma,40,MG,2,Unknown
2286,8918,IS_SECONDARY_SUSPECT,Plasma cell myeloma,60,MG,3,Oral
2286,7360,IS_SECONDARY_SUSPECT,Plasma cell myeloma,4,MG,4,Oral
2287,7360,IS_SECONDARY_SUSPECT,Unknown,3,MG,2,Oral
2287,7252,IS_SECONDARY_SUSPECT,Plasma cell myeloma,3,MG,3,Oral
2287,8918,IS_SECONDARY_SUSPECT,Plasma cell myeloma,60,MG,4,Oral
2288,9003,IS_SECONDARY_SUSPECT,Unknown,0.2,MG,2,Other
2288,7631,IS_SECONDARY_SUSPECT,Pneumocystis jirovecii pneumonia,123.2,MG,11,Other
2288,9004,IS_SECONDARY_SUSPECT,Immunosuppression,1.25,MG,13,Other
2288,7279,IS_SECONDARY_SUSPECT,Immunosuppression,12.3,MG,27,Other
2288,7163,IS_SECONDARY_SUSPECT,Oral candidiasis,1,DF,31,Oral
2289,8174,IS_SECONDARY_SUSPECT,Unknown,320,MG,2,Intravenous (not otherwise specified)
2292,7354,IS_SECONDARY_SUSPECT,B precursor type acute leukaemia,60,MG/M**2,2,Oral
2292,7332,IS_SECONDARY_SUSPECT,B precursor type acute leukaemia,12.5,MG,3,Intrathecal
2292,7352,IS_SECONDARY_SUSPECT,B precursor type acute leukaemia,1.4,MG/M**2,5,Intravenous (not otherwise specified)
2295,8670,IS_SECONDARY_SUSPECT,Malignant connective tissue neoplasm,20,MG,2,Oral
2298,7176,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Oral
2299,8004,IS_SECONDARY_SUSPECT,Unknown,84,MG,2,Unknown
2304,7176,IS_SECONDARY_SUSPECT,Unknown,15,MG,2,Oral
2305,9011,IS_SECONDARY_SUSPECT,Unknown,20,MG/KG,2,Intravenous (not otherwise specified)
2305,7163,IS_SECONDARY_SUSPECT,T-cell type acute leukaemia,10,MG/M**2,4,Oral
2305,9012,IS_SECONDARY_SUSPECT,T-cell type acute leukaemia,10,MG/M**2,6,Intravenous (not otherwise specified)
2305,7352,IS_SECONDARY_SUSPECT,T-cell type acute leukaemia,1.5,MG/M**2,8,Intravenous (not otherwise specified)
2306,9013,IS_SECONDARY_SUSPECT,Type 2 diabetes mellitus,10,UG,2,Subcutaneous
2306,7660,IS_SECONDARY_SUSPECT,Blood cholesterol abnormal,10,MG,3,Oral
2310,9009,IS_SECONDARY_SUSPECT,Unknown,1,PCT,2,Unknown
2311,8173,IS_SECONDARY_SUSPECT,Unknown,300,MG,2,Subcutaneous
2312,7163,IS_SECONDARY_SUSPECT,Plasma cell myeloma,40,MG,2,Oral
2312,7877,IS_SECONDARY_SUSPECT,Plasma cell myeloma,4,MG,3,Oral
2312,7922,IS_SECONDARY_SUSPECT,Plasma cell myeloma,3,MG,5,Oral
2313,7495,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,30,MG,2,Unknown
2313,7325,IS_SECONDARY_SUSPECT,Unknown,40,MG,6,Unknown
2313,7366,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,40,MG,9,Oral
2313,7230,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,20,MG,10,Unknown
2313,7371,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,40,MG,14,Unknown
2314,7995,IS_SECONDARY_SUSPECT,Unknown,900,MG,2,Intravenous (not otherwise specified)
2314,7994,IS_SECONDARY_SUSPECT,Chronic lymphocytic leukaemia,420,MG,5,Oral
2314,7993,IS_SECONDARY_SUSPECT,Chronic lymphocytic leukaemia,20,MG,6,Oral
2315,7254,IS_SECONDARY_SUSPECT,Short-bowel syndrome,0.33,ML,2,Subcutaneous
2317,7477,IS_SECONDARY_SUSPECT,Unknown,3,MG,2,Oral
2318,7861,IS_SECONDARY_SUSPECT,Colon cancer metastatic,200,MG,2,Intravenous (not otherwise specified)
2319,7283,IS_SECONDARY_SUSPECT,Unknown,2,MG,2,Oral
2320,7278,IS_SECONDARY_SUSPECT,Unknown,40,MG,2,Subcutaneous
2320,7332,IS_SECONDARY_SUSPECT,Crohn's disease,12.5,MG,5,Oral
2321,7993,IS_SECONDARY_SUSPECT,Recurrent cancer,200,MG,2,Oral
2321,7171,IS_SECONDARY_SUSPECT,Recurrent cancer,47,MG,5,Oral
2321,7781,IS_SECONDARY_SUSPECT,Recurrent cancer,1.5,MG/M**2,7,Intravenous (not otherwise specified)
2321,9016,IS_SECONDARY_SUSPECT,Recurrent cancer,2500,MG/M**2,9,Intravenous (not otherwise specified)
2324,8762,IS_SECONDARY_SUSPECT,Contraception,1,DF,2,Subdermal
2325,7278,IS_SECONDARY_SUSPECT,Unknown,40,MG,2,Subcutaneous
2330,7536,IS_SECONDARY_SUSPECT,Ovarian cancer recurrent,840,MG,2,Intravenous (not otherwise specified)
2330,7416,IS_SECONDARY_SUSPECT,Ovarian cancer recurrent,200,MG,3,Oral
2331,7685,IS_SECONDARY_SUSPECT,Unknown,6,MG,2,Unknown
2332,7718,IS_SECONDARY_SUSPECT,Hereditary angioedema with normal C1 esterase inhibitor,2,ML,2,Subcutaneous
2333,8004,IS_SECONDARY_SUSPECT,Unknown,84,MG,2,Unknown
2337,8004,IS_SECONDARY_SUSPECT,Unknown,52,MG,2,Unknown
2338,7438,IS_SECONDARY_SUSPECT,Unknown,0.08,UG/KG,2,Subcutaneous
2338,8400,IS_SECONDARY_SUSPECT,Pulmonary arterial hypertension,10,MG,4,Oral
2340,7983,IS_SECONDARY_SUSPECT,Liver transplant,600,MG,1,Subcutaneous
2340,7321,IS_SECONDARY_SUSPECT,Unknown,250,MG,3,Oral
2343,7176,IS_SECONDARY_SUSPECT,Unknown,15,MG,2,Oral
2344,9027,IS_SECONDARY_SUSPECT,Unknown,300,MG,2,Intravenous (not otherwise specified)
2345,8197,IS_SECONDARY_SUSPECT,Unknown,120,MG,2,Subcutaneous
2350,7365,IS_SECONDARY_SUSPECT,Unknown,5,MG,2,Oral
2352,9028,IS_SECONDARY_SUSPECT,Adenocarcinoma of colon,840,MG,2,Unknown
2352,9029,IS_SECONDARY_SUSPECT,Adenocarcinoma of colon,880,MG,3,Intravenous (not otherwise specified)
2352,9030,IS_SECONDARY_SUSPECT,Adenocarcinoma of colon,316.8,MG,4,Intravenous (not otherwise specified)
2353,9031,IS_SECONDARY_SUSPECT,Pulmonary arterial hypertension,2.5,MG,2,Oral
2354,7278,IS_SECONDARY_SUSPECT,Unknown,40,MG,2,Subcutaneous
2354,8220,IS_SECONDARY_SUSPECT,Colitis ulcerative,50,MG,3,Oral
2358,7176,IS_SECONDARY_SUSPECT,Unknown,25,MG,2,Oral
2359,7477,IS_SECONDARY_SUSPECT,Unknown,4,MG,2,Oral
2361,8225,IS_SECONDARY_SUSPECT,Uterine leiomyoma,300,MG,2,Oral
2364,7496,IS_SECONDARY_SUSPECT,Unknown,300,MG,2,Intravenous (not otherwise specified)
2367,8399,IS_SECONDARY_SUSPECT,Pulmonary hypertension,600,UG,2,Oral
2368,7995,IS_SECONDARY_SUSPECT,Chronic lymphocytic leukaemia,100,MG,2,Intravenous (not otherwise specified)
2368,7994,IS_SECONDARY_SUSPECT,Chronic lymphocytic leukaemia,420,MG,3,Oral
2369,8766,IS_SECONDARY_SUSPECT,Unknown,0.92,MG,2,Oral
2371,7613,IS_SECONDARY_SUSPECT,Unknown,240,MG,2,Intravenous (not otherwise specified)
2371,7662,IS_SECONDARY_SUSPECT,Pancreatic carcinoma,70,MG,11,Intravenous (not otherwise specified)
2372,7984,IS_SECONDARY_SUSPECT,Asthma,300,MG,3,Subcutaneous
2373,7278,IS_SECONDARY_SUSPECT,Unknown,40,MG,2,Subcutaneous
2374,8350,IS_SECONDARY_SUSPECT,Unknown,75,MG/M**2,2,Subcutaneous
2375,8253,IS_SECONDARY_SUSPECT,Unknown,300,MG,2,Intravenous (not otherwise specified)
2377,9039,IS_SECONDARY_SUSPECT,Unknown,400,MG,2,Oral
2380,7278,IS_SECONDARY_SUSPECT,Unknown,40,MG,2,Subcutaneous
2380,7332,IS_SECONDARY_SUSPECT,Crohn's disease,15,MG,3,Oral
2380,8100,IS_SECONDARY_SUSPECT,Crohn's disease,50,MG,5,Oral
2381,8509,IS_SECONDARY_SUSPECT,Hairy cell leukaemia,45,MG,2,Oral
2382,8749,IS_SECONDARY_SUSPECT,Chronic lymphocytic leukaemia,900,MG,1,Intravenous (not otherwise specified)
2382,7993,IS_SECONDARY_SUSPECT,Chronic lymphocytic leukaemia,400,MG,3,Oral
2383,9041,IS_SECONDARY_SUSPECT,Adenocarcinoma,60,MG/M**2,1,Intravenous (not otherwise specified)
2384,9042,IS_SECONDARY_SUSPECT,Gastrointestinal stromal tumour,30,MG,1,Oral
2388,7176,IS_SECONDARY_SUSPECT,Unknown,2.5,MG,2,Oral
2392,7662,IS_SECONDARY_SUSPECT,Leiomyosarcoma metastatic,3.53,MG,2,Intravenous (not otherwise specified)
2392,8949,IS_SECONDARY_SUSPECT,Leiomyosarcoma metastatic,1.7,MG,3,Intravenous (not otherwise specified)
2393,7537,IS_SECONDARY_SUSPECT,Transitional cell carcinoma,1139,MG,2,Intravenous (not otherwise specified)
2395,7718,IS_SECONDARY_SUSPECT,Unknown,300,MG,2,Subcutaneous
2399,7435,IS_SECONDARY_SUSPECT,Pancreatic carcinoma,240,MG,2,Intravenous (not otherwise specified)
2401,8762,IS_SECONDARY_SUSPECT,Unknown,1,DF,2,Subdermal
2405,8513,IS_SECONDARY_SUSPECT,Unknown,5,MG,2,Oral
2412,7354,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,100,MG,2,Oral
2412,7332,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,15,MG,4,Intrathecal
2412,7353,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,90,MG,5,Oral
2412,7237,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,1760,MG,6,Intravenous (not otherwise specified)
2413,8407,IS_SECONDARY_SUSPECT,Unknown,380,MG,2,Intramuscular
2414,8884,IS_SECONDARY_SUSPECT,Pneumonia,300,MG,2,Oral
2415,7931,IS_SECONDARY_SUSPECT,Hypertension,160,MG,2,Unknown
2415,9057,IS_SECONDARY_SUSPECT,Hypertension,160,MG,4,Unknown
2418,8118,IS_SECONDARY_SUSPECT,Unknown,2,MG,2,Oral
2419,7496,IS_SECONDARY_SUSPECT,Unknown,300,MG,2,Intravenous (not otherwise specified)
2420,7438,IS_SECONDARY_SUSPECT,Unknown,0.03,UG/KG,2,Intravenous drip
2421,7993,IS_SECONDARY_SUSPECT,Mantle cell lymphoma,400,MG,2,Oral
2421,9062,IS_SECONDARY_SUSPECT,Mantle cell lymphoma,173,MG,4,Intravenous (not otherwise specified)
2422,7176,IS_SECONDARY_SUSPECT,Unknown,20,MG,2,Oral
2422,7163,IS_SECONDARY_SUSPECT,Unknown,20,MG,4,Unknown
2422,7477,IS_SECONDARY_SUSPECT,Unknown,2.3,MG,6,Unknown
2425,8489,IS_SECONDARY_SUSPECT,Unknown,2.5,ML,2,Unknown
2426,7993,IS_SECONDARY_SUSPECT,Acute myeloid leukaemia,400,MG,2,Oral
2427,8538,IS_SECONDARY_SUSPECT,Unknown,75,MG,2,Oral
2428,7982,IS_SECONDARY_SUSPECT,Unknown,17,G,2,Subcutaneous
2428,7790,IS_SECONDARY_SUSPECT,Immunodeficiency common variable,17,G,3,Subcutaneous
2432,8399,IS_SECONDARY_SUSPECT,Unknown,200,UG,2,Oral
2432,7944,IS_SECONDARY_SUSPECT,Pulmonary hypertension,10,MG,4,Oral
2437,7982,IS_SECONDARY_SUSPECT,Unknown,30,G,2,Intravenous (not otherwise specified)
2441,8681,IS_SECONDARY_SUSPECT,Diabetes mellitus,0.75,MG,3,Unknown
2443,8058,IS_SECONDARY_SUSPECT,Alpha-1 antitrypsin deficiency,16000,MG,2,Intravenous (not otherwise specified)
2444,7922,IS_SECONDARY_SUSPECT,Plasma cell myeloma,3,MG,2,Oral
2444,7163,IS_SECONDARY_SUSPECT,Plasma cell myeloma,40,MG,3,Oral
2445,8827,IS_SECONDARY_SUSPECT,HER2 positive breast cancer,3.6,MG/KG,2,Intravenous (not otherwise specified)
2446,7920,IS_SECONDARY_SUSPECT,Follicular lymphoma,20,MG,2,Oral
2447,8766,IS_SECONDARY_SUSPECT,Unknown,0.23,MG,2,Oral
2449,8204,IS_SECONDARY_SUSPECT,Unknown,1000,MG,2,Unknown
2449,7538,IS_SECONDARY_SUSPECT,Endometrial cancer,175,MG/M**2,5,Intravenous (not otherwise specified)
2450,7920,IS_SECONDARY_SUSPECT,Plasma cell myeloma,25,MG,2,Oral
2450,7163,IS_SECONDARY_SUSPECT,Plasma cell myeloma,40,MG,3,Oral
2451,7685,IS_SECONDARY_SUSPECT,Unknown,6,MG,2,Unknown
2457,7836,IS_SECONDARY_SUSPECT,Unknown,60,MG,2,Oral
2457,9085,IS_SECONDARY_SUSPECT,Unknown,20,MG,5,Oral
2458,7438,IS_SECONDARY_SUSPECT,Unknown,0.099,UG/KG,2,Intravenous drip
2461,7993,IS_SECONDARY_SUSPECT,Unknown,50,MG,2,Oral
2461,7994,IS_SECONDARY_SUSPECT,Chronic lymphocytic leukaemia,420,MG,6,Oral
2463,7334,IS_SECONDARY_SUSPECT,Immunodeficiency common variable,70,G,2,Unknown
2465,8004,IS_SECONDARY_SUSPECT,Unknown,84,MG,2,Unknown
2465,8407,IS_SECONDARY_SUSPECT,Alcohol use disorder,380,MG,3,Intramuscular
2466,7438,IS_SECONDARY_SUSPECT,Unknown,0.023,UG/KG,2,Subcutaneous
2467,7176,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Oral
2469,8123,IS_SECONDARY_SUSPECT,Mucopolysaccharidosis,17.65,MG/KG,2,Intravenous (not otherwise specified)
2470,8085,IS_SECONDARY_SUSPECT,Metastatic malignant melanoma,400,MG,1,Intravenous (not otherwise specified)
2472,7632,IS_SECONDARY_SUSPECT,Unknown,0.8,MG,2,Unknown
2476,7613,IS_SECONDARY_SUSPECT,Gallbladder cancer,240,MG,2,Intravenous (not otherwise specified)
2476,9092,IS_SECONDARY_SUSPECT,Gallbladder cancer,400,MG/M**2,3,Intravenous (not otherwise specified)
2476,9030,IS_SECONDARY_SUSPECT,Gallbladder cancer,70,MG/M**2,4,Intravenous (not otherwise specified)
2477,8478,IS_SECONDARY_SUSPECT,Non-small cell lung cancer metastatic,40,MG,2,Oral
2478,7176,IS_SECONDARY_SUSPECT,Unknown,2.5,MG,2,Oral
2479,7477,IS_SECONDARY_SUSPECT,Unknown,3,MG,2,Oral
2483,8350,IS_SECONDARY_SUSPECT,Unknown,75,MG/M**2,2,Subcutaneous
2483,7993,IS_SECONDARY_SUSPECT,Acute myeloid leukaemia,50,MG,3,Oral
2487,7176,IS_SECONDARY_SUSPECT,Unknown,15,MG,2,Oral
2488,7994,IS_SECONDARY_SUSPECT,Chronic lymphocytic leukaemia,420,MG,2,Oral
2489,7416,IS_SECONDARY_SUSPECT,Unknown,100,MG,2,Unknown
2489,8204,IS_SECONDARY_SUSPECT,Ovarian cancer,500,MG,3,Unknown
2489,7538,IS_SECONDARY_SUSPECT,Ovarian cancer,285,MG,7,Intravenous (not otherwise specified)
2490,7416,IS_SECONDARY_SUSPECT,Unknown,200,MG,2,Oral
2491,9094,IS_SECONDARY_SUSPECT,Neovascular age-related macular degeneration,0.5,MG,3,Other
2493,8407,IS_SECONDARY_SUSPECT,Unknown,380,MG,2,Intramuscular
2494,8350,IS_SECONDARY_SUSPECT,Unknown,37,MG/M**2,2,Intravenous drip
2495,7883,IS_SECONDARY_SUSPECT,Plasma cell myeloma,30,MG,2,Intravenous drip
2495,7237,IS_SECONDARY_SUSPECT,Plasma cell myeloma,500,MG,3,Intravenous drip
2497,9101,IS_SECONDARY_SUSPECT,Malignant neoplasm progression,360,MG,2,Oral
2499,9102,IS_SECONDARY_SUSPECT,Unknown,300,MG,2,Oral
2500,8735,IS_SECONDARY_SUSPECT,Unknown,200,MG,2,Unknown
2504,7443,IS_SECONDARY_SUSPECT,Non-Hodgkin's lymphoma,138,MG,2,Intravenous (not otherwise specified)
2504,7473,IS_SECONDARY_SUSPECT,Non-Hodgkin's lymphoma,1824,MG,3,Intravenous (not otherwise specified)
2504,8454,IS_SECONDARY_SUSPECT,Non-Hodgkin's lymphoma,160,MG,5,Oral
2504,7940,IS_SECONDARY_SUSPECT,Non-Hodgkin's lymphoma,700,MG,7,Intravenous (not otherwise specified)
2507,7335,IS_SECONDARY_SUSPECT,Unknown,2.5,MG,2,Oral
2508,8757,IS_SECONDARY_SUSPECT,Unknown,0.2,MG,2,Intravenous (not otherwise specified)
2509,7662,IS_SECONDARY_SUSPECT,Renal cell carcinoma,67.2,MG,3,Intravenous (not otherwise specified)
2511,9108,IS_SECONDARY_SUSPECT,Unknown,5,MG/KG,2,Intravenous (not otherwise specified)
2513,9110,IS_SECONDARY_SUSPECT,K-ras gene mutation,325,MG,3,Intravenous (not otherwise specified)
2513,9111,IS_SECONDARY_SUSPECT,K-ras gene mutation,1.5,MG,5,Intravenous (not otherwise specified)
2515,7685,IS_SECONDARY_SUSPECT,Unknown,6,MG,2,Unknown
2517,7920,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Oral
2517,7163,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG,4,Intravenous (not otherwise specified)
2517,9011,IS_SECONDARY_SUSPECT,Plasma cell myeloma,10,MG/KG,6,Intravenous (not otherwise specified)
2518,8004,IS_SECONDARY_SUSPECT,Unknown,84,MG,2,Unknown
2521,7537,IS_SECONDARY_SUSPECT,Fallopian tube cancer,10,MG/KG,2,Intravenous (not otherwise specified)
2521,9115,IS_SECONDARY_SUSPECT,Fallopian tube cancer,40,MG/M**2,3,Intravenous (not otherwise specified)
2526,7940,IS_SECONDARY_SUSPECT,B-cell lymphoma,375,MG/M**2,2,Unknown
2526,7244,IS_SECONDARY_SUSPECT,B-cell lymphoma,57,MG,3,Unknown
2526,7352,IS_SECONDARY_SUSPECT,B-cell lymphoma,1.4,MG,4,Intravenous (not otherwise specified)
2526,7246,IS_SECONDARY_SUSPECT,B-cell lymphoma,286,MG,5,Unknown
2526,7237,IS_SECONDARY_SUSPECT,B-cell lymphoma,2140,MG,6,Intravenous bolus
2526,7171,IS_SECONDARY_SUSPECT,B-cell lymphoma,140,MG,7,Oral
2528,8004,IS_SECONDARY_SUSPECT,Unknown,84,MG,2,Unknown
2529,9011,IS_SECONDARY_SUSPECT,Unknown,900,MG,2,Intravenous (not otherwise specified)
2529,7163,IS_SECONDARY_SUSPECT,Plasma cell myeloma refractory,40,MG,3,Unknown
2529,9120,IS_SECONDARY_SUSPECT,Plasma cell myeloma,40,MG,9,Unknown
2530,7536,IS_SECONDARY_SUSPECT,Non-small cell lung cancer,1200,MG,2,Intravenous (not otherwise specified)
2532,8407,IS_SECONDARY_SUSPECT,Alcohol use disorder,380,MG,2,Intramuscular
2533,7163,IS_SECONDARY_SUSPECT,Plasma cell myeloma,40,MG,2,Unknown
2533,7922,IS_SECONDARY_SUSPECT,Plasma cell myeloma,4,MG,3,Oral
2533,7877,IS_SECONDARY_SUSPECT,Plasma cell myeloma,4,MG,4,Oral
2534,7685,IS_SECONDARY_SUSPECT,Unknown,6,MG,2,Unknown
2536,7685,IS_SECONDARY_SUSPECT,Unknown,6,MG,2,Unknown
2537,7438,IS_SECONDARY_SUSPECT,Unknown,0.13,UG/KG,2,Intravenous drip
2538,9121,IS_SECONDARY_SUSPECT,Unknown,0.75,MG,2,Oral
2538,7321,IS_SECONDARY_SUSPECT,Prophylaxis against transplant rejection,500,MG,6,Oral
2538,9122,IS_SECONDARY_SUSPECT,Prophylaxis against transplant rejection,1.5,MG/KG,7,Unknown
2543,8681,IS_SECONDARY_SUSPECT,Glycosylated haemoglobin increased,0.75,MG,2,Unknown
2544,7685,IS_SECONDARY_SUSPECT,Unknown,6,UG,2,Unknown
2545,9124,IS_SECONDARY_SUSPECT,Glioblastoma,1.2,MG,2,Subcutaneous
2545,7537,IS_SECONDARY_SUSPECT,Glioblastoma,10,MG/KG,3,Intravenous (not otherwise specified)
2546,7245,IS_SECONDARY_SUSPECT,Diffuse large B-cell lymphoma,2,MG,2,Intravenous (not otherwise specified)
2546,7244,IS_SECONDARY_SUSPECT,Diffuse large B-cell lymphoma,91,MG,4,Intravenous (not otherwise specified)
2546,7237,IS_SECONDARY_SUSPECT,Diffuse large B-cell lymphoma,1360,MG,5,Intravenous (not otherwise specified)
2546,7279,IS_SECONDARY_SUSPECT,Diffuse large B-cell lymphoma,100,MG,6,Intravenous (not otherwise specified)
2547,7685,IS_SECONDARY_SUSPECT,Unknown,6,MG,2,Unknown
2548,7283,IS_SECONDARY_SUSPECT,Unknown,1,MG,2,Oral
2551,8365,IS_SECONDARY_SUSPECT,Unknown,45,MG,2,Intramuscular
2551,7335,IS_SECONDARY_SUSPECT,Aortic valve disease,5,MG,3,Unknown
2554,8176,IS_SECONDARY_SUSPECT,B-cell lymphoma,152,MG,2,Intravenous (not otherwise specified)
2554,7237,IS_SECONDARY_SUSPECT,B-cell lymphoma,1500,MG,3,Intravenous (not otherwise specified)
2554,7244,IS_SECONDARY_SUSPECT,B-cell lymphoma,102,MG,4,Intravenous (not otherwise specified)
2554,7171,IS_SECONDARY_SUSPECT,B-cell lymphoma,100,MG,5,Oral
2555,7438,IS_SECONDARY_SUSPECT,Unknown,0.023,UG/KG,2,Subcutaneous
2556,7438,IS_SECONDARY_SUSPECT,Unknown,0.77,UG/KG,2,Intravenous drip
2557,8517,IS_SECONDARY_SUSPECT,Unknown,6,MG,2,Oral
2558,8204,IS_SECONDARY_SUSPECT,Unknown,1000,MG,2,Unknown
2558,7539,IS_SECONDARY_SUSPECT,Ovarian cancer,510,MG,3,Intravenous (not otherwise specified)
2558,7538,IS_SECONDARY_SUSPECT,Ovarian cancer,276,MG,5,Intravenous (not otherwise specified)
2558,7537,IS_SECONDARY_SUSPECT,Ovarian cancer,400,MG,7,Intravenous (not otherwise specified)
2559,9044,IS_SECONDARY_SUSPECT,Unknown,200,MG,2,Unknown
2560,9131,IS_SECONDARY_SUSPECT,B precursor type acute leukaemia,0.5,MG/M**2,6,Intravenous (not otherwise specified)
2562,8340,IS_SECONDARY_SUSPECT,Unknown,150,MG,2,Oral
2565,9136,IS_SECONDARY_SUSPECT,K-ras gene mutation,30,MG,3,Oral
2567,7176,IS_SECONDARY_SUSPECT,Unknown,15,MG,2,Oral
2568,7176,IS_SECONDARY_SUSPECT,Monoclonal gammopathy,25,MG,2,Oral
2569,8578,IS_SECONDARY_SUSPECT,Unknown,75,MG,2,Subcutaneous
2570,7862,IS_SECONDARY_SUSPECT,Unknown,300,MG,2,Subcutaneous
2571,9138,IS_SECONDARY_SUSPECT,Pulmonary arterial hypertension,10,MG,4,Oral
2572,8817,IS_SECONDARY_SUSPECT,Unknown,300,MG,2,Intravenous (not otherwise specified)
2573,9139,IS_SECONDARY_SUSPECT,Unknown,150,MG,2,Unknown
2574,7993,IS_SECONDARY_SUSPECT,Acute myeloid leukaemia,50,MG,2,Oral
2575,8762,IS_SECONDARY_SUSPECT,Unknown,1,DF,2,Subdermal
2577,7280,IS_SECONDARY_SUSPECT,Breast cancer metastatic,125,MG,2,Unknown
2578,7632,IS_SECONDARY_SUSPECT,Unknown,1.6,MG,2,Unknown
2579,8551,IS_SECONDARY_SUSPECT,COVID-19,700,MG,2,Intravenous (not otherwise specified)
2580,9144,IS_SECONDARY_SUSPECT,Hypertension,40,MG,5,Unknown
2580,8232,IS_SECONDARY_SUSPECT,Blood potassium decreased,160,MG,6,Unknown
2580,7594,IS_SECONDARY_SUSPECT,Hypertension,160,MG,13,Unknown
2581,9146,IS_SECONDARY_SUSPECT,Narcolepsy,35.6,MG,3,Oral
2582,8308,IS_SECONDARY_SUSPECT,Asthma,180,Unknown,2,Respiratory (inhalation)
2583,8551,IS_SECONDARY_SUSPECT,COVID-19,700,MG,2,Intravenous (not otherwise specified)
2584,8544,IS_SECONDARY_SUSPECT,Ovarian cancer,600,MG,2,Oral
2586,8468,IS_SECONDARY_SUSPECT,Unknown,180,MG,2,Oral
2587,7283,IS_SECONDARY_SUSPECT,Unknown,2,MG,2,Oral
2588,8321,IS_SECONDARY_SUSPECT,Prophylaxis,5000,IU,2,Subcutaneous
2590,7278,IS_SECONDARY_SUSPECT,Unknown,40,MG,2,Subcutaneous
2592,9147,IS_SECONDARY_SUSPECT,Unknown,40,MG,2,Unknown
2593,8618,IS_SECONDARY_SUSPECT,Unknown,40,UG,2,Unknown
2598,8364,IS_SECONDARY_SUSPECT,Metastatic renal cell carcinoma,40,MG,2,Oral
2599,7384,IS_SECONDARY_SUSPECT,Unknown,0.025,MG/KG,2,Oral
2600,7278,IS_SECONDARY_SUSPECT,Crohn's disease,40,MG,2,Subcutaneous
2603,7283,IS_SECONDARY_SUSPECT,Plasma cell myeloma,3,MG,2,Oral
2604,8762,IS_SECONDARY_SUSPECT,Unknown,1,DF,2,Subdermal
2605,7994,IS_SECONDARY_SUSPECT,Unknown,420,MG,2,Oral
2605,7171,IS_SECONDARY_SUSPECT,Chronic graft versus host disease,10,MG,3,Oral
2606,8729,IS_SECONDARY_SUSPECT,Unknown,50,G,2,Unknown
2607,7283,IS_SECONDARY_SUSPECT,Unknown,2,MG,2,Oral
2608,7438,IS_SECONDARY_SUSPECT,Unknown,0.081,UG/KG,2,Subcutaneous
2611,7176,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Oral
2612,7685,IS_SECONDARY_SUSPECT,Unknown,6,MG,2,Unknown
2613,8176,IS_SECONDARY_SUSPECT,B-cell lymphoma,176,MG,2,Intravenous (not otherwise specified)
2613,7237,IS_SECONDARY_SUSPECT,B-cell lymphoma,1612.5,MG,3,Intravenous (not otherwise specified)
2613,7244,IS_SECONDARY_SUSPECT,B-cell lymphoma,108,MG,4,Intravenous (not otherwise specified)
2613,7279,IS_SECONDARY_SUSPECT,B-cell lymphoma,100,MG,5,Oral
2617,7685,IS_SECONDARY_SUSPECT,Unknown,6,MG,2,Unknown
2623,9156,IS_SECONDARY_SUSPECT,Unknown,20,MG,2,Oral
2623,9157,IS_SECONDARY_SUSPECT,Colorectal cancer metastatic,200,MG,3,Oral
2626,8407,IS_SECONDARY_SUSPECT,Unknown,380,MG,2,Intramuscular
2627,7790,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Subcutaneous
2628,8762,IS_SECONDARY_SUSPECT,Unknown,1,DF,2,Subdermal
2629,7790,IS_SECONDARY_SUSPECT,Unknown,55,G,2,Subcutaneous
2630,9158,IS_SECONDARY_SUSPECT,Ovarian clear cell carcinoma,6,MG,2,Oral
2631,8240,IS_SECONDARY_SUSPECT,Unknown,400,MG,2,Oral
2632,7438,IS_SECONDARY_SUSPECT,Unknown,0.036,UG/KG,2,Intravenous drip
2635,8194,IS_SECONDARY_SUSPECT,Unknown,300,MG,2,Unknown
2636,9159,IS_SECONDARY_SUSPECT,Ovarian cancer,40,MG/M**2,2,Intravenous (not otherwise specified)
2637,7278,IS_SECONDARY_SUSPECT,Unknown,40,MG,2,Subcutaneous
2639,7685,IS_SECONDARY_SUSPECT,Unknown,6,MG,2,Unknown
2640,7899,IS_SECONDARY_SUSPECT,Unknown,360,MG,2,Intravenous (not otherwise specified)
2641,7278,IS_SECONDARY_SUSPECT,Crohn's disease,40,MG,3,Subcutaneous
2645,8551,IS_SECONDARY_SUSPECT,COVID-19,700,MG,2,Intravenous (not otherwise specified)
2649,8407,IS_SECONDARY_SUSPECT,Unknown,380,MG,2,Intramuscular
2651,7176,IS_SECONDARY_SUSPECT,Bone neoplasm,15,MG,2,Oral
2652,7437,IS_SECONDARY_SUSPECT,Unknown,30,MG,2,Unknown
2653,7685,IS_SECONDARY_SUSPECT,Unknown,6,MG,2,Unknown
2654,8099,IS_SECONDARY_SUSPECT,Non-small cell lung cancer,40,MG,2,Oral
2655,8099,IS_SECONDARY_SUSPECT,Unknown,20,MG,2,Oral
2655,7536,IS_SECONDARY_SUSPECT,Non-small cell lung cancer,1200,MG,3,Intravenous (not otherwise specified)
2657,7995,IS_SECONDARY_SUSPECT,Unknown,900,MG,2,Intravenous (not otherwise specified)
2657,7994,IS_SECONDARY_SUSPECT,Chronic lymphocytic leukaemia,420,MG,6,Oral
2658,7237,IS_SECONDARY_SUSPECT,Chronic lymphocytic leukaemia,696,MG,2,Intravenous (not otherwise specified)
2658,7994,IS_SECONDARY_SUSPECT,Chronic lymphocytic leukaemia,420,MG,4,Oral
2659,7632,IS_SECONDARY_SUSPECT,Unknown,2.4,MG,3,Unknown
2660,7237,IS_SECONDARY_SUSPECT,Marginal zone lymphoma,580,MG,2,Intravenous (not otherwise specified)
2660,7883,IS_SECONDARY_SUSPECT,Marginal zone lymphoma,47,MG,5,Intravenous (not otherwise specified)
2661,8928,IS_SECONDARY_SUSPECT,Unknown,66,MG,2,Subcutaneous
2662,9136,IS_SECONDARY_SUSPECT,Non-small cell lung cancer stage IV,30,MG,3,Oral
2664,8544,IS_SECONDARY_SUSPECT,Renal cell carcinoma,40,MG,1,Oral
2664,7662,IS_SECONDARY_SUSPECT,Renal cell carcinoma,1,MG/KG,3,Intravenous (not otherwise specified)
2667,8705,IS_SECONDARY_SUSPECT,B-cell lymphoma refractory,560,MG,2,Oral
2667,7171,IS_SECONDARY_SUSPECT,B-cell lymphoma refractory,100,MG,4,Oral
2667,7995,IS_SECONDARY_SUSPECT,B-cell lymphoma refractory,1000,MG,6,Intravenous (not otherwise specified)
2667,8876,IS_SECONDARY_SUSPECT,B-cell lymphoma refractory,15,MG,8,Oral
2668,7993,IS_SECONDARY_SUSPECT,Acute myeloid leukaemia,400,MG,2,Oral
2668,9165,IS_SECONDARY_SUSPECT,Acute myeloid leukaemia,800,MG,3,Intravenous drip
2669,9168,IS_SECONDARY_SUSPECT,Pulmonary arterial hypertension,5,MG,2,Oral
2669,8671,IS_SECONDARY_SUSPECT,Pulmonary arterial hypertension,10,MG,6,Oral
2670,7438,IS_SECONDARY_SUSPECT,Unknown,0.039,UG/KG,2,Subcutaneous
2675,7237,IS_SECONDARY_SUSPECT,Non-Hodgkin's lymphoma,500,MG/M**2,2,Intravenous (not otherwise specified)
2675,7883,IS_SECONDARY_SUSPECT,Non-Hodgkin's lymphoma,30,MG/M**2,3,Intravenous (not otherwise specified)
2677,7718,IS_SECONDARY_SUSPECT,Hereditary angioedema,300,MG,1,Subcutaneous
2677,7719,IS_SECONDARY_SUSPECT,Immune system disorder,1000,IU,3,Intravenous (not otherwise specified)
2677,7882,IS_SECONDARY_SUSPECT,Immune system disorder,30,MG,22,Subcutaneous
2678,8762,IS_SECONDARY_SUSPECT,Contraception,1,DF,2,Subdermal
2679,7685,IS_SECONDARY_SUSPECT,Unknown,6000,UG,2,Unknown
2682,7685,IS_SECONDARY_SUSPECT,Unknown,6,MG,3,Unknown
2683,8541,IS_SECONDARY_SUSPECT,Unknown,5,MG,2,Subcutaneous
2684,7685,IS_SECONDARY_SUSPECT,Unknown,6,MG,2,Unknown
2685,8670,IS_SECONDARY_SUSPECT,Unknown,20,MG,2,Oral
2685,7435,IS_SECONDARY_SUSPECT,Unknown,480,MG,4,Intravenous (not otherwise specified)
2685,8375,IS_SECONDARY_SUSPECT,Unknown,1,MG/KG,6,Intravenous (not otherwise specified)
2686,7994,IS_SECONDARY_SUSPECT,Chronic lymphocytic leukaemia,420,MG,1,Oral
2686,7995,IS_SECONDARY_SUSPECT,Unknown,900,MG,3,Intravenous (not otherwise specified)
2687,7537,IS_SECONDARY_SUSPECT,Endometrial cancer,1335,MG,2,Intravenous (not otherwise specified)
2690,8085,IS_SECONDARY_SUSPECT,Pancreatic carcinoma metastatic,400,MG,2,Intravenous (not otherwise specified)
2690,9172,IS_SECONDARY_SUSPECT,Pancreatic carcinoma metastatic,1850,MG,3,Intravenous (not otherwise specified)
2690,8903,IS_SECONDARY_SUSPECT,Pancreatic carcinoma metastatic,231,MG,4,Intravenous (not otherwise specified)
2693,9158,IS_SECONDARY_SUSPECT,Endometrial cancer stage IV,6,MG,2,Oral
2694,7235,IS_SECONDARY_SUSPECT,Menopause,0.625,MG,5,Oral
2696,9173,IS_SECONDARY_SUSPECT,Diabetes mellitus,2,MG,2,Subcutaneous
2697,8762,IS_SECONDARY_SUSPECT,Unknown,1,DF,2,Subdermal
2698,7685,IS_SECONDARY_SUSPECT,Unknown,6,MG,2,Unknown
2701,7613,IS_SECONDARY_SUSPECT,Unknown,207,MG,2,Intravenous (not otherwise specified)
2701,7940,IS_SECONDARY_SUSPECT,Unknown,700,MG,5,Intravenous (not otherwise specified)
2701,7244,IS_SECONDARY_SUSPECT,Unknown,53,MG,8,Intravenous (not otherwise specified)
2701,7352,IS_SECONDARY_SUSPECT,Unknown,1.1,MG,11,Intravenous (not otherwise specified)
2701,7246,IS_SECONDARY_SUSPECT,Unknown,264,MG,14,Intravenous (not otherwise specified)
2701,7237,IS_SECONDARY_SUSPECT,Unknown,1990,MG,17,Intravenous (not otherwise specified)
2701,7171,IS_SECONDARY_SUSPECT,Unknown,110,MG,20,Oral
2703,7443,IS_SECONDARY_SUSPECT,Bile duct cancer,43,MG,3,Intravenous (not otherwise specified)
2703,7473,IS_SECONDARY_SUSPECT,Bile duct cancer,1710,MG,4,Intravenous (not otherwise specified)
2704,8173,IS_SECONDARY_SUSPECT,Unknown,300,MG,2,Subcutaneous
2710,7307,IS_SECONDARY_SUSPECT,Hyperparathyroidism secondary,1,UG,2,Intravenous (not otherwise specified)
2713,9174,IS_SECONDARY_SUSPECT,Unknown,1500,MG,2,Oral
2716,7940,IS_SECONDARY_SUSPECT,Diffuse large B-cell lymphoma,375,MG/M**2,2,Intravenous (not otherwise specified)
2716,7473,IS_SECONDARY_SUSPECT,Diffuse large B-cell lymphoma,1000,MG/M**2,3,Intravenous (not otherwise specified)
2716,7163,IS_SECONDARY_SUSPECT,Diffuse large B-cell lymphoma,40,MG,4,Oral
2716,7443,IS_SECONDARY_SUSPECT,Diffuse large B-cell lymphoma,75,MG/M**2,5,Intravenous (not otherwise specified)
2717,7176,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Oral
2720,7681,IS_SECONDARY_SUSPECT,Relapsing-remitting multiple sclerosis,20,MG,2,Subcutaneous
2721,7520,IS_SECONDARY_SUSPECT,Triple positive breast cancer,150,MG,2,Intravenous (not otherwise specified)
2721,7735,IS_SECONDARY_SUSPECT,Triple positive breast cancer,150,MG,3,Unknown
2724,7176,IS_SECONDARY_SUSPECT,Unknown,5,MG,2,Oral
2725,7176,IS_SECONDARY_SUSPECT,Unknown,15,MG,2,Oral
2727,8399,IS_SECONDARY_SUSPECT,Unknown,1400,UG,2,Oral
2727,7944,IS_SECONDARY_SUSPECT,Pulmonary arterial hypertension,10,MG,3,Oral
2728,8565,IS_SECONDARY_SUSPECT,Unknown,40,MG,2,Oral
2729,7685,IS_SECONDARY_SUSPECT,Unknown,6,MG,2,Unknown
2731,7993,IS_SECONDARY_SUSPECT,Unknown,50,MG,2,Oral
2731,7995,IS_SECONDARY_SUSPECT,Chronic lymphocytic leukaemia,100,MG,6,Intravenous (not otherwise specified)
2731,7994,IS_SECONDARY_SUSPECT,Chronic lymphocytic leukaemia,420,MG,11,Oral
2732,8509,IS_SECONDARY_SUSPECT,Unknown,75,MG,2,Oral
2734,7460,IS_SECONDARY_SUSPECT,Unknown,15,MG,2,Intravenous (not otherwise specified)
2736,7278,IS_SECONDARY_SUSPECT,Unknown,40,MG,2,Subcutaneous
2737,8776,IS_SECONDARY_SUSPECT,Malignant melanoma,300,MG,2,Intravenous (not otherwise specified)
2739,7685,IS_SECONDARY_SUSPECT,Unknown,6,MG,2,Unknown
2740,7278,IS_SECONDARY_SUSPECT,Unknown,40,MG,2,Subcutaneous
2745,7268,IS_SECONDARY_SUSPECT,Unknown,80,MG,2,Unknown
2746,8509,IS_SECONDARY_SUSPECT,Unknown,45,MG,2,Oral
2746,8241,IS_SECONDARY_SUSPECT,Hairy cell leukaemia,45,MG,3,Oral
2747,7176,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Oral
2750,7176,IS_SECONDARY_SUSPECT,Breast neoplasm,25,MG,2,Oral
2752,7278,IS_SECONDARY_SUSPECT,Unknown,40,MG,2,Subcutaneous
2755,8762,IS_SECONDARY_SUSPECT,Unknown,1,DF,2,Subdermal
2756,8451,IS_SECONDARY_SUSPECT,Short-bowel syndrome,2.7,MG,2,Subcutaneous
2757,7176,IS_SECONDARY_SUSPECT,Unknown,5,MG,2,Oral
2761,7993,IS_SECONDARY_SUSPECT,Unknown,200,MG,2,Oral
2761,8042,IS_SECONDARY_SUSPECT,Acute myeloid leukaemia,36,MG,4,Intravenous (not otherwise specified)
2762,7918,IS_SECONDARY_SUSPECT,Unknown,400,MG,2,Subcutaneous
2765,7416,IS_SECONDARY_SUSPECT,Ovarian cancer recurrent,200,MG,2,Oral
2765,7536,IS_SECONDARY_SUSPECT,Ovarian cancer recurrent,840,MG,3,Intravenous drip
2766,8671,IS_SECONDARY_SUSPECT,Pulmonary arterial hypertension,10,MG,2,Oral
2770,8735,IS_SECONDARY_SUSPECT,Unknown,200,MG,2,Oral
2773,7278,IS_SECONDARY_SUSPECT,Unknown,80,MG,2,Subcutaneous
2774,7438,IS_SECONDARY_SUSPECT,Unknown,0.093,UG/KG,2,Subcutaneous
2777,7176,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Oral
2778,8775,IS_SECONDARY_SUSPECT,Unknown,1600,UG,2,Oral
2781,8762,IS_SECONDARY_SUSPECT,Unknown,1,DF,2,Subdermal
2783,8848,IS_SECONDARY_SUSPECT,Non-small cell lung cancer stage IV,720,MG,2,Oral
2783,9136,IS_SECONDARY_SUSPECT,K-ras gene mutation,20,MG,3,Oral
2784,7993,IS_SECONDARY_SUSPECT,Chronic lymphocytic leukaemia,20,MG,2,Oral
2785,8705,IS_SECONDARY_SUSPECT,Chronic lymphocytic leukaemia,420,MG,2,Oral
2786,8848,IS_SECONDARY_SUSPECT,K-ras gene mutation,480,MG,2,Oral
2790,8901,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Oral
2791,8901,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Oral
2792,8901,IS_SECONDARY_SUSPECT,Unknown,15,MG,2,Oral
2793,8901,IS_SECONDARY_SUSPECT,Unknown,5,MG,3,Oral
2794,8901,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Unknown
2795,7176,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Oral
2796,8005,IS_SECONDARY_SUSPECT,Malignant melanoma,80,MG,1,Intravenous (not otherwise specified)
2797,7662,IS_SECONDARY_SUSPECT,Renal cell carcinoma,1,MG/KG,2,Intravenous (not otherwise specified)
2797,8364,IS_SECONDARY_SUSPECT,Renal cell carcinoma,20,MG,3,Oral
2798,7965,IS_SECONDARY_SUSPECT,Unknown,45,MG,2,Subcutaneous
2805,7862,IS_SECONDARY_SUSPECT,Unknown,300,MG,2,Subcutaneous
2809,8321,IS_SECONDARY_SUSPECT,Prophylaxis,6000,IU,2,Subcutaneous
2814,7901,IS_SECONDARY_SUSPECT,Still's disease,150,MG,2,Subcutaneous
2815,7613,IS_SECONDARY_SUSPECT,Unknown,114.75,MG,2,Unknown
2815,7662,IS_SECONDARY_SUSPECT,Renal cell carcinoma,76.5,MG,3,Unknown
2818,8817,IS_SECONDARY_SUSPECT,Unknown,100,MG,2,Unknown
2818,7233,IS_SECONDARY_SUSPECT,Anaemia,75,UG,3,Unknown
2819,7438,IS_SECONDARY_SUSPECT,Unknown,0.117,UG/KG,2,Intravenous drip
2820,8670,IS_SECONDARY_SUSPECT,Unknown,40,MG,2,Oral
2822,9173,IS_SECONDARY_SUSPECT,Type 2 diabetes mellitus,2,MG,2,Subcutaneous
2823,7438,IS_SECONDARY_SUSPECT,Unknown,0.1,UG/KG,2,Subcutaneous
2824,9198,IS_SECONDARY_SUSPECT,Depression,150,MG,2,Oral
2825,7253,IS_SECONDARY_SUSPECT,Plasma cell myeloma,1800,MG,3,Subcutaneous
2825,7163,IS_SECONDARY_SUSPECT,Plasma cell myeloma,40,MG,4,Oral
2826,7632,IS_SECONDARY_SUSPECT,Unknown,0.6,MG,2,Subcutaneous
2827,8004,IS_SECONDARY_SUSPECT,Unknown,84,MG,2,Unknown
2829,8201,IS_SECONDARY_SUSPECT,Amyloidosis,61,MG,2,Oral
2833,7353,IS_SECONDARY_SUSPECT,Chronic graft versus host disease,10,MG,3,Oral
2835,8762,IS_SECONDARY_SUSPECT,Unknown,68,MG,2,Subdermal
2836,8249,IS_SECONDARY_SUSPECT,Asthma,1,DF,3,Unknown
2837,7283,IS_SECONDARY_SUSPECT,Unknown,1,MG,2,Oral
2838,7176,IS_SECONDARY_SUSPECT,Unknown,5,MG,2,Oral
2843,9208,IS_SECONDARY_SUSPECT,Ovarian cancer metastatic,200,MG,2,Oral
2844,7685,IS_SECONDARY_SUSPECT,Unknown,6,MG,2,Unknown
2845,7176,IS_SECONDARY_SUSPECT,Unknown,15,MG,2,Oral
2854,7920,IS_SECONDARY_SUSPECT,Unknown,25,MG,2,Oral
2854,7253,IS_SECONDARY_SUSPECT,Unknown,1800,MG,4,Subcutaneous
2854,7163,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG,5,Oral
2854,7188,IS_SECONDARY_SUSPECT,Plasma cell myeloma,2.45,MG/M**2,7,Subcutaneous
2858,8544,IS_SECONDARY_SUSPECT,Drug withdrawal syndrome,25,MG,1,Oral
2858,9219,IS_SECONDARY_SUSPECT,Drug withdrawal syndrome,25,MG,2,Oral
2858,8407,IS_SECONDARY_SUSPECT,Drug use disorder,380,MG,47,Intramuscular
2858,9220,IS_SECONDARY_SUSPECT,Unknown,0.18,MG,49,Oral
2859,8399,IS_SECONDARY_SUSPECT,Unknown,1600,UG,2,Unknown
2860,7177,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG,2,Oral
2860,7176,IS_SECONDARY_SUSPECT,Plasma cell myeloma,15,MG,3,Oral
2864,9226,IS_SECONDARY_SUSPECT,Unknown,36000,IU,2,Oral
2866,7997,IS_SECONDARY_SUSPECT,Unknown,40,MG,2,Subcutaneous
2867,8548,IS_SECONDARY_SUSPECT,Unknown,15,MG,2,Oral
2869,7537,IS_SECONDARY_SUSPECT,Glioblastoma multiforme,10,MG/KG,2,Intravenous (not otherwise specified)
2869,8997,IS_SECONDARY_SUSPECT,Hypoglycaemia,10,PCT,3,Intravenous bolus
2870,7685,IS_SECONDARY_SUSPECT,Unknown,6,MG,2,Unknown
2875,7438,IS_SECONDARY_SUSPECT,Unknown,0.076,UG/KG,2,Subcutaneous
2877,8019,IS_SECONDARY_SUSPECT,Supplementation therapy,250,MG,2,Unknown
2879,7536,IS_SECONDARY_SUSPECT,Unknown,1200,MG,2,Intravenous (not otherwise specified)
2879,8852,IS_SECONDARY_SUSPECT,Skin cancer,73826,UG,6,Intramuscular
2880,7994,IS_SECONDARY_SUSPECT,Central nervous system lymphoma,560,MG,2,Oral
2882,7176,IS_SECONDARY_SUSPECT,Unknown,25,MG,2,Oral
2883,8551,IS_SECONDARY_SUSPECT,COVID-19,700,MG,2,Intravenous (not otherwise specified)
2884,7718,IS_SECONDARY_SUSPECT,Hereditary angioedema,300,MG,2,Subcutaneous
2885,9031,IS_SECONDARY_SUSPECT,Pulmonary arterial hypertension,1.5,MG,2,Oral
2886,7438,IS_SECONDARY_SUSPECT,Unknown,0.05,UG/KG,2,Subcutaneous
2889,7176,IS_SECONDARY_SUSPECT,Unknown,20,MG,2,Oral
2890,8174,IS_SECONDARY_SUSPECT,Unknown,5,MG/KG,2,Intravenous (not otherwise specified)
2892,7278,IS_SECONDARY_SUSPECT,Unknown,40,MG,2,Subcutaneous
2897,9110,IS_SECONDARY_SUSPECT,K-ras gene mutation,500,MG,3,Intravenous (not otherwise specified)
2900,7438,IS_SECONDARY_SUSPECT,Unknown,0.028,UG/KG,2,Intravenous drip
2904,7683,IS_SECONDARY_SUSPECT,Unknown,16,MG/KG,2,Intravenous (not otherwise specified)
2904,7188,IS_SECONDARY_SUSPECT,Plasma cell myeloma,1.3,MG/M**2,4,Subcutaneous
2904,7163,IS_SECONDARY_SUSPECT,Plasma cell myeloma,20,MG,7,Intravenous (not otherwise specified)
2906,7965,IS_SECONDARY_SUSPECT,Unknown,90,MG,2,Subcutaneous
2907,7327,IS_SECONDARY_SUSPECT,Hypersensitivity,10,MG,3,Unknown
2909,9238,IS_SECONDARY_SUSPECT,Ovarian cancer metastatic,600,MG/M**2,2,Intravenous (not otherwise specified)
2911,7411,IS_SECONDARY_SUSPECT,Psoriasis,30,MG,2,Oral
2912,7361,IS_SECONDARY_SUSPECT,Unknown,11,MG,2,Unknown
2913,8173,IS_SECONDARY_SUSPECT,Unknown,150,MG,2,Subcutaneous
2914,7632,IS_SECONDARY_SUSPECT,Unknown,1,MG,2,Unknown
2915,7860,IS_SECONDARY_SUSPECT,Unknown,14,MG,2,Oral
2915,7861,IS_SECONDARY_SUSPECT,Non-small cell lung cancer metastatic,200,MG,3,Intravenous (not otherwise specified)
2917,8350,IS_SECONDARY_SUSPECT,Unknown,85,MG,2,Intravenous drip
2917,7435,IS_SECONDARY_SUSPECT,Osteosarcoma metastatic,138,MG,5,Intravenous drip
2919,8670,IS_SECONDARY_SUSPECT,Unknown,40,MG,2,Oral
2920,9241,IS_SECONDARY_SUSPECT,Bladder cancer,1,DF,1,Oral
2920,7443,IS_SECONDARY_SUSPECT,Bladder cancer,144.9,MG,3,Intravenous (not otherwise specified)
2920,8185,IS_SECONDARY_SUSPECT,Bladder cancer,2068,MG,4,Intravenous (not otherwise specified)
2921,7982,IS_SECONDARY_SUSPECT,Immunodeficiency common variable,10,G,2,Intravenous (not otherwise specified)
2922,7254,IS_SECONDARY_SUSPECT,Short-bowel syndrome,5.1,MG,2,Unknown
2924,7536,IS_SECONDARY_SUSPECT,Small cell lung cancer extensive stage,1200,MG,2,Intravenous drip
2924,7539,IS_SECONDARY_SUSPECT,Small cell lung cancer extensive stage,448,MG,3,Intravenous (not otherwise specified)
2924,7246,IS_SECONDARY_SUSPECT,Small cell lung cancer extensive stage,158,MG,4,Intravenous (not otherwise specified)
2927,8812,IS_SECONDARY_SUSPECT,Unknown,100,MG,2,Oral
2927,8813,IS_SECONDARY_SUSPECT,Hormone receptor positive HER2 negative breast cancer,50,MG,3,Oral
2928,7335,IS_SECONDARY_SUSPECT,Cerebrovascular accident prophylaxis,5,MG,2,Oral
2929,7995,IS_SECONDARY_SUSPECT,Follicular lymphoma,1000,MG,2,Intravenous drip
2934,7993,IS_SECONDARY_SUSPECT,Acute myeloid leukaemia,400,MG,2,Oral
2936,7438,IS_SECONDARY_SUSPECT,Unknown,0.09,UG/KG,2,Subcutaneous
2939,7278,IS_SECONDARY_SUSPECT,Unknown,40,MG,2,Subcutaneous
2939,8220,IS_SECONDARY_SUSPECT,Crohn's disease,50,MG,3,Oral
2941,7613,IS_SECONDARY_SUSPECT,Cholangiocarcinoma,240,MG,3,Intravenous (not otherwise specified)
2942,7438,IS_SECONDARY_SUSPECT,Unknown,0.035,UG/KG,2,Intravenous drip
2943,7246,IS_SECONDARY_SUSPECT,B-cell lymphoma,184,MG,1,Intravenous (not otherwise specified)
2943,7991,IS_SECONDARY_SUSPECT,B-cell lymphoma,9250,MG,2,Intravenous drip
2943,7940,IS_SECONDARY_SUSPECT,B-cell lymphoma,700,MG,3,Intravenous (not otherwise specified)
2943,8650,IS_SECONDARY_SUSPECT,B-cell lymphoma,9300,MG,4,Intravenous drip
2944,8189,IS_SECONDARY_SUSPECT,Hyperlipidaemia,140,MG,2,Unknown
2946,8762,IS_SECONDARY_SUSPECT,Unknown,1,DF,2,Subdermal
2947,7502,IS_SECONDARY_SUSPECT,Ovarian cancer,60,MG,2,Oral
2947,7536,IS_SECONDARY_SUSPECT,Ovarian cancer,840,MG,5,Intravenous (not otherwise specified)
2948,7993,IS_SECONDARY_SUSPECT,Acute myeloid leukaemia,50,MG,2,Oral
2949,7438,IS_SECONDARY_SUSPECT,Unknown,0.082,UG/KG,2,Subcutaneous
2950,8335,IS_SECONDARY_SUSPECT,Cardiac failure congestive,0.5,DF,2,Unknown
2954,7632,IS_SECONDARY_SUSPECT,Unknown,2.4,MG,2,Unknown
2955,7176,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Oral
2956,8762,IS_SECONDARY_SUSPECT,Unknown,1,DF,2,Subdermal
2957,8224,IS_SECONDARY_SUSPECT,Unknown,1,DF,2,Oral
2957,8225,IS_SECONDARY_SUSPECT,Endometriosis,200,MG,3,Oral
2958,8222,IS_SECONDARY_SUSPECT,Angioedema,2500,IU,2,Unknown
2960,8762,IS_SECONDARY_SUSPECT,Contraception,1,DF,2,Subdermal
2961,7254,IS_SECONDARY_SUSPECT,Short-bowel syndrome,0.2,ML,2,Unknown
2962,7474,IS_SECONDARY_SUSPECT,Urinary tract infection,750,MG,3,Unknown
2963,7536,IS_SECONDARY_SUSPECT,K-ras gene mutation,1200,MG,3,Intravenous (not otherwise specified)
2964,7662,IS_SECONDARY_SUSPECT,Unknown,950,MG,2,Intravenous (not otherwise specified)
2965,7438,IS_SECONDARY_SUSPECT,Unknown,0.106,UG/KG,2,Intravenous drip
2966,7685,IS_SECONDARY_SUSPECT,Unknown,6,UG,2,Unknown
2967,7254,IS_SECONDARY_SUSPECT,Short-bowel syndrome,0.25,ML,2,Subcutaneous
2968,7176,IS_SECONDARY_SUSPECT,Unknown,10,MG,3,Oral
2969,7176,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Oral
2970,8725,IS_SECONDARY_SUSPECT,Unknown,12,UG,4,Respiratory (inhalation)
2972,7685,IS_SECONDARY_SUSPECT,Unknown,6,MG,2,Unknown
2974,7883,IS_SECONDARY_SUSPECT,Chronic lymphocytic leukaemia,52.2,MG,2,Intravenous drip
2974,7237,IS_SECONDARY_SUSPECT,Chronic lymphocytic leukaemia,522,MG,3,Intravenous drip
2974,8705,IS_SECONDARY_SUSPECT,Chronic lymphocytic leukaemia,420,MG,4,Oral
2974,7163,IS_SECONDARY_SUSPECT,Cytokine release syndrome,10,MG,5,Intravenous drip
2975,8975,IS_SECONDARY_SUSPECT,Asthma prophylaxis,100,MG,2,Subcutaneous
2976,9031,IS_SECONDARY_SUSPECT,Pulmonary arterial hypertension,1,MG,2,Oral
2977,9261,IS_SECONDARY_SUSPECT,Unknown,15,MG,2,Sublingual
2981,7438,IS_SECONDARY_SUSPECT,Unknown,0.03,UG/KG,2,Subcutaneous
2982,7176,IS_SECONDARY_SUSPECT,Unknown,2.5,MG,2,Oral
2983,7994,IS_SECONDARY_SUSPECT,Unknown,560,MG,2,Oral
2984,7993,IS_SECONDARY_SUSPECT,Myelodysplastic syndrome,400,MG,2,Oral
2986,7918,IS_SECONDARY_SUSPECT,Unknown,400,MG,2,Subcutaneous
2987,8118,IS_SECONDARY_SUSPECT,Unknown,2,MG,2,Oral
2988,7442,IS_SECONDARY_SUSPECT,Endometrial cancer metastatic,800,MG,1,Intravenous (not otherwise specified)
2989,8225,IS_SECONDARY_SUSPECT,Uterine leiomyoma,300,MG,4,Oral
2991,7176,IS_SECONDARY_SUSPECT,Unknown,5,MG,6,Oral
2993,9267,IS_SECONDARY_SUSPECT,Off label use,900,MG,2,Intravenous (not otherwise specified)
2994,8400,IS_SECONDARY_SUSPECT,Pulmonary arterial hypertension,10,MG,3,Oral
2995,7191,IS_SECONDARY_SUSPECT,Unknown,4.5,G,3,Oral
2996,7283,IS_SECONDARY_SUSPECT,Unknown,2,MG,2,Oral
2997,9268,IS_SECONDARY_SUSPECT,Unknown,7.5,MG/KG,2,Intravenous (not otherwise specified)
3000,7965,IS_SECONDARY_SUSPECT,Unknown,90,MG,2,Subcutaneous
3001,7401,IS_SECONDARY_SUSPECT,Unknown,56,MG/M**2,2,Intravenous (not otherwise specified)
3001,7876,IS_SECONDARY_SUSPECT,Plasma cell myeloma,16,MG/KG,3,Intravenous (not otherwise specified)
3004,7438,IS_SECONDARY_SUSPECT,Unknown,0.027,UG/KG,2,Subcutaneous
3005,7176,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Oral
3007,9268,IS_SECONDARY_SUSPECT,Unknown,66.8,MG,2,Intravenous (not otherwise specified)
3009,7477,IS_SECONDARY_SUSPECT,Unknown,3,MG,2,Oral
3009,7283,IS_SECONDARY_SUSPECT,Plasma cell myeloma,2,MG,3,Oral
3012,8240,IS_SECONDARY_SUSPECT,Unknown,200,MG,2,Oral
3013,7945,IS_SECONDARY_SUSPECT,Unknown,7,MG,2,Intrathecal
3014,8578,IS_SECONDARY_SUSPECT,Unknown,150,MG,2,Subcutaneous
3015,7613,IS_SECONDARY_SUSPECT,Metastatic malignant melanoma,480,MG,2,Intravenous (not otherwise specified)
3021,8858,IS_SECONDARY_SUSPECT,Unknown,42,MG,2,Unknown
3023,8014,IS_SECONDARY_SUSPECT,Unknown,280,MG,2,Oral
3025,9274,IS_SECONDARY_SUSPECT,Unknown,100,MG,3,Unknown
3026,9120,IS_SECONDARY_SUSPECT,Plasma cell myeloma,56,MG/M**2,2,Intravenous (not otherwise specified)
3028,9275,IS_SECONDARY_SUSPECT,Unknown,500,MG,2,Oral
3030,8775,IS_SECONDARY_SUSPECT,Unknown,200,UG,2,Oral
3030,8671,IS_SECONDARY_SUSPECT,Pulmonary arterial hypertension,10,MG,3,Oral
3031,8838,IS_SECONDARY_SUSPECT,Psoriatic arthropathy,400,MG,2,Subcutaneous
3033,9276,IS_SECONDARY_SUSPECT,Unknown,1800,MG,2,Intravenous (not otherwise specified)
3034,7401,IS_SECONDARY_SUSPECT,Unknown,20,MG/M**2,2,Intravenous (not otherwise specified)
3034,9277,IS_SECONDARY_SUSPECT,Plasma cell myeloma,4,MG,4,Oral
3038,8014,IS_SECONDARY_SUSPECT,Chronic lymphocytic leukaemia,280,MG,2,Oral
3039,9279,IS_SECONDARY_SUSPECT,Unknown,20,UG,2,Subcutaneous
3040,7283,IS_SECONDARY_SUSPECT,Unknown,3,MG,2,Oral
3043,8551,IS_SECONDARY_SUSPECT,COVID-19,700,MG,2,Intravenous (not otherwise specified)
3044,8551,IS_SECONDARY_SUSPECT,COVID-19,700,MG,2,Intravenous (not otherwise specified)
3047,8176,IS_SECONDARY_SUSPECT,B-cell lymphoma,192,MG,2,Intravenous (not otherwise specified)
3049,8812,IS_SECONDARY_SUSPECT,Unknown,100,MG,2,Oral
3049,8813,IS_SECONDARY_SUSPECT,Hormone receptor negative HER2 positive breast cancer,50,MG,3,Oral
3051,7176,IS_SECONDARY_SUSPECT,Unknown,10,MG,3,Oral
3053,8610,IS_SECONDARY_SUSPECT,Rheumatoid arthritis,125,MG,2,Subcutaneous
3054,7553,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,60,MG,2,Oral
3054,7230,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,20,MG,4,Unknown
3056,9031,IS_SECONDARY_SUSPECT,Pulmonary arterial hypertension,2.5,MG,2,Oral
3058,9297,IS_SECONDARY_SUSPECT,Thrombocytopenia,20,MG,2,Oral
3065,7995,IS_SECONDARY_SUSPECT,Unknown,900,MG,2,Intravenous (not otherwise specified)
3065,7994,IS_SECONDARY_SUSPECT,Chronic lymphocytic leukaemia,420,MG,4,Oral
3066,7176,IS_SECONDARY_SUSPECT,Unknown,5,MG,2,Oral
3067,7334,IS_SECONDARY_SUSPECT,Unknown,20,G,2,Intravenous (not otherwise specified)
3068,8189,IS_SECONDARY_SUSPECT,Unknown,140,MG,2,Unknown
3070,7438,IS_SECONDARY_SUSPECT,Unknown,0.056,UG/KG,2,Intravenous drip
3071,7685,IS_SECONDARY_SUSPECT,Unknown,6,MG,2,Unknown
3073,8671,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Oral
3073,8775,IS_SECONDARY_SUSPECT,Pulmonary arterial hypertension,200,UG,5,Oral
3075,7685,IS_SECONDARY_SUSPECT,Unknown,6,MG,2,Unknown
3078,7539,IS_SECONDARY_SUSPECT,Non-Hodgkin's lymphoma,500,MG,3,Intravenous (not otherwise specified)
3078,7246,IS_SECONDARY_SUSPECT,Non-Hodgkin's lymphoma,588,MG,4,Intravenous (not otherwise specified)
3078,7991,IS_SECONDARY_SUSPECT,Non-Hodgkin's lymphoma,9800,MG,5,Intravenous (not otherwise specified)
3078,7940,IS_SECONDARY_SUSPECT,Non-Hodgkin's lymphoma,700,MG,6,Intravenous (not otherwise specified)
3080,8762,IS_SECONDARY_SUSPECT,Contraception,1,DF,2,Subdermal
3082,8762,IS_SECONDARY_SUSPECT,Contraception,1,DF,2,Subdermal
3083,8762,IS_SECONDARY_SUSPECT,Unknown,1,DF,2,Subdermal
3086,7237,IS_SECONDARY_SUSPECT,Plasma cell myeloma,600,MG,2,Intravenous (not otherwise specified)
3088,7278,IS_SECONDARY_SUSPECT,Unknown,40,MG,2,Subcutaneous
3091,7176,IS_SECONDARY_SUSPECT,Unknown,5,MG,2,Oral
3092,8014,IS_SECONDARY_SUSPECT,Unknown,140,MG,2,Unknown
3093,7685,IS_SECONDARY_SUSPECT,Neutropenia,6,UG,2,Unknown
3095,7176,IS_SECONDARY_SUSPECT,Unknown,15,MG,2,Oral
3097,7283,IS_SECONDARY_SUSPECT,Unknown,3,MG,2,Oral
3098,8528,IS_SECONDARY_SUSPECT,Antibiotic prophylaxis,3.375,G,2,Intravenous (not otherwise specified)
3100,7254,IS_SECONDARY_SUSPECT,Unknown,0.279,ML,2,Other
3101,7283,IS_SECONDARY_SUSPECT,Unknown,4,MG,2,Oral
3102,7538,IS_SECONDARY_SUSPECT,Oropharyngeal cancer,30,DF,3,Intravenous (not otherwise specified)
3104,7237,IS_SECONDARY_SUSPECT,Plasma cell myeloma,600,MG,2,Intravenous (not otherwise specified)
3105,7997,IS_SECONDARY_SUSPECT,Unknown,20,MG,2,Subcutaneous
3106,8399,IS_SECONDARY_SUSPECT,Unknown,1400,UG,2,Oral
3107,8419,IS_SECONDARY_SUSPECT,Unknown,1100,MG,2,Intravenous (not otherwise specified)
3108,8681,IS_SECONDARY_SUSPECT,Diabetes mellitus,0.75,MG,2,Unknown
3112,7993,IS_SECONDARY_SUSPECT,Chronic lymphocytic leukaemia,3200,MG,2,Unknown
3114,8762,IS_SECONDARY_SUSPECT,Unknown,1,DF,2,Subdermal
3117,7685,IS_SECONDARY_SUSPECT,Unknown,6,MG,2,Subcutaneous
3119,7176,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Oral
3119,7283,IS_SECONDARY_SUSPECT,Plasma cell myeloma,2,MG,4,Oral
3121,7818,IS_SECONDARY_SUSPECT,Unknown,1075,MG,2,Intravenous (not otherwise specified)
3121,8986,IS_SECONDARY_SUSPECT,Hepatocellular carcinoma,1200,MG,10,Intravenous drip
3122,7176,IS_SECONDARY_SUSPECT,Unknown,15,MG,2,Oral
3123,9044,IS_SECONDARY_SUSPECT,Unknown,193.25,MG,2,Intravenous (not otherwise specified)
3128,7176,IS_SECONDARY_SUSPECT,Off label use,15,MG,2,Oral
3130,7176,IS_SECONDARY_SUSPECT,Unknown,5,MG,2,Oral
3135,8859,IS_SECONDARY_SUSPECT,Unknown,3,MG,2,Oral
3135,7163,IS_SECONDARY_SUSPECT,Unknown,40,MG,4,Oral
3135,7253,IS_SECONDARY_SUSPECT,Plasma cell myeloma,16,MG/KG,6,Intravenous drip
3137,9267,IS_SECONDARY_SUSPECT,Unknown,1200,MG,2,Intravenous (not otherwise specified)
3138,7642,IS_SECONDARY_SUSPECT,Unevaluable event,10,MG,3,Oral
3141,8901,IS_SECONDARY_SUSPECT,Myasthenic syndrome,20,MG,4,Oral
3143,7176,IS_SECONDARY_SUSPECT,Unknown,5,MG,2,Oral
3144,7176,IS_SECONDARY_SUSPECT,Unknown,15,MG,2,Oral
3146,7536,IS_SECONDARY_SUSPECT,Pancreatic carcinoma metastatic,840,MG,2,Intravenous (not otherwise specified)
3146,7473,IS_SECONDARY_SUSPECT,Pancreatic carcinoma metastatic,1748,MG,3,Intravenous (not otherwise specified)
3146,8067,IS_SECONDARY_SUSPECT,Pancreatic carcinoma metastatic,210,MG,4,Intravenous (not otherwise specified)
3147,7997,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Subcutaneous
3150,7278,IS_SECONDARY_SUSPECT,Rheumatoid arthritis,40,MG,2,Subcutaneous
3153,9311,IS_SECONDARY_SUSPECT,Atrophic vulvovaginitis,4,UG,2,Vaginal
3154,7237,IS_SECONDARY_SUSPECT,B-cell lymphoma,520,MG,2,Intravenous (not otherwise specified)
3154,7469,IS_SECONDARY_SUSPECT,Unknown,600,MG,3,Intravenous (not otherwise specified)
3155,7955,IS_SECONDARY_SUSPECT,Myoclonus,0.5,MG,2,Oral
3156,8502,IS_SECONDARY_SUSPECT,Hodgkin's disease,549.9,MG,2,Unknown
3159,7176,IS_SECONDARY_SUSPECT,Off label use,10,MG,2,Oral
3160,7176,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Oral
3161,7176,IS_SECONDARY_SUSPECT,Unknown,25,MG,2,Oral
3163,7498,IS_SECONDARY_SUSPECT,Unknown,300,UG,2,Buccal
3167,7278,IS_SECONDARY_SUSPECT,Psoriasis,40,MG,2,Subcutaneous
3174,7438,IS_SECONDARY_SUSPECT,Unknown,0.065,UG/KG,2,Intravenous drip
3175,7898,IS_SECONDARY_SUSPECT,Unknown,8.5,MG,2,Oral
3177,9316,IS_SECONDARY_SUSPECT,Unknown,0.006,UG/KG,2,Subcutaneous
3178,7898,IS_SECONDARY_SUSPECT,Unknown,5.75,MG,2,Oral
3179,7438,IS_SECONDARY_SUSPECT,Unknown,0.086,UG/KG,2,Intravenous drip
3180,7438,IS_SECONDARY_SUSPECT,Unknown,0.043,UG/KG,2,Intravenous drip
3183,8353,IS_SECONDARY_SUSPECT,Unknown,801,MG,2,Oral
3184,9319,IS_SECONDARY_SUSPECT,Unknown,3.5,MG,2,Oral
3184,8400,IS_SECONDARY_SUSPECT,Pulmonary arterial hypertension,10,MG,5,Oral
3185,7283,IS_SECONDARY_SUSPECT,Unknown,2,MG,2,Oral
3188,8176,IS_SECONDARY_SUSPECT,Follicular lymphoma,138,MG,2,Intravenous (not otherwise specified)
3188,7995,IS_SECONDARY_SUSPECT,Follicular lymphoma,1000,MG,3,Intravenous (not otherwise specified)
3189,7438,IS_SECONDARY_SUSPECT,Unknown,0.037,UG/KG,2,Intravenous drip
3198,7278,IS_SECONDARY_SUSPECT,Ankylosing spondylitis,160,MG,2,Subcutaneous
3200,9320,IS_SECONDARY_SUSPECT,Cushing's syndrome,300,MG,3,Oral
3201,7255,IS_SECONDARY_SUSPECT,Unknown,300,MG,2,Intravenous (not otherwise specified)
3202,9187,IS_SECONDARY_SUSPECT,Unknown,2,DF,2,Unknown
3207,9031,IS_SECONDARY_SUSPECT,Pulmonary arterial hypertension,2.5,MG,2,Oral
3211,8176,IS_SECONDARY_SUSPECT,Follicular lymphoma,138,MG,2,Intravenous (not otherwise specified)
3211,7995,IS_SECONDARY_SUSPECT,Follicular lymphoma,1000,MG,3,Intravenous (not otherwise specified)
3212,8407,IS_SECONDARY_SUSPECT,Unknown,380,MG,2,Intramuscular
3215,7176,IS_SECONDARY_SUSPECT,Unknown,15,MG,2,Oral
3217,9322,IS_SECONDARY_SUSPECT,Unknown,75,MG,2,Oral
3219,7883,IS_SECONDARY_SUSPECT,Unknown,69,MG,2,Intravenous (not otherwise specified)
3219,7237,IS_SECONDARY_SUSPECT,Diffuse large B-cell lymphoma,645,MG,3,Intravenous (not otherwise specified)
3221,9323,IS_SECONDARY_SUSPECT,Myasthenia gravis,3600,MG,2,Intravenous (not otherwise specified)
3231,7438,IS_SECONDARY_SUSPECT,Unknown,0.078,UG/KG,2,Intravenous drip
3234,9329,IS_SECONDARY_SUSPECT,Unknown,882,MG,2,Intramuscular
3235,7498,IS_SECONDARY_SUSPECT,Unknown,300,UG,2,Buccal
3236,7176,IS_SECONDARY_SUSPECT,Unknown,15,MG,2,Oral
3239,9031,IS_SECONDARY_SUSPECT,Pulmonary arterial hypertension,2.5,MG,2,Oral
3240,9297,IS_SECONDARY_SUSPECT,Unknown,20,MG,2,Oral
3241,7498,IS_SECONDARY_SUSPECT,Unknown,300,UG,2,Buccal
3243,8801,IS_SECONDARY_SUSPECT,Hereditary angioedema,110,MG,2,Oral
3244,7498,IS_SECONDARY_SUSPECT,Unknown,300,UG,2,Buccal
3245,9336,IS_SECONDARY_SUSPECT,Non-small cell lung cancer,80,MG,2,Oral
3249,7334,IS_SECONDARY_SUSPECT,Hypogammaglobulinaemia,15,G,2,Intravenous (not otherwise specified)
3251,8194,IS_SECONDARY_SUSPECT,Unknown,300,MG,3,Unknown
3253,8838,IS_SECONDARY_SUSPECT,Unknown,200,MG,2,Unknown
3254,7176,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Oral
3256,7177,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,20,MG,2,Oral
3258,9337,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia recurrent,10,MG/M**2,2,Intravenous (not otherwise specified)
3258,9131,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia recurrent,0.6,MG/M**2,3,Intravenous (not otherwise specified)
3258,7237,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia recurrent,750,MG/M**2,4,Intravenous (not otherwise specified)
3258,7246,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia recurrent,50,MG/M**2,5,Intravenous (not otherwise specified)
3258,7171,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia recurrent,60,MG/M**2,6,Oral
3259,7176,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Oral
3260,8660,IS_SECONDARY_SUSPECT,Unknown,150,MG,2,Subcutaneous
3264,7278,IS_SECONDARY_SUSPECT,Colitis ulcerative,40,MG,2,Subcutaneous
3266,7662,IS_SECONDARY_SUSPECT,Uveal melanoma,95,MG,2,Intravenous (not otherwise specified)
3267,8042,IS_SECONDARY_SUSPECT,Acute myeloid leukaemia,215,MG,2,Unknown
3268,7438,IS_SECONDARY_SUSPECT,Unknown,0.1,UG/KG,2,Subcutaneous
3270,7438,IS_SECONDARY_SUSPECT,Unknown,0.06,UG/KG,2,Subcutaneous
3271,9134,IS_SECONDARY_SUSPECT,Unknown,180,MG,2,Oral
3272,7438,IS_SECONDARY_SUSPECT,Unknown,0.08,UG/KG,2,Intravenous drip
3274,7685,IS_SECONDARY_SUSPECT,Unknown,6,MG,2,Unknown
3275,7898,IS_SECONDARY_SUSPECT,Unknown,5,MG,2,Oral
3277,8578,IS_SECONDARY_SUSPECT,Unknown,150,MG,2,Subcutaneous
3278,8762,IS_SECONDARY_SUSPECT,Unknown,1,DF,2,Subdermal
3281,7394,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Oral
3282,7176,IS_SECONDARY_SUSPECT,Off label use,25,MG,2,Oral
3283,8176,IS_SECONDARY_SUSPECT,B-cell lymphoma,1.8,MG/KG,2,Intravenous (not otherwise specified)
3286,7176,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Oral
3288,7171,IS_SECONDARY_SUSPECT,Unknown,55,MG,2,Oral
3288,9341,IS_SECONDARY_SUSPECT,Chronic graft versus host disease,200,MG,7,Oral
3289,7176,IS_SECONDARY_SUSPECT,Unknown,2.5,MG,2,Oral
3290,7298,IS_SECONDARY_SUSPECT,Axillary pain,2,DF,2,Unknown
3291,7176,IS_SECONDARY_SUSPECT,Unknown,25,MG,2,Oral
3292,7176,IS_SECONDARY_SUSPECT,Unknown,15,MG,2,Oral
3297,7176,IS_SECONDARY_SUSPECT,Unknown,25,MG,2,Oral
3299,7176,IS_SECONDARY_SUSPECT,Unknown,10,MG,3,Oral
3300,7176,IS_SECONDARY_SUSPECT,Unknown,25,MG,2,Oral
3306,7685,IS_SECONDARY_SUSPECT,Unknown,6,MG,2,Unknown
3307,7176,IS_SECONDARY_SUSPECT,Diffuse large B-cell lymphoma,15,MG,2,Oral
3309,7853,IS_SECONDARY_SUSPECT,Dermatitis atopic,2,DF,2,Subcutaneous
3310,7496,IS_SECONDARY_SUSPECT,Unknown,600,MG,2,Intravenous (not otherwise specified)
3312,8014,IS_SECONDARY_SUSPECT,Chronic lymphocytic leukaemia,140,MG,2,Oral
3313,7176,IS_SECONDARY_SUSPECT,Unknown,25,MG,2,Oral
3314,7176,IS_SECONDARY_SUSPECT,Unknown,15,MG,2,Oral
3315,7832,IS_SECONDARY_SUSPECT,Hypogammaglobulinaemia,35,G,2,Intravenous (not otherwise specified)
3316,7176,IS_SECONDARY_SUSPECT,Unknown,5,MG,2,Oral
3319,7176,IS_SECONDARY_SUSPECT,Myelodysplastic syndrome,10,MG,2,Oral
3322,7536,IS_SECONDARY_SUSPECT,K-ras gene mutation,1200,MG,3,Intravenous (not otherwise specified)
3326,8451,IS_SECONDARY_SUSPECT,Short-bowel syndrome,2.57,MG,2,Subcutaneous
3327,7613,IS_SECONDARY_SUSPECT,Unknown,205.2,MG,2,Intravenous (not otherwise specified)
3327,7662,IS_SECONDARY_SUSPECT,Malignant melanoma,68.4,MG,3,Intravenous (not otherwise specified)
3327,7171,IS_SECONDARY_SUSPECT,Malignant melanoma,80,MG,4,Oral
3327,9004,IS_SECONDARY_SUSPECT,Malignant melanoma,32,MG,6,Oral
3332,7632,IS_SECONDARY_SUSPECT,Unknown,0.4,MG,2,Unknown
3337,7230,IS_SECONDARY_SUSPECT,Unknown,40,MG,2,Unknown
3337,7195,IS_SECONDARY_SUSPECT,Unknown,81,MG,4,Unknown
3341,7438,IS_SECONDARY_SUSPECT,Unknown,0.064,UG/KG,2,Intravenous drip
3345,7438,IS_SECONDARY_SUSPECT,Unknown,0.099,UG/KG,2,Intravenous drip
3346,7438,IS_SECONDARY_SUSPECT,Unknown,0.051,UG/KG,2,Subcutaneous
3346,7440,IS_SECONDARY_SUSPECT,Pulmonary arterial hypertension,40,MG,3,Oral
3348,7176,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Oral
3351,7176,IS_SECONDARY_SUSPECT,Unknown,25,MG,2,Oral
3352,8578,IS_SECONDARY_SUSPECT,Unknown,150,MG,2,Subcutaneous
3354,7685,IS_SECONDARY_SUSPECT,Unknown,6000,UG,2,Unknown
3356,9297,IS_SECONDARY_SUSPECT,Liver disorder,20,MG,2,Oral
3358,7176,IS_SECONDARY_SUSPECT,Unknown,20,MG,2,Oral
3359,7176,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Oral
3360,8290,IS_SECONDARY_SUSPECT,Unknown,140,MG,2,Unknown
3363,7176,IS_SECONDARY_SUSPECT,Unknown,25,MG,2,Oral
3366,8548,IS_SECONDARY_SUSPECT,Unknown,15,MG,2,Oral
3367,8941,IS_SECONDARY_SUSPECT,Malignant melanoma,150,MG,2,Oral
3367,7759,IS_SECONDARY_SUSPECT,Malignant melanoma,2,MG,4,Oral
3369,7176,IS_SECONDARY_SUSPECT,Unknown,5,MG,2,Oral
3370,9354,IS_SECONDARY_SUSPECT,Secondary progressive multiple sclerosis,2,MG,2,Oral
3371,7283,IS_SECONDARY_SUSPECT,Unknown,1,MG,2,Oral
3372,7685,IS_SECONDARY_SUSPECT,Unknown,6,UG,2,Unknown
3374,7278,IS_SECONDARY_SUSPECT,Unknown,40,MG,2,Subcutaneous
3375,7685,IS_SECONDARY_SUSPECT,Unknown,6,MG,2,Unknown
3376,8762,IS_SECONDARY_SUSPECT,Unknown,1,DF,2,Subdermal
3380,8224,IS_SECONDARY_SUSPECT,Unknown,1,DF,2,Oral
3380,8225,IS_SECONDARY_SUSPECT,Uterine leiomyoma,1,DF,4,Oral
3382,9031,IS_SECONDARY_SUSPECT,Pulmonary arterial hypertension,1.5,MG,2,Oral
3385,7898,IS_SECONDARY_SUSPECT,Pulmonary arterial hypertension,0.125,MG,2,Oral
3386,7176,IS_SECONDARY_SUSPECT,Unknown,25,MG,2,Oral
3388,7632,IS_SECONDARY_SUSPECT,Unknown,0.5,MG,2,Unknown
3389,7662,IS_SECONDARY_SUSPECT,Prostate cancer,1,MG/KG,2,Intravenous (not otherwise specified)
3390,7176,IS_SECONDARY_SUSPECT,Unknown,25,MG,4,Oral
3392,7977,IS_SECONDARY_SUSPECT,Hodgkin's disease,365,MG,2,Unknown
3392,9358,IS_SECONDARY_SUSPECT,Hodgkin's disease,5460,MG,3,Unknown
3392,9359,IS_SECONDARY_SUSPECT,Hodgkin's disease,80,MG,4,Unknown
3394,8399,IS_SECONDARY_SUSPECT,Unknown,200,UG,2,Oral
3398,7176,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Oral
3400,9329,IS_SECONDARY_SUSPECT,Unknown,1064,MG,2,Intramuscular
3402,7553,IS_SECONDARY_SUSPECT,Unknown,60,MG,2,Unknown
3403,8034,IS_SECONDARY_SUSPECT,Dyskinesia,274,MG,2,Oral
3403,7192,IS_SECONDARY_SUSPECT,Unknown,3,MG,5,Unknown
3403,7696,IS_SECONDARY_SUSPECT,Unknown,1000,UG,9,Unknown
3403,7547,IS_SECONDARY_SUSPECT,Unknown,5000,UG,10,Unknown
3403,8433,IS_SECONDARY_SUSPECT,Unknown,10,UG,11,Unknown
3404,7283,IS_SECONDARY_SUSPECT,Unknown,2,MG,2,Oral
3405,8762,IS_SECONDARY_SUSPECT,Unknown,1,DF,2,Subdermal
3411,8004,IS_SECONDARY_SUSPECT,Unknown,84,MG,2,Unknown
3414,9031,IS_SECONDARY_SUSPECT,Pulmonary arterial hypertension,2.5,MG,2,Oral
3418,7993,IS_SECONDARY_SUSPECT,Acute myeloid leukaemia,400,MG,2,Oral
3418,9165,IS_SECONDARY_SUSPECT,Myelodysplastic syndrome,800,MG,3,Intravenous drip
3419,8350,IS_SECONDARY_SUSPECT,Unknown,37.5,MG/M**2,2,Intravenous drip
3421,7662,IS_SECONDARY_SUSPECT,Metastatic malignant melanoma,252,MG,2,Intravenous (not otherwise specified)
3423,7283,IS_SECONDARY_SUSPECT,Unknown,1,MG,2,Oral
3424,7283,IS_SECONDARY_SUSPECT,Unknown,4,MG,2,Oral
3426,7176,IS_SECONDARY_SUSPECT,Unknown,15,MG,2,Oral
3429,7283,IS_SECONDARY_SUSPECT,Plasma cell myeloma,2,MG,2,Oral
3431,8964,IS_SECONDARY_SUSPECT,Unknown,200,MG,2,Intravenous (not otherwise specified)
3433,7898,IS_SECONDARY_SUSPECT,Pulmonary arterial hypertension,0.375,MG,2,Oral
3434,7898,IS_SECONDARY_SUSPECT,Unknown,12,MG,2,Oral
3437,7278,IS_SECONDARY_SUSPECT,Rheumatoid arthritis,40,MG,2,Subcutaneous
3438,7176,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Oral
3439,7176,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Oral
3442,7176,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Oral
3444,7383,IS_SECONDARY_SUSPECT,Malignant melanoma,6450,MG,2,Unknown
3444,7662,IS_SECONDARY_SUSPECT,Malignant melanoma,291,MG,6,Unknown
3445,9136,IS_SECONDARY_SUSPECT,K-ras gene mutation,960,MG,3,Oral
3448,7613,IS_SECONDARY_SUSPECT,Unknown,480,MG,2,Intravenous (not otherwise specified)
3452,7782,IS_SECONDARY_SUSPECT,Anticoagulant therapy,20,MG,3,Unknown
3458,7438,IS_SECONDARY_SUSPECT,Unknown,0.043,UG/KG,2,Subcutaneous
3460,7438,IS_SECONDARY_SUSPECT,Unknown,0.087,UG/KG,2,Intravenous drip
3462,7176,IS_SECONDARY_SUSPECT,Unknown,5,MG,2,Oral
3463,7280,IS_SECONDARY_SUSPECT,Unknown,100,MG,2,Oral
3465,7176,IS_SECONDARY_SUSPECT,Unknown,5,MG,2,Oral
3466,7176,IS_SECONDARY_SUSPECT,Unknown,10,MG,3,Oral
3468,9031,IS_SECONDARY_SUSPECT,Pulmonary arterial hypertension,2.5,MG,2,Oral
3469,7338,IS_SECONDARY_SUSPECT,Rheumatoid arthritis,5,MG,2,Oral
3470,7632,IS_SECONDARY_SUSPECT,Premature baby,0.9,MG,2,Unknown
3471,7332,IS_SECONDARY_SUSPECT,Juvenile idiopathic arthritis,15,MG,2,Unknown
3471,9369,IS_SECONDARY_SUSPECT,Juvenile idiopathic arthritis,87.5,MG,3,Unknown
3471,7413,IS_SECONDARY_SUSPECT,Unknown,1,MG,4,Unknown
3472,7662,IS_SECONDARY_SUSPECT,Malignant melanoma,389,MG,2,Unknown
3472,9370,IS_SECONDARY_SUSPECT,Malignant melanoma,1750,MG,3,Unknown
3473,8353,IS_SECONDARY_SUSPECT,Scleroderma,267,MG,2,Oral
3474,8400,IS_SECONDARY_SUSPECT,Pulmonary hypertension,10,MG,2,Unknown
3475,7438,IS_SECONDARY_SUSPECT,Unknown,0.084,UG/KG,2,Subcutaneous
3478,7460,IS_SECONDARY_SUSPECT,Unknown,35,MG,2,Intravenous (not otherwise specified)
3486,8622,IS_SECONDARY_SUSPECT,Unknown,30,G,2,Subcutaneous
3487,7254,IS_SECONDARY_SUSPECT,Short-bowel syndrome,0.35,ML,2,Subcutaneous
3490,8762,IS_SECONDARY_SUSPECT,Unknown,1,DF,2,Subdermal
3491,7438,IS_SECONDARY_SUSPECT,Unknown,0.054,UG/KG,2,Subcutaneous
3493,7176,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Oral
3496,8762,IS_SECONDARY_SUSPECT,Unknown,1,DF,2,Subdermal
3498,9031,IS_SECONDARY_SUSPECT,Pulmonary arterial hypertension,2,MG,2,Oral
3503,7438,IS_SECONDARY_SUSPECT,Unknown,0.067,UG/KG,2,Subcutaneous
3509,7176,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Oral
3510,7283,IS_SECONDARY_SUSPECT,Unknown,2,MG,2,Oral
3511,7685,IS_SECONDARY_SUSPECT,Unknown,6,UG,2,Unknown
3513,7685,IS_SECONDARY_SUSPECT,Unknown,6,MG,2,Unknown
3514,8189,IS_SECONDARY_SUSPECT,Unknown,140,MG,2,Unknown
3518,8725,IS_SECONDARY_SUSPECT,Unknown,72,UG,3,Unknown
3519,7438,IS_SECONDARY_SUSPECT,Unknown,0.015,UG/KG,2,Intravenous drip
3520,7898,IS_SECONDARY_SUSPECT,Pulmonary arterial hypertension,10,MG,2,Oral
3521,9374,IS_SECONDARY_SUSPECT,Renal cancer,18,MG,2,Oral
3524,7278,IS_SECONDARY_SUSPECT,Rheumatoid arthritis,40,MG,2,Subcutaneous
3525,8826,IS_SECONDARY_SUSPECT,Invasive breast carcinoma,1200,MG,2,Oral
3525,8827,IS_SECONDARY_SUSPECT,Invasive breast carcinoma,248,MG,3,Intravenous (not otherwise specified)
3530,8762,IS_SECONDARY_SUSPECT,Contraception,1,DF,2,Subdermal
3531,9162,IS_SECONDARY_SUSPECT,Unknown,800,MG,2,Oral
3531,7537,IS_SECONDARY_SUSPECT,Clear cell renal cell carcinoma,10,MG/KG,3,Intravenous (not otherwise specified)
3532,7438,IS_SECONDARY_SUSPECT,Unknown,0.036,UG/KG,2,Subcutaneous
3534,7506,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,150,MG,3,Unknown
3535,7545,IS_SECONDARY_SUSPECT,Unknown,150,MG,2,Unknown
3535,7506,IS_SECONDARY_SUSPECT,Dyspepsia,75,MG,3,Unknown
3536,7182,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,150,MG,2,Unknown
3538,7176,IS_SECONDARY_SUSPECT,Unknown,5,MG,3,Oral
3542,8762,IS_SECONDARY_SUSPECT,Contraception,1,DF,2,Unknown
3546,7176,IS_SECONDARY_SUSPECT,Unknown,25,MG,2,Oral
3555,7545,IS_SECONDARY_SUSPECT,Dyspepsia,150,MG,2,Unknown
3559,7685,IS_SECONDARY_SUSPECT,Unknown,6,MG,2,Unknown
3562,8775,IS_SECONDARY_SUSPECT,Unknown,1800,UG,2,Oral
3565,7280,IS_SECONDARY_SUSPECT,Unknown,100,MG,2,Unknown
3568,8312,IS_SECONDARY_SUSPECT,Schizophrenia,100,MG,2,Oral
3573,7506,IS_SECONDARY_SUSPECT,Gastritis,150,MG,4,Unknown
3578,9031,IS_SECONDARY_SUSPECT,Pulmonary arterial hypertension,1,MG,2,Unknown
3579,7506,IS_SECONDARY_SUSPECT,Dyspepsia,300,MG,2,Unknown
3582,7506,IS_SECONDARY_SUSPECT,Dyspepsia,150,MG,2,Unknown
3583,7545,IS_SECONDARY_SUSPECT,Unknown,150,MG,2,Unknown
3589,7283,IS_SECONDARY_SUSPECT,Unknown,3,MG,2,Oral
3592,7278,IS_SECONDARY_SUSPECT,Unknown,40,MG,2,Subcutaneous
3594,7251,IS_SECONDARY_SUSPECT,Unknown,52.9,MG,2,Unknown
3595,7506,IS_SECONDARY_SUSPECT,Dyspepsia,150,MG,2,Unknown
3596,9393,IS_SECONDARY_SUSPECT,Bladder cancer,1,DF,1,Unknown
3596,8544,IS_SECONDARY_SUSPECT,Bladder cancer,1,DF,2,Unknown
3596,7443,IS_SECONDARY_SUSPECT,Bladder cancer,137,MG,6,Unknown
3596,8185,IS_SECONDARY_SUSPECT,Bladder cancer,1960,MG,8,Unknown
3598,7979,IS_SECONDARY_SUSPECT,Unknown,30,G,2,Subcutaneous
3599,7945,IS_SECONDARY_SUSPECT,Unknown,12,MG,2,Intrathecal
3600,7506,IS_SECONDARY_SUSPECT,Dyspepsia,150,MG,2,Unknown
3603,7545,IS_SECONDARY_SUSPECT,Unknown,300,MG,2,Unknown
3603,7506,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,150,MG,3,Unknown
3608,7545,IS_SECONDARY_SUSPECT,Unknown,300,MG,2,Unknown
3611,7361,IS_SECONDARY_SUSPECT,Arthritis,5,MG,2,Oral
3613,7438,IS_SECONDARY_SUSPECT,Unknown,0.017,UG/KG,2,Subcutaneous
3617,9394,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Oral
3623,7997,IS_SECONDARY_SUSPECT,Unknown,20,MG,2,Subcutaneous
3624,9268,IS_SECONDARY_SUSPECT,Unknown,10,MG/KG,2,Intravenous (not otherwise specified)
3626,7506,IS_SECONDARY_SUSPECT,Dyspepsia,300,MG,2,Unknown
3628,7506,IS_SECONDARY_SUSPECT,Dyspepsia,75,MG,2,Unknown
3632,7177,IS_SECONDARY_SUSPECT,Plasma cell myeloma,40,MG,2,Intravenous drip
3632,7253,IS_SECONDARY_SUSPECT,Plasma cell myeloma,1200,MG,9,Intravenous drip
3633,7506,IS_SECONDARY_SUSPECT,Dyspepsia,150,MG,2,Unknown
3636,7237,IS_SECONDARY_SUSPECT,Neoplasm,60,MG/KG,3,Intravenous (not otherwise specified)
3636,7861,IS_SECONDARY_SUSPECT,Neoplasm,400,MG,5,Intravenous (not otherwise specified)
3637,8189,IS_SECONDARY_SUSPECT,Unknown,140,MG,2,Unknown
3639,7537,IS_SECONDARY_SUSPECT,Endometrial cancer,975,MG,2,Intravenous (not otherwise specified)
3643,7438,IS_SECONDARY_SUSPECT,Unknown,0.044,UG/KG,2,Subcutaneous
3644,7506,IS_SECONDARY_SUSPECT,Dyspepsia,150,MG,2,Oral
3645,7545,IS_SECONDARY_SUSPECT,Unknown,150,MG,2,Unknown
3645,7506,IS_SECONDARY_SUSPECT,Hyperchlorhydria,75,MG,3,Unknown
3647,7506,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,150,MG,2,Unknown
3648,7506,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,150,MG,3,Unknown
3649,7545,IS_SECONDARY_SUSPECT,Unknown,150,MG,2,Unknown
3650,7685,IS_SECONDARY_SUSPECT,Unknown,6,MG,2,Unknown
3653,7861,IS_SECONDARY_SUSPECT,Transitional cell carcinoma,200,MG,2,Intravenous (not otherwise specified)
3654,7685,IS_SECONDARY_SUSPECT,Unknown,6,MG,2,Unknown
3655,9174,IS_SECONDARY_SUSPECT,Unknown,1500,MG,2,Oral
3658,7545,IS_SECONDARY_SUSPECT,Dyspepsia,150,MG,2,Unknown
3659,7545,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,150,MG,2,Unknown
3664,7545,IS_SECONDARY_SUSPECT,Unknown,150,MG,2,Unknown
3665,7545,IS_SECONDARY_SUSPECT,Dyspepsia,300,MG,2,Unknown
3666,7506,IS_SECONDARY_SUSPECT,Dyspepsia,150,MG,2,Unknown
3668,7506,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,150,MG,3,Unknown
3670,7506,IS_SECONDARY_SUSPECT,Dyspepsia,150,MG,2,Unknown
3675,7506,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,150,MG,2,Unknown
3676,8812,IS_SECONDARY_SUSPECT,Breast cancer,125,MG,2,Oral
3677,7898,IS_SECONDARY_SUSPECT,Pulmonary arterial hypertension,0.375,MG,2,Oral
3678,8762,IS_SECONDARY_SUSPECT,Unknown,1,DF,2,Subdermal
3680,7685,IS_SECONDARY_SUSPECT,Unknown,6,MG,2,Unknown
3681,7283,IS_SECONDARY_SUSPECT,Unknown,4,MG,2,Oral
3682,8847,IS_SECONDARY_SUSPECT,Type 2 diabetes mellitus,2,MG,2,Subcutaneous
3684,8655,IS_SECONDARY_SUSPECT,Magnetic resonance imaging,10,ML,2,Unknown
3685,8243,IS_SECONDARY_SUSPECT,Back pain,37.5,UG,2,Transdermal
3686,9374,IS_SECONDARY_SUSPECT,Unknown,18,MG,2,Oral
3687,9399,IS_SECONDARY_SUSPECT,Unknown,750,MG,2,Oral
3688,7901,IS_SECONDARY_SUSPECT,Still's disease,180,MG,1,Unknown
3688,9404,IS_SECONDARY_SUSPECT,Unknown,100,MG,3,Unknown
3688,7904,IS_SECONDARY_SUSPECT,Haemophagocytic lymphohistiocytosis,20,MG,7,Unknown
3688,7433,IS_SECONDARY_SUSPECT,Still's disease,1.6,MG,10,Oral
3688,9405,IS_SECONDARY_SUSPECT,Still's disease,70,G,11,Intravenous (not otherwise specified)
3689,9406,IS_SECONDARY_SUSPECT,Gallbladder cancer metastatic,400,MG/M**2,2,Unknown
3689,9030,IS_SECONDARY_SUSPECT,Gallbladder cancer metastatic,50,MG/M**2,3,Intravenous (not otherwise specified)
3692,9031,IS_SECONDARY_SUSPECT,Pulmonary arterial hypertension,1,MG,2,Oral
3693,7438,IS_SECONDARY_SUSPECT,Unknown,0.05,UG/KG,2,Intravenous drip
3694,9406,IS_SECONDARY_SUSPECT,Cholangiocarcinoma,750,MG,2,Intravenous (not otherwise specified)
3694,9030,IS_SECONDARY_SUSPECT,Cholangiocarcinoma,130.892,MG,3,Intravenous (not otherwise specified)
3694,7613,IS_SECONDARY_SUSPECT,Cholangiocarcinoma,240,MG,4,Intravenous (not otherwise specified)
3695,9030,IS_SECONDARY_SUSPECT,Colon cancer,144.179,MG,5,Intravenous (not otherwise specified)
3696,7176,IS_SECONDARY_SUSPECT,Unknown,15,MG,2,Oral
3701,7438,IS_SECONDARY_SUSPECT,Unknown,0.056,UG/KG,2,Intravenous drip
3706,7489,IS_SECONDARY_SUSPECT,Diabetes mellitus,2,MG,4,Unknown
3706,7678,IS_SECONDARY_SUSPECT,Seizure,1000,MG,5,Unknown
3706,7660,IS_SECONDARY_SUSPECT,Unknown,20,MG,6,Unknown
3706,9408,IS_SECONDARY_SUSPECT,Unknown,5,MG,7,Unknown
3708,8240,IS_SECONDARY_SUSPECT,T-cell prolymphocytic leukaemia,400,MG,2,Oral
3710,8725,IS_SECONDARY_SUSPECT,Unknown,54,UG,3,Unknown
3712,7539,IS_SECONDARY_SUSPECT,Non-small cell lung cancer,566,MG,2,Unknown
3712,9410,IS_SECONDARY_SUSPECT,Non-small cell lung cancer,875,MG,3,Unknown
3714,7545,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,150,MG,2,Unknown
3714,7506,IS_SECONDARY_SUSPECT,Abdominal pain upper,75,MG,3,Unknown
3718,7438,IS_SECONDARY_SUSPECT,Unknown,0.037,UG/KG,2,Intravenous drip
3720,7545,IS_SECONDARY_SUSPECT,Dyspepsia,150,MG,2,Unknown
3721,7545,IS_SECONDARY_SUSPECT,Unknown,150,MG,2,Unknown
3725,7545,IS_SECONDARY_SUSPECT,Unknown,150,MG,2,Unknown
3726,7545,IS_SECONDARY_SUSPECT,Unknown,150,MG,2,Unknown
3729,7951,IS_SECONDARY_SUSPECT,Unknown,1000,UG,2,Unknown
3729,9412,IS_SECONDARY_SUSPECT,Ewing's sarcoma,185,MG,5,Intravenous (not otherwise specified)
3735,8400,IS_SECONDARY_SUSPECT,Pulmonary arterial hypertension,10,MG,2,Oral
3736,7176,IS_SECONDARY_SUSPECT,Plasma cell myeloma,5,MG,2,Oral
3737,8340,IS_SECONDARY_SUSPECT,Unknown,100,MG,2,Oral
3738,8247,IS_SECONDARY_SUSPECT,Unknown,50,MG,2,Oral
3739,7662,IS_SECONDARY_SUSPECT,Glioblastoma,217.8,MG,2,Unknown
3741,7176,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Oral
3742,7545,IS_SECONDARY_SUSPECT,Unknown,300,MG,2,Unknown
3742,7506,IS_SECONDARY_SUSPECT,Hyperchlorhydria,150,MG,3,Unknown
3743,7545,IS_SECONDARY_SUSPECT,Unknown,150,MG,2,Unknown
3743,7506,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,75,MG,3,Unknown
3744,7850,IS_SECONDARY_SUSPECT,Unknown,90,MG,2,Unknown
3746,7993,IS_SECONDARY_SUSPECT,Unknown,200,MG,2,Oral
3747,7176,IS_SECONDARY_SUSPECT,Unknown,25,MG,2,Oral
3750,9421,IS_SECONDARY_SUSPECT,Hodgkin's disease,1440,MG,2,Unknown
3751,7438,IS_SECONDARY_SUSPECT,Unknown,0.04,UG/KG,2,Intravenous drip
3758,7883,IS_SECONDARY_SUSPECT,Chronic lymphocytic leukaemia,50,MG,2,Intravenous (not otherwise specified)
3764,9425,IS_SECONDARY_SUSPECT,Unknown,50,MG,2,Unknown
3765,7685,IS_SECONDARY_SUSPECT,Unknown,6,MG,2,Unknown
3767,8189,IS_SECONDARY_SUSPECT,Unknown,420,MG,2,Unknown
3769,8502,IS_SECONDARY_SUSPECT,Hodgkin's disease,1.2,MG/KG,2,Intravenous (not otherwise specified)
3769,9358,IS_SECONDARY_SUSPECT,Hodgkin's disease,375,MG/M**2,4,Intravenous (not otherwise specified)
3769,9427,IS_SECONDARY_SUSPECT,Hodgkin's disease,6,MG/M**2,6,Intravenous (not otherwise specified)
3769,7244,IS_SECONDARY_SUSPECT,Hodgkin's disease,25,MG/M**2,8,Intravenous (not otherwise specified)
3770,7685,IS_SECONDARY_SUSPECT,Unknown,6,UG,2,Unknown
3771,8850,IS_SECONDARY_SUSPECT,Hepatobiliary cancer,50,MG/M**2,2,Intravenous (not otherwise specified)
3771,8851,IS_SECONDARY_SUSPECT,Hepatobiliary cancer,2400,MG/M**2,3,Intravenous (not otherwise specified)
3778,7685,IS_SECONDARY_SUSPECT,Unknown,6,MG,2,Unknown
3780,7176,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Oral
3781,7176,IS_SECONDARY_SUSPECT,Unknown,25,MG,2,Oral
3782,7176,IS_SECONDARY_SUSPECT,Unknown,15,MG,2,Oral
3785,7176,IS_SECONDARY_SUSPECT,Unknown,25,MG,2,Oral
3789,7496,IS_SECONDARY_SUSPECT,Unknown,600,MG,3,Intravenous (not otherwise specified)
3791,7332,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,15,MG,2,Intrathecal
3791,7171,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,40,MG,3,Oral
3791,7354,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,50,MG,4,Oral
3791,7353,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,100,MG,6,Oral
3791,7781,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,2,MG,8,Intravenous (not otherwise specified)
3792,7176,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Oral
3794,7176,IS_SECONDARY_SUSPECT,Unknown,15,MG,2,Oral
3795,7333,IS_SECONDARY_SUSPECT,B precursor type acute leukaemia,920,MG,2,Unknown
3795,9429,IS_SECONDARY_SUSPECT,B precursor type acute leukaemia,1225,MG,3,Unknown
3795,7332,IS_SECONDARY_SUSPECT,B precursor type acute leukaemia,12.5,MG,4,Unknown
3797,7506,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,150,MG,3,Unknown
3798,7506,IS_SECONDARY_SUSPECT,Dyspepsia,150,MG,2,Unknown
3800,7176,IS_SECONDARY_SUSPECT,Unknown,25,MG,2,Oral
3802,7506,IS_SECONDARY_SUSPECT,Dyspepsia,150,MG,3,Unknown
3804,7506,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,150,MG,3,Unknown
3805,7545,IS_SECONDARY_SUSPECT,Unknown,150,MG,2,Unknown
3805,7182,IS_SECONDARY_SUSPECT,Dyspepsia,75,MG,3,Unknown
3810,8906,IS_SECONDARY_SUSPECT,Unknown,16.5,ML,2,Oral
3813,9432,IS_SECONDARY_SUSPECT,Unknown,0.3,MG,2,Unknown
3815,9031,IS_SECONDARY_SUSPECT,Pulmonary arterial hypertension,2.5,MG,2,Oral
3816,7237,IS_SECONDARY_SUSPECT,Chronic lymphocytic leukaemia,700,MG,2,Intravenous (not otherwise specified)
3817,8762,IS_SECONDARY_SUSPECT,Unknown,1,DF,2,Subdermal
3818,7545,IS_SECONDARY_SUSPECT,Unknown,300,MG,2,Unknown
3821,9031,IS_SECONDARY_SUSPECT,Pulmonary arterial hypertension,2,MG,2,Oral
3822,9434,IS_SECONDARY_SUSPECT,Neurofibromatosis,25,MG,2,Oral
3823,7506,IS_SECONDARY_SUSPECT,Dyspepsia,150,MG,2,Unknown
3825,7506,IS_SECONDARY_SUSPECT,Dyspepsia,75,MG,2,Unknown
3826,7545,IS_SECONDARY_SUSPECT,Unknown,150,MG,2,Unknown
3829,8225,IS_SECONDARY_SUSPECT,Uterine leiomyoma,1,DF,2,Oral
3830,8775,IS_SECONDARY_SUSPECT,Unknown,1600,UG,2,Oral
3831,7545,IS_SECONDARY_SUSPECT,Unknown,300,MG,2,Unknown
3832,7545,IS_SECONDARY_SUSPECT,Unknown,150,MG,2,Unknown
3833,7176,IS_SECONDARY_SUSPECT,Unknown,20,MG,2,Oral
3834,9436,IS_SECONDARY_SUSPECT,Unknown,75,MG,2,Unknown
3835,7176,IS_SECONDARY_SUSPECT,Unknown,25,MG,2,Oral
3837,7545,IS_SECONDARY_SUSPECT,Dyspepsia,150,MG,2,Unknown
3838,7853,IS_SECONDARY_SUSPECT,Unknown,300,MG,2,Subcutaneous
3841,9031,IS_SECONDARY_SUSPECT,Pulmonary arterial hypertension,2.5,MG,2,Oral
3842,7718,IS_SECONDARY_SUSPECT,Unknown,300,MG,2,Subcutaneous
3843,8383,IS_SECONDARY_SUSPECT,Pulmonary arterial hypertension,32,MG,2,Oral
3844,8838,IS_SECONDARY_SUSPECT,Arthritis,400,MG,2,Subcutaneous
3845,9437,IS_SECONDARY_SUSPECT,Unknown,500,UG,2,Urethral
3848,7506,IS_SECONDARY_SUSPECT,Dyspepsia,150,MG,2,Unknown
3850,7456,IS_SECONDARY_SUSPECT,Severe myoclonic epilepsy of infancy,550,MG,2,Oral
3852,7899,IS_SECONDARY_SUSPECT,Unknown,100,MG,2,Unknown
3852,8776,IS_SECONDARY_SUSPECT,Metastatic malignant melanoma,200,MG,4,Unknown
3854,8189,IS_SECONDARY_SUSPECT,Unknown,140,MG,2,Unknown
3856,7334,IS_SECONDARY_SUSPECT,Unknown,150,G,2,Intravenous (not otherwise specified)
3857,7506,IS_SECONDARY_SUSPECT,Dyspepsia,300,MG,2,Unknown
3865,7176,IS_SECONDARY_SUSPECT,Unknown,25,MG,2,Oral
3870,7438,IS_SECONDARY_SUSPECT,Unknown,0.06,UG/KG,2,Subcutaneous
3872,7994,IS_SECONDARY_SUSPECT,Chronic lymphocytic leukaemia,420,MG,2,Oral
3875,7249,IS_SECONDARY_SUSPECT,Unknown,120,MG,2,Oral
3875,7248,IS_SECONDARY_SUSPECT,Multiple sclerosis,10,MG,4,Oral
3877,7176,IS_SECONDARY_SUSPECT,Unknown,15,MG,2,Oral
3878,8827,IS_SECONDARY_SUSPECT,HER2 positive breast cancer,3.6,MG/KG,2,Intravenous (not otherwise specified)
3880,8321,IS_SECONDARY_SUSPECT,Prophylaxis,5000,IU,2,Subcutaneous
3881,9341,IS_SECONDARY_SUSPECT,Graft versus host disease,200,MG,2,Oral
3883,7192,IS_SECONDARY_SUSPECT,Unknown,5,MG,10,Unknown
3883,7162,IS_SECONDARY_SUSPECT,Unknown,5,MG,11,Unknown
3883,8034,IS_SECONDARY_SUSPECT,Dyskinesia,274,MG,14,Oral
3884,7438,IS_SECONDARY_SUSPECT,Unknown,0.066,UG/KG,2,Intravenous drip
3885,7319,IS_SECONDARY_SUSPECT,Type 2 diabetes mellitus,62,IU,11,Subcutaneous
3888,9412,IS_SECONDARY_SUSPECT,Metastasis,136.482,MG,2,Intravenous drip
3888,7696,IS_SECONDARY_SUSPECT,Vitamin B12 deficiency,1000,UG,5,Unknown
3888,7620,IS_SECONDARY_SUSPECT,Diarrhoea,2,MG,7,Oral
3888,7203,IS_SECONDARY_SUSPECT,Unknown,40,MG,9,Oral
3888,7270,IS_SECONDARY_SUSPECT,Unknown,8,MG,10,Oral
3888,7247,IS_SECONDARY_SUSPECT,Unknown,400,MG,12,Oral
3888,7911,IS_SECONDARY_SUSPECT,Pain,50,MG,13,Oral
3890,8686,IS_SECONDARY_SUSPECT,Asthma,2,DF,2,Unknown
3893,7176,IS_SECONDARY_SUSPECT,Unknown,25,MG,2,Oral
3899,7545,IS_SECONDARY_SUSPECT,Unknown,150,MG,2,Unknown
3903,7438,IS_SECONDARY_SUSPECT,Unknown,0.07,UG/KG,2,Intravenous drip
3908,7176,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Oral
3909,7176,IS_SECONDARY_SUSPECT,Unknown,5,MG,2,Oral
3910,7278,IS_SECONDARY_SUSPECT,Psoriasis,40,MG,2,Subcutaneous
3912,7176,IS_SECONDARY_SUSPECT,Unknown,5,MG,2,Oral
3913,9031,IS_SECONDARY_SUSPECT,Pulmonary arterial hypertension,2.5,MG,2,Oral
3915,9191,IS_SECONDARY_SUSPECT,Unknown,2,DF,2,Respiratory (inhalation)
3915,7194,IS_SECONDARY_SUSPECT,Unknown,30,MG,6,Oral
3915,7341,IS_SECONDARY_SUSPECT,Unknown,325,MG,7,Unknown
3915,9446,IS_SECONDARY_SUSPECT,Unknown,800,MG,9,Unknown
3915,7653,IS_SECONDARY_SUSPECT,Unknown,10,MG,13,Unknown
3915,7230,IS_SECONDARY_SUSPECT,Unknown,40,MG,15,Unknown
3915,7505,IS_SECONDARY_SUSPECT,Unknown,75,MG,17,Unknown
3918,7365,IS_SECONDARY_SUSPECT,Pulmonary embolism,10,MG,2,Oral
3920,7984,IS_SECONDARY_SUSPECT,Hypersensitivity,300,MG,2,Subcutaneous
3924,9319,IS_SECONDARY_SUSPECT,Unknown,0.125,MG,2,Oral
3926,7438,IS_SECONDARY_SUSPECT,Unknown,0.068,UG/KG,2,Intravenous drip
3928,9451,IS_SECONDARY_SUSPECT,Unknown,300,MG,2,Unknown
3929,7176,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Oral
3930,7545,IS_SECONDARY_SUSPECT,Unknown,300,MG,2,Unknown
3934,7632,IS_SECONDARY_SUSPECT,Growth failure,1.6,MG,2,Unknown
3935,9453,IS_SECONDARY_SUSPECT,Parenteral nutrition,76,G,2,Unknown
3936,7898,IS_SECONDARY_SUSPECT,Unknown,2.25,MG,2,Oral
3938,7176,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Oral
3940,8762,IS_SECONDARY_SUSPECT,Unknown,1,DF,2,Subdermal
3941,7506,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,150,MG,2,Unknown
3942,7438,IS_SECONDARY_SUSPECT,Unknown,0.05,UG/KG,2,Subcutaneous
3944,7545,IS_SECONDARY_SUSPECT,Hyperchlorhydria,150,MG,2,Unknown
3946,7545,IS_SECONDARY_SUSPECT,Gastric pH increased,150,MG,2,Unknown
3950,7545,IS_SECONDARY_SUSPECT,Unknown,150,MG,2,Unknown
3954,7545,IS_SECONDARY_SUSPECT,Unknown,150,MG,2,Unknown
3956,8737,IS_SECONDARY_SUSPECT,Juvenile idiopathic arthritis,125,MG,2,Subcutaneous
3957,9455,IS_SECONDARY_SUSPECT,Unknown,4,MG,2,Oral
3958,7176,IS_SECONDARY_SUSPECT,Unknown,15,MG,2,Oral
3959,7176,IS_SECONDARY_SUSPECT,Unknown,15,MG,2,Oral
3962,9456,IS_SECONDARY_SUSPECT,Attention deficit hyperactivity disorder,2,DF,2,Oral
3965,7176,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Oral
3967,7955,IS_SECONDARY_SUSPECT,Unknown,0.5,MG,2,Oral
3967,9170,IS_SECONDARY_SUSPECT,Unknown,1000,MG,3,Oral
3979,7861,IS_SECONDARY_SUSPECT,Sarcoma,200,MG,2,Intravenous drip
3980,9031,IS_SECONDARY_SUSPECT,Pulmonary arterial hypertension,2.5,MG,2,Unknown
3981,7662,IS_SECONDARY_SUSPECT,Glioblastoma multiforme,105,MG,2,Unknown
3982,8775,IS_SECONDARY_SUSPECT,Unknown,1400,UG,2,Oral
3993,7898,IS_SECONDARY_SUSPECT,Unknown,3.25,MG,2,Oral
3994,7898,IS_SECONDARY_SUSPECT,Unknown,5.25,MG,2,Oral
3996,7438,IS_SECONDARY_SUSPECT,Unknown,0.111,UG/KG,2,Intravenous drip
3997,7685,IS_SECONDARY_SUSPECT,Unknown,6,MG,2,Unknown
3998,7438,IS_SECONDARY_SUSPECT,Unknown,0.069,UG/KG,2,Subcutaneous
3999,9031,IS_SECONDARY_SUSPECT,Pulmonary arterial hypertension,2.5,MG,2,Oral
4002,8400,IS_SECONDARY_SUSPECT,Pulmonary arterial hypertension,10,MG,2,Oral
4004,7176,IS_SECONDARY_SUSPECT,Unknown,15,MG,2,Oral
4005,9031,IS_SECONDARY_SUSPECT,Pulmonary arterial hypertension,2.5,MG,2,Oral
4006,7173,IS_SECONDARY_SUSPECT,Unknown,1750,MG,8,Intravenous (not otherwise specified)
4012,8671,IS_SECONDARY_SUSPECT,Pulmonary arterial hypertension,10,MG,2,Oral
4013,8775,IS_SECONDARY_SUSPECT,Pulmonary arterial hypertension,800,UG,2,Oral
4015,8622,IS_SECONDARY_SUSPECT,Unknown,40,ML,2,Subcutaneous
4019,7283,IS_SECONDARY_SUSPECT,Unknown,1,MG,2,Oral
4025,7435,IS_SECONDARY_SUSPECT,Renal cell carcinoma,480,MG,3,Intravenous (not otherwise specified)
4025,8375,IS_SECONDARY_SUSPECT,Renal cell carcinoma,1,MG/KG,4,Intravenous (not otherwise specified)
4026,7176,IS_SECONDARY_SUSPECT,Off label use,15,MG,2,Oral
4027,8775,IS_SECONDARY_SUSPECT,Pulmonary hypertension,600,UG,2,Oral
4029,9480,IS_SECONDARY_SUSPECT,Unknown,0.1,UG/KG,2,Intravenous drip
4030,7685,IS_SECONDARY_SUSPECT,Unknown,6,MG,2,Unknown
4032,8578,IS_SECONDARY_SUSPECT,Psoriasis,150,MG,2,Subcutaneous
4038,8173,IS_SECONDARY_SUSPECT,Psoriatic arthropathy,300,MG,2,Subcutaneous
4039,7176,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Oral
4044,7438,IS_SECONDARY_SUSPECT,Unknown,0.073,UG/KG,2,Subcutaneous
4045,7545,IS_SECONDARY_SUSPECT,Unknown,300,MG,2,Unknown
4046,7537,IS_SECONDARY_SUSPECT,Endometrial cancer,1235,MG,2,Intravenous (not otherwise specified)
4047,9031,IS_SECONDARY_SUSPECT,Pulmonary arterial hypertension,1,MG,2,Oral
4049,8204,IS_SECONDARY_SUSPECT,Breast cancer,500,MG,4,Intravenous (not otherwise specified)
4051,8222,IS_SECONDARY_SUSPECT,Immune system disorder,1000,IU,2,Intravenous (not otherwise specified)
4053,7176,IS_SECONDARY_SUSPECT,Unknown,15,MG,2,Oral
4057,7176,IS_SECONDARY_SUSPECT,Unknown,5,MG,2,Oral
4058,7685,IS_SECONDARY_SUSPECT,Unknown,6,MG,2,Unknown
4059,7325,IS_SECONDARY_SUSPECT,Unknown,40,MG,4,Oral
4059,7546,IS_SECONDARY_SUSPECT,Unknown,20,MG,10,Oral
4059,7366,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,20,MG,11,Oral
4059,7371,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,20,MG,12,Unknown
4059,7203,IS_SECONDARY_SUSPECT,Unknown,40,MG,16,Unknown
4059,7230,IS_SECONDARY_SUSPECT,Unknown,40,MG,21,Oral
4059,7552,IS_SECONDARY_SUSPECT,Unknown,20,MG,24,Oral
4059,7553,IS_SECONDARY_SUSPECT,Gastrooesophageal reflux disease,60,MG,25,Unknown
4060,7438,IS_SECONDARY_SUSPECT,Unknown,0.012,UG/KG,2,Intravenous drip
4062,8762,IS_SECONDARY_SUSPECT,Contraception,1,DF,2,Subdermal
4064,7862,IS_SECONDARY_SUSPECT,Unknown,300,MG,2,Subcutaneous
4065,7438,IS_SECONDARY_SUSPECT,Unknown,0.052,UG/KG,2,Intravenous drip
4068,7176,IS_SECONDARY_SUSPECT,Unknown,15,MG,2,Oral
4069,9031,IS_SECONDARY_SUSPECT,Pulmonary arterial hypertension,2.5,MG,2,Oral
4070,9031,IS_SECONDARY_SUSPECT,Pulmonary arterial hypertension,2.5,MG,2,Oral
4071,7335,IS_SECONDARY_SUSPECT,Unknown,5,MG,2,Oral
4072,7335,IS_SECONDARY_SUSPECT,Unknown,5,MG,2,Oral
4075,7176,IS_SECONDARY_SUSPECT,Unknown,15,MG,2,Oral
4076,8225,IS_SECONDARY_SUSPECT,Uterine leiomyoma,300,MG,3,Oral
4078,9406,IS_SECONDARY_SUSPECT,Cholangiocarcinoma,810,MG,2,Intravenous (not otherwise specified)
4078,9030,IS_SECONDARY_SUSPECT,Cholangiocarcinoma,111.112,MG,3,Intravenous (not otherwise specified)
4078,7613,IS_SECONDARY_SUSPECT,Cholangiocarcinoma,240,MG,4,Intravenous (not otherwise specified)
4079,7176,IS_SECONDARY_SUSPECT,Unknown,25,MG,2,Oral
4080,7176,IS_SECONDARY_SUSPECT,Unknown,5,MG,2,Oral
4081,7176,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Oral
4082,9488,IS_SECONDARY_SUSPECT,Pancreatic carcinoma,300,MG/KG,2,Intravenous (not otherwise specified)
4083,7536,IS_SECONDARY_SUSPECT,Unknown,1680,MG,2,Intravenous (not otherwise specified)
4083,7940,IS_SECONDARY_SUSPECT,Diffuse large B-cell lymphoma,375,MG/M**2,5,Intravenous (not otherwise specified)
4083,8185,IS_SECONDARY_SUSPECT,Diffuse large B-cell lymphoma,750,MG/M**2,9,Intravenous (not otherwise specified)
4083,7978,IS_SECONDARY_SUSPECT,Diffuse large B-cell lymphoma,75,MG/M**2,12,Intravenous (not otherwise specified)
4084,7685,IS_SECONDARY_SUSPECT,Unknown,6,UG,2,Unknown
4086,7995,IS_SECONDARY_SUSPECT,B-cell lymphoma,1000,MG,2,Intravenous (not otherwise specified)
4089,7176,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Oral
4092,7176,IS_SECONDARY_SUSPECT,Unknown,5,MG,3,Oral
4094,9490,IS_SECONDARY_SUSPECT,Unknown,1,DF,2,Unknown
4098,7176,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Oral
4100,7176,IS_SECONDARY_SUSPECT,Unknown,25,MG,2,Oral
4108,8838,IS_SECONDARY_SUSPECT,Unknown,200,MG,2,Unknown
4110,9406,IS_SECONDARY_SUSPECT,Neuroendocrine carcinoma,400,MG/M**2,2,Intravenous (not otherwise specified)
4110,9030,IS_SECONDARY_SUSPECT,Neuroendocrine carcinoma,50,MG/M**2,3,Intravenous (not otherwise specified)
4112,7334,IS_SECONDARY_SUSPECT,Off label use,70,G,2,Intravenous (not otherwise specified)
4113,7176,IS_SECONDARY_SUSPECT,Off label use,20,MG,2,Oral
4114,7176,IS_SECONDARY_SUSPECT,Unknown,20,MG,2,Oral
4120,8775,IS_SECONDARY_SUSPECT,Unknown,1200,UG,2,Oral
4121,8014,IS_SECONDARY_SUSPECT,Unknown,280,MG,2,Oral
4122,8766,IS_SECONDARY_SUSPECT,Unknown,0.92,MG,2,Oral
4124,7176,IS_SECONDARY_SUSPECT,Plasma cell myeloma,25,MG,2,Oral
4126,7278,IS_SECONDARY_SUSPECT,Unknown,40,MG,2,Subcutaneous
4128,7685,IS_SECONDARY_SUSPECT,Unknown,6,MG,2,Unknown
4131,7163,IS_SECONDARY_SUSPECT,Acute lymphocytic leukaemia,4,MG,4,Oral
4132,7438,IS_SECONDARY_SUSPECT,Unknown,0.046,UG/KG,2,Subcutaneous
4133,8762,IS_SECONDARY_SUSPECT,Unknown,1,DF,2,Subdermal
4134,7283,IS_SECONDARY_SUSPECT,Unknown,1,MG,2,Oral
4136,8775,IS_SECONDARY_SUSPECT,Pulmonary arterial hypertension,1200,UG,2,Oral
4137,7392,IS_SECONDARY_SUSPECT,Unknown,2,MG,2,Unknown
4139,9004,IS_SECONDARY_SUSPECT,Lung transplant,0.5,MG,2,Unknown
4139,7321,IS_SECONDARY_SUSPECT,Lung transplant,1000,MG,3,Unknown
4140,9495,IS_SECONDARY_SUSPECT,Lung cancer metastatic,600,MG,2,Intravenous (not otherwise specified)
4141,7662,IS_SECONDARY_SUSPECT,Renal cell carcinoma,138,MG,2,Unknown
4142,7537,IS_SECONDARY_SUSPECT,Ovarian cancer,10,MG/KG,2,Intravenous (not otherwise specified)
4143,9496,IS_SECONDARY_SUSPECT,Bipolar disorder,675,MG,3,Intramuscular
4148,7176,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Oral
4151,8225,IS_SECONDARY_SUSPECT,Endometriosis,200,MG,2,Oral
4156,8561,IS_SECONDARY_SUSPECT,HIV infection,50,MG,2,Transplacental
4159,9173,IS_SECONDARY_SUSPECT,Type 2 diabetes mellitus,2,MG,2,Subcutaneous
4161,7993,IS_SECONDARY_SUSPECT,Acute myeloid leukaemia,100,MG,2,Oral
4162,9501,IS_SECONDARY_SUSPECT,3,EPINEPHRINE BITARTRATE\LIDOCAINE HYDROCHLORIDE,Dental,2,000 epinephrine
4163,9019,IS_SECONDARY_SUSPECT,Diabetes mellitus,3,MG,2,Oral
4164,7237,IS_SECONDARY_SUSPECT,Chronic lymphocytic leukaemia,591,MG,2,Intravenous (not otherwise specified)
4164,7993,IS_SECONDARY_SUSPECT,Chronic lymphocytic leukaemia,20,MG,3,Oral
4165,7632,IS_SECONDARY_SUSPECT,Bone density abnormal,3,MG,2,Unknown
4168,8766,IS_SECONDARY_SUSPECT,Unknown,0.92,MG,2,Oral
4169,7283,IS_SECONDARY_SUSPECT,Unknown,4,MG,2,Oral
4172,8099,IS_SECONDARY_SUSPECT,Unknown,20,MG,2,Oral
4172,7536,IS_SECONDARY_SUSPECT,Colorectal cancer,1200,MG,3,Intravenous (not otherwise specified)
4173,7613,IS_SECONDARY_SUSPECT,Unknown,480,MG,2,Unknown
4174,7254,IS_SECONDARY_SUSPECT,Short-bowel syndrome,2.5,MG,2,Unknown
4175,8188,IS_SECONDARY_SUSPECT,Prostate cancer,160,MG,2,Oral
4176,7354,IS_SECONDARY_SUSPECT,Philadelphia positive acute lymphocytic leukaemia,125,MG,2,Oral
4176,7171,IS_SECONDARY_SUSPECT,Philadelphia positive acute lymphocytic leukaemia,35,MG,4,Oral
4176,7353,IS_SECONDARY_SUSPECT,Philadelphia positive acute lymphocytic leukaemia,85,MG,5,Oral
4176,7781,IS_SECONDARY_SUSPECT,Philadelphia positive acute lymphocytic leukaemia,2,MG,6,Intravenous (not otherwise specified)
4177,7176,IS_SECONDARY_SUSPECT,Unknown,5,MG,2,Oral
4179,8762,IS_SECONDARY_SUSPECT,Contraception,1,DF,2,Subdermal
4180,7176,IS_SECONDARY_SUSPECT,Unknown,15,MG,2,Oral
4182,8775,IS_SECONDARY_SUSPECT,Unknown,1200,UG,2,Oral
4183,8478,IS_SECONDARY_SUSPECT,Unknown,20,MG,2,Oral
4183,7435,IS_SECONDARY_SUSPECT,Renal cell carcinoma,240,MG,3,Intravenous (not otherwise specified)
4184,8223,IS_SECONDARY_SUSPECT,Nephroblastoma,2,MG,2,Oral
4186,7176,IS_SECONDARY_SUSPECT,Unknown,15,MG,2,Oral
4191,9061,IS_SECONDARY_SUSPECT,Unknown,50,MG,2,Subcutaneous
4192,7356,IS_SECONDARY_SUSPECT,Urinary incontinence,8,MG,2,Oral
4193,7178,IS_SECONDARY_SUSPECT,Spinal osteoarthritis,150,MG,2,Oral
4195,7178,IS_SECONDARY_SUSPECT,Multiple sclerosis,75,MG,2,Oral
4196,7687,IS_SECONDARY_SUSPECT,Gigantism,15,MG,2,Subcutaneous
4197,7178,IS_SECONDARY_SUSPECT,Unknown,300,MG,2,Oral
4198,8506,IS_SECONDARY_SUSPECT,Unknown,0.33,MG/KG,2,Intravenous (not otherwise specified)
4200,7338,IS_SECONDARY_SUSPECT,Osteoarthritis,5,MG,2,Oral
4201,9095,IS_SECONDARY_SUSPECT,Unknown,4,MG,2,Oral
4202,7178,IS_SECONDARY_SUSPECT,Neuropathy peripheral,200,MG,2,Oral
4203,7280,IS_SECONDARY_SUSPECT,Unknown,125,MG,2,Oral
4204,7191,IS_SECONDARY_SUSPECT,Cataplexy,3.25,G,2,Oral
4205,7178,IS_SECONDARY_SUSPECT,Neuropathy peripheral,150,MG,2,Unknown
4206,7178,IS_SECONDARY_SUSPECT,Osteoarthritis,600,MG,2,Oral
4207,7280,IS_SECONDARY_SUSPECT,Unknown,125,MG,3,Oral
4208,7178,IS_SECONDARY_SUSPECT,Unknown,500,MG,2,Oral
4210,7315,IS_SECONDARY_SUSPECT,Pain,200,MG,2,Oral
4212,7305,IS_SECONDARY_SUSPECT,Peripheral nervous system function test abnormal,1,MG,2,Oral
4213,9527,IS_SECONDARY_SUSPECT,Unknown,250,MG,2,Oral
4214,7178,IS_SECONDARY_SUSPECT,Limb discomfort,75,MG,2,Oral
4215,7178,IS_SECONDARY_SUSPECT,Fibromyalgia,100,MG,2,Oral
4216,7178,IS_SECONDARY_SUSPECT,Unknown,600,MG,2,Oral
4217,7361,IS_SECONDARY_SUSPECT,Unknown,22,MG,2,Oral
4218,7178,IS_SECONDARY_SUSPECT,Diabetic neuropathy,200,MG,2,Unknown
4219,7178,IS_SECONDARY_SUSPECT,Burning sensation,150,MG,2,Unknown
4220,7160,IS_SECONDARY_SUSPECT,Unknown,7.5,MG,2,Oral
4221,7537,IS_SECONDARY_SUSPECT,Hepatocellular carcinoma,15,MG/KG,2,Intravenous (not otherwise specified)
4221,9533,IS_SECONDARY_SUSPECT,Pain,2,MG,3,Oral
4222,7178,IS_SECONDARY_SUSPECT,Radiculopathy,300,MG,2,Oral
4223,7206,IS_SECONDARY_SUSPECT,Unknown,100,MG,2,Oral
4224,7178,IS_SECONDARY_SUSPECT,Osteoarthritis,600,MG,2,Oral
4226,7280,IS_SECONDARY_SUSPECT,Breast cancer female,125,MG,2,Unknown
4227,7361,IS_SECONDARY_SUSPECT,Unknown,11,MG,2,Oral
4228,7280,IS_SECONDARY_SUSPECT,Unknown,100,MG,2,Oral
4228,7486,IS_SECONDARY_SUSPECT,Breast cancer metastatic,2.5,MG,3,Oral
4229,7280,IS_SECONDARY_SUSPECT,Unknown,125,MG,2,Oral
4230,7361,IS_SECONDARY_SUSPECT,Unknown,11,MG,2,Oral
4232,7178,IS_SECONDARY_SUSPECT,Post herpetic neuralgia,100,MG,2,Oral
4233,7525,IS_SECONDARY_SUSPECT,Relapsing multiple sclerosis,4,MG,2,Intravenous drip
4234,7452,IS_SECONDARY_SUSPECT,Unknown,8.4,G,2,Oral
4237,7416,IS_SECONDARY_SUSPECT,Unknown,100,MG,2,Oral
4238,7361,IS_SECONDARY_SUSPECT,Pain,11,MG,2,Oral
4239,7478,IS_SECONDARY_SUSPECT,Unknown,50,MG,2,Unknown
4240,7496,IS_SECONDARY_SUSPECT,Unknown,600,MG,2,Intravenous (not otherwise specified)
4241,7338,IS_SECONDARY_SUSPECT,Unknown,5,MG,2,Oral
4242,7178,IS_SECONDARY_SUSPECT,Neuropathy peripheral,100,MG,2,Oral
4244,7178,IS_SECONDARY_SUSPECT,Pain in extremity,150,MG,2,Oral
4246,7178,IS_SECONDARY_SUSPECT,Neuropathy peripheral,150,MG,2,Oral
4247,7874,IS_SECONDARY_SUSPECT,Factor VIII deficiency,3000,IU,2,Intravenous (not otherwise specified)
4248,7361,IS_SECONDARY_SUSPECT,Unknown,11,MG,2,Oral
4249,7178,IS_SECONDARY_SUSPECT,Unknown,3,DF,2,Unknown
4251,7191,IS_SECONDARY_SUSPECT,Cataplexy,4.5,G,2,Oral
4252,7632,IS_SECONDARY_SUSPECT,Unknown,0.8,MG,3,Subcutaneous
4253,7178,IS_SECONDARY_SUSPECT,Pain,300,MG,2,Oral
4255,7178,IS_SECONDARY_SUSPECT,Neuropathy peripheral,300,MG,2,Oral
4256,7178,IS_SECONDARY_SUSPECT,Sciatica,100,MG,2,Oral
4257,7178,IS_SECONDARY_SUSPECT,Neuropathy peripheral,600,MG,2,Oral
4259,7178,IS_SECONDARY_SUSPECT,Polyneuropathy,150,MG,2,Oral
4260,7178,IS_SECONDARY_SUSPECT,Neuropathy peripheral,200,MG,2,Oral
4260,7505,IS_SECONDARY_SUSPECT,Back pain,150,MG,7,Oral
4261,7437,IS_SECONDARY_SUSPECT,Unknown,30,MG,2,Oral
4262,7681,IS_SECONDARY_SUSPECT,Unknown,14,MG,2,Oral
4263,7536,IS_SECONDARY_SUSPECT,Pancreatic carcinoma metastatic,840,MG,2,Intravenous drip
4263,7473,IS_SECONDARY_SUSPECT,Pancreatic carcinoma metastatic,1000,MG/M**2,3,Intravenous (not otherwise specified)
4263,8067,IS_SECONDARY_SUSPECT,Pancreatic carcinoma metastatic,125,MG/M**2,4,Intravenous (not otherwise specified)
4264,7940,IS_SECONDARY_SUSPECT,Diffuse large B-cell lymphoma,743,MG,3,Intravenous (not otherwise specified)
4264,7244,IS_SECONDARY_SUSPECT,Diffuse large B-cell lymphoma,99,MG,4,Intravenous (not otherwise specified)
4264,7237,IS_SECONDARY_SUSPECT,Diffuse large B-cell lymphoma,1486,MG,5,Intravenous (not otherwise specified)
4264,7171,IS_SECONDARY_SUSPECT,Diffuse large B-cell lymphoma,100,MG,6,Intravenous (not otherwise specified)
4266,7178,IS_SECONDARY_SUSPECT,Neuralgia,50,MG,2,Oral
4267,7178,IS_SECONDARY_SUSPECT,Unknown,700,MG,2,Oral
4268,7249,IS_SECONDARY_SUSPECT,Unknown,240,MG,2,Other
4269,7178,IS_SECONDARY_SUSPECT,Fibromyalgia,300,MG,2,Oral
4271,7536,IS_SECONDARY_SUSPECT,Pancreatic carcinoma metastatic,840,MG,2,Intravenous (not otherwise specified)
4271,8067,IS_SECONDARY_SUSPECT,Pancreatic carcinoma metastatic,125,MG/M**2,3,Intravenous (not otherwise specified)
4271,7473,IS_SECONDARY_SUSPECT,Pancreatic carcinoma metastatic,1000,MG/M**2,4,Intravenous (not otherwise specified)
4273,7452,IS_SECONDARY_SUSPECT,Unknown,8.4,G,2,Oral
4275,7384,IS_SECONDARY_SUSPECT,Unknown,0.5,MG,2,Oral
4276,7178,IS_SECONDARY_SUSPECT,Systemic lupus erythematosus,225,MG,2,Oral
4277,7178,IS_SECONDARY_SUSPECT,Pain in extremity,150,MG,2,Oral
4278,7178,IS_SECONDARY_SUSPECT,Neuralgia,75,MG,2,Oral
4280,7245,IS_SECONDARY_SUSPECT,Diffuse large B-cell lymphoma,2,MG,2,Intravenous (not otherwise specified)
4280,7244,IS_SECONDARY_SUSPECT,Diffuse large B-cell lymphoma,100.6,MG,4,Intravenous (not otherwise specified)
4280,7237,IS_SECONDARY_SUSPECT,Diffuse large B-cell lymphoma,1508,MG,5,Intravenous (not otherwise specified)
4280,7171,IS_SECONDARY_SUSPECT,Diffuse large B-cell lymphoma,100,MG,6,Oral
4281,7244,IS_SECONDARY_SUSPECT,Diffuse large B-cell lymphoma,76,MG,4,Intravenous (not otherwise specified)
4281,7237,IS_SECONDARY_SUSPECT,Diffuse large B-cell lymphoma,1140,MG,5,Intravenous (not otherwise specified)
4281,7171,IS_SECONDARY_SUSPECT,Diffuse large B-cell lymphoma,100,MG,6,Oral
4282,7874,IS_SECONDARY_SUSPECT,Factor VIII deficiency,5600,IU,2,Intravenous drip
4283,7178,IS_SECONDARY_SUSPECT,Polyneuropathy,150,MG,2,Oral
4284,7490,IS_SECONDARY_SUSPECT,Menopausal symptoms,1,DF,2,Oral
4285,7940,IS_SECONDARY_SUSPECT,Diffuse large B-cell lymphoma,574,MG,3,Intravenous (not otherwise specified)
4285,7244,IS_SECONDARY_SUSPECT,Diffuse large B-cell lymphoma,77,MG,4,Intravenous (not otherwise specified)
4285,7237,IS_SECONDARY_SUSPECT,Diffuse large B-cell lymphoma,1150,MG,5,Intravenous (not otherwise specified)
4285,7171,IS_SECONDARY_SUSPECT,Diffuse large B-cell lymphoma,100,MG,6,Intravenous (not otherwise specified)
4286,7235,IS_SECONDARY_SUSPECT,Vulval operation,0.5,G,2,Vaginal
4287,7178,IS_SECONDARY_SUSPECT,Fibromyalgia,50,MG,2,Oral
4288,7178,IS_SECONDARY_SUSPECT,Unknown,75,MG,2,Oral
4289,7496,IS_SECONDARY_SUSPECT,Unknown,600,MG,2,Intravenous (not otherwise specified)
4290,7178,IS_SECONDARY_SUSPECT,Sciatic nerve neuropathy,50,MG,2,Unknown
4291,7860,IS_SECONDARY_SUSPECT,Unknown,8,MG,2,Oral
4291,7861,IS_SECONDARY_SUSPECT,Hepatocellular carcinoma,200,MG,3,Intravenous drip
4292,7237,IS_SECONDARY_SUSPECT,Chemotherapy,52,MG,3,Unknown
4293,7178,IS_SECONDARY_SUSPECT,Narcolepsy,150,MG,2,Oral
4294,8091,IS_SECONDARY_SUSPECT,Unknown,40,MG,3,Unknown
4295,7178,IS_SECONDARY_SUSPECT,Arthritis,150,MG,2,Oral
4296,7280,IS_SECONDARY_SUSPECT,Unknown,100,MG,2,Unknown
4297,7178,IS_SECONDARY_SUSPECT,Pain,200,MG,2,Unknown
4298,7416,IS_SECONDARY_SUSPECT,Unknown,200,MG,2,Oral
4298,7502,IS_SECONDARY_SUSPECT,Ovarian cancer recurrent,60,MG,4,Oral
4298,7536,IS_SECONDARY_SUSPECT,Ovarian cancer recurrent,840,MG,7,Intravenous (not otherwise specified)
4299,7490,IS_SECONDARY_SUSPECT,Back pain,1,DF,2,Oral
4300,7178,IS_SECONDARY_SUSPECT,Diabetic neuropathy,300,MG,2,Oral
4301,7178,IS_SECONDARY_SUSPECT,Pruritus,100,MG,2,Oral
4302,7338,IS_SECONDARY_SUSPECT,Dermatitis atopic,5,MG,2,Oral
4303,7178,IS_SECONDARY_SUSPECT,Unknown,150,MG,2,Oral
4304,7940,IS_SECONDARY_SUSPECT,Diffuse large B-cell lymphoma,626,MG,3,Intravenous (not otherwise specified)
4304,7244,IS_SECONDARY_SUSPECT,Diffuse large B-cell lymphoma,83.5,MG,4,Intravenous (not otherwise specified)
4304,7237,IS_SECONDARY_SUSPECT,Diffuse large B-cell lymphoma,1253,MG,5,Intravenous (not otherwise specified)
4304,7171,IS_SECONDARY_SUSPECT,Diffuse large B-cell lymphoma,100,MG,6,Oral
4305,7414,IS_SECONDARY_SUSPECT,Dyslipidaemia,80,MG,2,Unknown
4306,7361,IS_SECONDARY_SUSPECT,Unknown,11,MG,2,Oral
4307,7416,IS_SECONDARY_SUSPECT,Unknown,300,MG,2,Unknown
4308,7961,IS_SECONDARY_SUSPECT,Hypoparathyroidism,100,UG,2,Other
4309,7982,IS_SECONDARY_SUSPECT,Hypogammaglobulinaemia,30,G,2,Subcutaneous
4310,7979,IS_SECONDARY_SUSPECT,Unknown,50,G,2,Subcutaneous
4311,9168,IS_SECONDARY_SUSPECT,Unknown,1,DF,2,Intravenous (not otherwise specified)
4312,7383,IS_SECONDARY_SUSPECT,Hairy cell leukaemia,300,MG,2,Oral
4312,7384,IS_SECONDARY_SUSPECT,Neoplasm malignant,2,MG,3,Oral
4313,8151,IS_SECONDARY_SUSPECT,Focal dyscognitive seizures,1500,MG,2,Unknown
4314,7790,IS_SECONDARY_SUSPECT,Congenital hypogammaglobulinaemia,10,G,2,Subcutaneous
4315,7715,IS_SECONDARY_SUSPECT,Lung disorder,50,MG,2,Oral
4316,7979,IS_SECONDARY_SUSPECT,Unknown,45,G,2,Subcutaneous
4317,7982,IS_SECONDARY_SUSPECT,Polyneuropathy,40,G,2,Intravenous (not otherwise specified)
4318,9031,IS_SECONDARY_SUSPECT,Unknown,0.5,MG,5,Unknown
4319,7790,IS_SECONDARY_SUSPECT,Unknown,8,G,2,Subcutaneous
4322,8014,IS_SECONDARY_SUSPECT,Unknown,140,MG,2,Oral
4323,7982,IS_SECONDARY_SUSPECT,Immunodeficiency common variable,35,G,2,Intravenous (not otherwise specified)
4324,7982,IS_SECONDARY_SUSPECT,Immunodeficiency common variable,30,G,2,Intravenous (not otherwise specified)
4325,7979,IS_SECONDARY_SUSPECT,Unknown,42.5,G,2,Subcutaneous
4326,7361,IS_SECONDARY_SUSPECT,Unknown,11,MG,2,Oral
4327,7982,IS_SECONDARY_SUSPECT,Unknown,500,MG/KG,2,Subcutaneous
4328,7378,IS_SECONDARY_SUSPECT,Unknown,100,MG,2,Unknown
4328,9600,IS_SECONDARY_SUSPECT,Non-small cell lung cancer,200,MG,3,Intravenous (not otherwise specified)
4328,9601,IS_SECONDARY_SUSPECT,Non-small cell lung cancer,372,MG,5,Intravenous (not otherwise specified)
4329,7790,IS_SECONDARY_SUSPECT,Unknown,8,G,2,Subcutaneous
4330,7982,IS_SECONDARY_SUSPECT,Unknown,50,G,2,Intravenous (not otherwise specified)
4331,7178,IS_SECONDARY_SUSPECT,Neuralgia,200,MG,2,Oral
4332,8058,IS_SECONDARY_SUSPECT,Alpha-1 antitrypsin deficiency,4476,MG,2,Intravenous (not otherwise specified)
4333,7982,IS_SECONDARY_SUSPECT,Unknown,25,G,2,Intravenous (not otherwise specified)
4334,7982,IS_SECONDARY_SUSPECT,Unknown,5,G,2,Subcutaneous
4336,8468,IS_SECONDARY_SUSPECT,Lung adenocarcinoma,90,MG,2,Oral
4337,7416,IS_SECONDARY_SUSPECT,Unknown,200,MG,2,Unknown
4338,7983,IS_SECONDARY_SUSPECT,Renal transplant,4,ML,2,Subcutaneous
4339,7178,IS_SECONDARY_SUSPECT,Post herpetic neuralgia,50,MG,2,Unknown
4340,7982,IS_SECONDARY_SUSPECT,Unknown,21,G,2,Subcutaneous
4341,7536,IS_SECONDARY_SUSPECT,Hepatocellular carcinoma,1200,MG,2,Intravenous (not otherwise specified)
4343,8098,IS_SECONDARY_SUSPECT,Uterine prolapse,2,MG,2,Unknown
4344,7790,IS_SECONDARY_SUSPECT,Unknown,8,G,2,Subcutaneous
4345,7996,IS_SECONDARY_SUSPECT,Unknown,60,G,2,Intravenous (not otherwise specified)
4346,7790,IS_SECONDARY_SUSPECT,Immunodeficiency common variable,6,G,2,Subcutaneous
4347,7982,IS_SECONDARY_SUSPECT,Unknown,33,G,2,Intravenous (not otherwise specified)
4348,7982,IS_SECONDARY_SUSPECT,Immunodeficiency common variable,30,G,2,Intravenous (not otherwise specified)
4350,7979,IS_SECONDARY_SUSPECT,Unknown,50,G,2,Subcutaneous
4352,7982,IS_SECONDARY_SUSPECT,Unknown,40,G,2,Intravenous (not otherwise specified)
4353,7982,IS_SECONDARY_SUSPECT,Myasthenia gravis,45,G,2,Intravenous (not otherwise specified)
4354,7982,IS_SECONDARY_SUSPECT,Hypogammaglobulinaemia,35,G,2,Intravenous (not otherwise specified)
4355,7442,IS_SECONDARY_SUSPECT,Oropharyngeal cancer,658,MG,1,Intravenous (not otherwise specified)
4355,9603,IS_SECONDARY_SUSPECT,Oropharyngeal cancer,10,MG,2,Subcutaneous
4355,7300,IS_SECONDARY_SUSPECT,Pain,2,MG,4,Oral
4356,7979,IS_SECONDARY_SUSPECT,Unknown,22.5,G,2,Subcutaneous
4357,7790,IS_SECONDARY_SUSPECT,Unknown,8,G,2,Subcutaneous
4358,7790,IS_SECONDARY_SUSPECT,Unknown,18,G,2,Subcutaneous
4359,7979,IS_SECONDARY_SUSPECT,Primary immunodeficiency syndrome,60,G,2,Subcutaneous
4360,7632,IS_SECONDARY_SUSPECT,Unknown,3.2,MG,2,Subcutaneous
4361,7982,IS_SECONDARY_SUSPECT,Unknown,2000,MG/KG,2,Intravenous (not otherwise specified)
4362,8093,IS_SECONDARY_SUSPECT,Unknown,10,MG,4,Unknown
4363,7288,IS_SECONDARY_SUSPECT,Unknown,2.5,MG,2,Unknown
4364,7982,IS_SECONDARY_SUSPECT,Unknown,10,G,2,Subcutaneous
4365,7982,IS_SECONDARY_SUSPECT,Unknown,60,G,2,Intravenous (not otherwise specified)
4366,7790,IS_SECONDARY_SUSPECT,Sjogren's syndrome,10,G,2,Subcutaneous
4367,7176,IS_SECONDARY_SUSPECT,Unknown,10,MG,2,Oral
4368,8577,IS_SECONDARY_SUSPECT,Unknown,150,MG,2,Oral
4369,7904,IS_SECONDARY_SUSPECT,Unknown,40,MG,2,Subcutaneous
4371,7790,IS_SECONDARY_SUSPECT,Unknown,35,G,2,Subcutaneous
4372,8040,IS_SECONDARY_SUSPECT,Multiple sclerosis,30,UG,2,Unknown
4373,7982,IS_SECONDARY_SUSPECT,Unknown,80,G,2,Intravenous (not otherwise specified)
4374,7979,IS_SECONDARY_SUSPECT,Unknown,30,G,2,Subcutaneous
4375,7416,IS_SECONDARY_SUSPECT,Unknown,200,MG,2,Oral
4376,8176,IS_SECONDARY_SUSPECT,B-cell lymphoma,140,MG,2,Intravenous (not otherwise specified)
4377,9031,IS_SECONDARY_SUSPECT,Unknown,2,MG,10,Unknown
4379,7979,IS_SECONDARY_SUSPECT,Unknown,30,G,3,Subcutaneous
4380,8014,IS_SECONDARY_SUSPECT,Unknown,280,MG,2,Oral
4383,7982,IS_SECONDARY_SUSPECT,Unknown,20,G,2,Subcutaneous
4384,7850,IS_SECONDARY_SUSPECT,Adenocarcinoma metastatic,90,MG,2,Unknown
4385,7961,IS_SECONDARY_SUSPECT,Hypoparathyroidism,50,UG,2,Subcutaneous
4386,7790,IS_SECONDARY_SUSPECT,Combined immunodeficiency,20,G,2,Subcutaneous
4388,7790,IS_SECONDARY_SUSPECT,Unknown,16,G,2,Subcutaneous
4389,8735,IS_SECONDARY_SUSPECT,Ovarian cancer,100,MG,2,Oral
4390,7982,IS_SECONDARY_SUSPECT,Unknown,30,G,2,Intravenous (not otherwise specified)
4391,8340,IS_SECONDARY_SUSPECT,Unknown,150,MG,2,Oral
4392,7978,IS_SECONDARY_SUSPECT,Colon cancer,85,MG/M**2,2,Intravenous (not otherwise specified)
4392,8294,IS_SECONDARY_SUSPECT,Colon cancer,400,MG/M**2,4,Intravenous (not otherwise specified)
4392,8702,IS_SECONDARY_SUSPECT,Colon cancer,400,MG/M**2,6,Intravenous (not otherwise specified)
4394,7790,IS_SECONDARY_SUSPECT,Primary immunodeficiency syndrome,16,G,2,Subcutaneous
4396,7662,IS_SECONDARY_SUSPECT,Cervix carcinoma,1,MG/KG,4,Unknown
4397,7790,IS_SECONDARY_SUSPECT,Unknown,20,G,2,Subcutaneous
4399,7254,IS_SECONDARY_SUSPECT,Diarrhoea,0.261,ML,5,Subcutaneous
4400,7790,IS_SECONDARY_SUSPECT,Unknown,6,G,2,Subcutaneous
4401,7982,IS_SECONDARY_SUSPECT,Unknown,42,G,2,Intravenous (not otherwise specified)
4403,7416,IS_SECONDARY_SUSPECT,Unknown,200,MG,2,Unknown
4404,7982,IS_SECONDARY_SUSPECT,Osteoporosis,20,G,2,Intravenous (not otherwise specified)
4405,7982,IS_SECONDARY_SUSPECT,Unknown,35,G,2,Intravenous (not otherwise specified)
4406,7979,IS_SECONDARY_SUSPECT,Unknown,20,G,2,Subcutaneous
4407,8735,IS_SECONDARY_SUSPECT,Unknown,200,MG,2,Oral
4408,7688,IS_SECONDARY_SUSPECT,Unknown,160,MG,2,Oral
4409,7979,IS_SECONDARY_SUSPECT,Unknown,47.5,G,2,Subcutaneous
4410,8419,IS_SECONDARY_SUSPECT,Unknown,2580,MG,2,Intravenous (not otherwise specified)
4411,7861,IS_SECONDARY_SUSPECT,Malignant melanoma,400,MG,2,Intravenous drip
4411,9632,IS_SECONDARY_SUSPECT,Malignant melanoma,25,MG,5,Intravenous drip
4412,7982,IS_SECONDARY_SUSPECT,Psoriatic arthropathy,10,G,2,Intravenous (not otherwise specified)
4413,7982,IS_SECONDARY_SUSPECT,Unknown,43,G,2,Intravenous (not otherwise specified)
4414,7280,IS_SECONDARY_SUSPECT,Bone cancer metastatic,125,MG,2,Unknown
4415,8735,IS_SECONDARY_SUSPECT,Unknown,200,MG,2,Unknown
4416,7443,IS_SECONDARY_SUSPECT,Non-Hodgkin's lymphoma,204,MG,1,Intravenous (not otherwise specified)
4416,7940,IS_SECONDARY_SUSPECT,Non-Hodgkin's lymphoma,800,MG,3,Intravenous (not otherwise specified)
4416,7333,IS_SECONDARY_SUSPECT,B-cell lymphoma,8.2,G,5,Intravenous (not otherwise specified)
4418,8419,IS_SECONDARY_SUSPECT,Unknown,1800,MG,2,Intravenous (not otherwise specified)
4419,7982,IS_SECONDARY_SUSPECT,Unknown,70,G,2,Intravenous (not otherwise specified)
4420,7940,IS_SECONDARY_SUSPECT,B-cell lymphoma,800,MG,3,Intramuscular
4420,7443,IS_SECONDARY_SUSPECT,B-cell lymphoma,204,MG,4,Intravenous (not otherwise specified)
4420,7469,IS_SECONDARY_SUSPECT,B-cell lymphoma,8,MG/KG,5,Intravenous (not otherwise specified)
4420,7333,IS_SECONDARY_SUSPECT,B-cell lymphoma,8.2,G,6,Intravenous (not otherwise specified)
4421,7632,IS_SECONDARY_SUSPECT,Secondary adrenocortical insufficiency,0.4,MG,2,Subcutaneous
4422,7718,IS_SECONDARY_SUSPECT,Unknown,2,ML,2,Subcutaneous
4422,7882,IS_SECONDARY_SUSPECT,Hereditary angioedema,30,MG,9,Subcutaneous
4424,7790,IS_SECONDARY_SUSPECT,Unknown,30,G,2,Subcutaneous
4426,8350,IS_SECONDARY_SUSPECT,Unknown,75,MG/M**2,2,Subcutaneous
4426,7993,IS_SECONDARY_SUSPECT,Myelodysplastic syndrome,400,MG,3,Oral
4427,7861,IS_SECONDARY_SUSPECT,Colorectal cancer,200,MG,3,Intravenous drip
4428,7790,IS_SECONDARY_SUSPECT,Primary immunodeficiency syndrome,2,G,2,Unknown
4430,7982,IS_SECONDARY_SUSPECT,Unknown,40,G,2,Intravenous (not otherwise specified)
4431,8531,IS_SECONDARY_SUSPECT,Unknown,4,MG,2,Oral
4431,7861,IS_SECONDARY_SUSPECT,Renal cell carcinoma,200,MG,3,Intravenous (not otherwise specified)
4432,7982,IS_SECONDARY_SUSPECT,Unknown,40,G,2,Intravenous (not otherwise specified)
4433,7861,IS_SECONDARY_SUSPECT,Squamous cell carcinoma of head and neck,200,MG,2,Intravenous drip
4434,8321,IS_SECONDARY_SUSPECT,Prophylaxis,5000,IU,2,Subcutaneous
4435,7383,IS_SECONDARY_SUSPECT,Unknown,150,MG,2,Oral
4435,8569,IS_SECONDARY_SUSPECT,Anaplastic thyroid cancer,2,MG,38,Oral
4436,7383,IS_SECONDARY_SUSPECT,Unknown,25,MG,2,Oral
4436,7759,IS_SECONDARY_SUSPECT,Astrocytoma,0.375,MG,9,Oral
4437,8254,IS_SECONDARY_SUSPECT,Immune enhancement therapy,1,MG,2,Subcutaneous
4437,7448,IS_SECONDARY_SUSPECT,Unknown,100,MG,3,Intravenous (not otherwise specified)
4437,9650,IS_SECONDARY_SUSPECT,Unknown,0.5,ML,4,Intramuscular
4437,9651,IS_SECONDARY_SUSPECT,Unknown,0.5,ML,5,Intramuscular
4437,9652,IS_SECONDARY_SUSPECT,Unknown,1,ML,6,Intramuscular
4438,7790,IS_SECONDARY_SUSPECT,Immunodeficiency common variable,12,G,2,Subcutaneous
4440,8204,IS_SECONDARY_SUSPECT,Unknown,1000,MG,2,Unknown
4440,7538,IS_SECONDARY_SUSPECT,Endometrial cancer,175,MG/M**2,5,Intravenous (not otherwise specified)
4441,7416,IS_SECONDARY_SUSPECT,Unknown,200,MG,2,Unknown
4441,8204,IS_SECONDARY_SUSPECT,Ovarian cancer,500,MG,3,Unknown
4441,7538,IS_SECONDARY_SUSPECT,Ovarian cancer,270,MG,7,Intravenous (not otherwise specified)
4442,9654,IS_SECONDARY_SUSPECT,Malignant melanoma,400,MG,2,Oral
4443,7176,IS_SECONDARY_SUSPECT,Unknown,15,MG,2,Oral
4445,8014,IS_SECONDARY_SUSPECT,Unknown,140,MG,2,Oral
4446,7861,IS_SECONDARY_SUSPECT,Bile duct cancer,200,MG,3,Intravenous (not otherwise specified)
4447,8775,IS_SECONDARY_SUSPECT,Unknown,400,UG,2,Oral
4447,8671,IS_SECONDARY_SUSPECT,Pulmonary arterial hypertension,10,MG,4,Oral
